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The present research consists of a number of studies which sought to examine the 
psychological processes associated with negative adjustment outcomes for adults 
with inflammatory bowel disease (IBD) and considered the potential benefits of a 
novel psychological intervention for improving outcomes in this population. 
The first study in this thesis (Chapter 2) systematically examined the evidence 
between psychological factors and adjustment outcomes in adults with IBD. 
Emotion focused coping strategies, perceived stress, IBD related cognitions (such 
as illness perceptions), emotions and emotional control (such as hostility, 
aggression and  alexithymia), interpersonal traits (such as anxious attachment 
style) and personality traits (such as neuroticism and perfectionism), were linked 
to negative adjustment outcomes for adults with IBD after controlling for the 
influence of sociodemographic and disease related factors. 
The second qualitative study (Chapter 4) found that adults with IBD described 
concerns pertaining to underperformance at work and preventing an accident in 
public as linked to their symptoms of anxiety. Low mood was reported to be 
associated with a perceived lack of understanding of IBD from others and stigma. 
Distinct cognitive and behavioural responses were described by participants in 
each of these domains. Participants in this study stated a desire for psychological 
support delivered by a professional with specialised knowledge of IBD to evaluate 




The third quantitative study (chapter 5) found that unhelpful cognitive, emotional 
and behavioural responses (assessed at baseline), after adjusting for 
sociodemographic and disease related factors, were associated with negative 
adjustment outcomes at baseline (cross sectional) and 3 month follow up.  
 
The final clinical, pilot study found that transdiagnostic cognitive behaviour 
therapy (TD-CBT) had clinical benefits for adults with IBD who were distressed. 
Uncontrolled effect sizes were superior to those of a previous RCT.  
 
This series of studies consistently identified unhelpful cognitive, emotional and 
behavioural responses that are associated with and predictive of negative 
adjustment outcomes for adults with IBD. Further, TD-CBT was found to be of 
benefit. These findings provide insight into how psychological interventions 
should be designed and delivered to be helpful and acceptable for people with 
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Chapter 1:  Thesis overview 
 
This thesis brings together a series of studies examining the psychological 
processes associated with negative adjustment outcomes for adults with 
inflammatory bowel disease (IBD). IBD is a chronic long term condition which 
poses significant psychosocial adjustment challenges. The overall aim of the 
studies included in this thesis was to determine empirically the psychological 
factors associated with anxiety, depression, general psychological distress and 
poor quality of life for adults with IBD, with a view to suggesting evidence based 
targets that could be modified though a psychological intervention. 
 
The first stage of this research systematically reviewed the existing literature 
which addressed psychological factors and their associations with adjustment 
outcomes in adults with IBD. This review introduces the key features of IBD 
including its aetiology, symptom presentation, epidemiology, diagnosis, 
prognosis, and treatment. It then discusses specific features of IBD which can 
make it a particularly difficult disease to live with and briefly considers previous 
research evaluating the efficacy of psychological intervention for improving 
outcomes in this population. Conceptual distinctions between psychological 
factors and adjustment outcomes are outlined. Following a review of the 
empirical evidence, this chapter ends with suggestions for future research which 





The findings of this review identified that although several psychological factors 
were linked to poor adjustment outcomes, this was based on the findings of a 
limited number of studies exploring a diverse range of psychological variables 
with only one study providing any longitudinal data (Jordan et al, 2016). The 
review concluded that future studies should expand the range of cognitive, 
emotional and behavioural factors examined in relation to adjustment outcomes 
to fully capture the experience of living with IBD and employ a prospective design 
to assess the direction of these associations (Jordan et al, 2016). It was suggested 
that the findings of qualitative studies could provide some insight into 
psychological processes worthy of further investigation in quantitative studies. 
Qualitative findings to date have delivered a detailed description of the burden of 
living with IBD from the patients’ perspective but have not offered any insight 
into how these experiences linked to anxiety or low mood (Jordan et al, 2016).   
 
A further important limitation identified in the systematic review pertains to 
previous randomised controlled trials of psychotherapy for improving 
biopsychosocial outcomes for people with IBD. A Cochrane meta-analysis of 
randomised controlled trials (RCTs) concluded that there was no evidence that 
psychological interventions enhanced emotional states, quality of life (QOL) or 
reduced disease activity in the short term or at 12 months in adults with IBD. A 
major problem associated with the studies included in this review was that 19 out 
of 20 studies recruited adult patients without distress at the start. This is likely to 
have significantly reduced any potential treatment effects as participants 




On the basis of the limitations identified within the current evidence base a mixed 
methods research approach was adopted in this thesis to further explore the 
psychological factors associated with negative adjustment outcomes. The logic 
model illustrated in figure 1. 1 below provides an overview of the studies included 
in this thesis. The methodological issues specific to each along with the 
questionnaires and analytical strategies utilised will be described in detail in the 
appropriate chapters. 
  
A qualitative approach with in-depth semi-structured face to face interviews was 
employed to 1) investigate the specific situations, thoughts, perceptions, 
appraisals, beliefs and behaviour that people with IBD described as linked to their 
symptoms of anxiety and low mood 2) explore the type of psychological help or 
support people with IBD and elevated symptoms of anxiety and low mood would 
like as part of routine medical care. A secondary aim was to consider these 
findings in relation to the knowledge associated with the competencies set for 
psychological therapists delivering interventions for long term conditions. 
 
Qualitative methods are particularly well placed to elicit rich descriptions and 
explanations of individual experiences as they do not impose fixed choice answers 
(Klein et al, 2006). Consequently this approach allowed participants to articulate 
any idiosyncratic beliefs and behaviour linked to their experience of disturbance 
to mood (Sofaer, 1999). Qualitative research has been criticised for being 




weakness would be addressed by the strengths of the quantitative methods 
employed in the subsequent studies in this thesis (Dures et al, 2011).  
 
A quantitative approach was therefore adopted to further investigate the 
cognitive, emotional and behavioural responses associated with negative 
adjustment outcomes; anxiety, low mood, general psychological distress and poor 
quality of life. Data on sociodemographic, clinical, and psychological factors and 
adjustment outcomes were collected at baseline and 3 month follow up. A cross 
sectional and prospective analysis was carried out in order to assess the 
relationships between psychological factors assessed at baseline and adjustment 
outcomes measured at baseline and 3 month follow up.  
 
It was hypothesised that unhelpful beliefs about experiencing and expressing 
negative emotions (BeS), unhelpful behavioural responses to gastrointestinal 
symptoms (IBS-BRQ), a lack of acceptance beliefs towards symptoms (CPAQ), 
avoiding exercise due to a fear it will make symptoms worse (CBSQ: FA), believing 
symptoms are damaging (CBSQ: D), focusing on symptoms (CBSQ: SF), excessive 
resting to manage symptoms (CBSQ: AR), all or nothing behaviour (CBSQ: AL) and 
avoidance of activities due to embarrassment about symptoms and worries about 
how others will judge symptoms (CBSQ: EA), would be associated with baseline 
(Time 1) cases of anxiety, depression, psychological distress and poor health 
related quality of life, when taking sociodemographic, and disease related 
variables into account. Further, it was anticipated that these cognitive, 




of being a moderate case of anxiety, depression, general psychological distress 
and poor health related quality of life at three month follow up in the prospective 
analysis (Time 2). 
 
Due to a much larger sample size the results from these quantitative analyses 
were more generalisable to the wider IBD population and potentially confounding 
sociodemographic and clinical variables were taken into account. The results of 
the prospective analysis also provided the most robust evidence to date for the 
direction of the relationship between psychological factors and negative 
adjustment outcomes. Merging insights from these qualitative and quantitative 
studies was intended to facilitate a broad understanding of the topic under study 
(Yardley & Bishop, 2009).  
 
Finally, given the results of previous randomised controlled trials, it was 
important to evaluate whether a psychological intervention could help those with 
IBD and clinically significant distress. A pragmatic quantitative approach was 
chosen and a non-randomised uncontrolled trial design was adopted for 
investigating the benefits of clinic based CBT for this group. Although this meant 
that there were limitations to the conclusion that could be drawn on the basis of 
this study’s findings, it gave a preliminary indication of any potential benefits. 
Further, uncontrolled effect sizes could be calculated and considered in relation 
to those of a previous RCT. It was hypothesised that levels of anxiety and low 
mood would reduce after the clinic based CBT and that the uncontrolled effect 




The final chapter of this thesis brings together the overall findings of this 
collection of studies and considers the evidence for: 
 1) psychological factors and their associations with negative adjustment 
outcomes for adults with IBD; 
2) the benefits of a psychological intervention for improving outcomes in this 
population and  
3) the implications for healthcare and further research. 
 








Chapter 2: A systematic review of the psychological correlates 
of adjustment outcomes in adults with inflammatory bowel 
disease. 
 
This chapter has been published in clinical psychological review (full reference 
below). Presented here is the authors accepted manuscript version of the paper.  
 
 
Statement of contributions: I generated the idea for the scope of this review 
which in conjunction with TC was developed into a study protocol. I planned and 
executed the search strategy, identified & reviewed & selected studies to be 
included, extracted the data and planned and carried out the data synthesis and 
write up of this review. To ensure rigour in this process JS reviewed a randomly 
selected range of excluded studies to check for accuracy and independently 
extracted data. Both TC & NF were involved in developing the analysis strategy 






Reference; Jordan C, Sin J, Fear N.T, Chalder, T, (2016). A systematic review of the 
psychological correlates of adjustment outcomes in adults with inflammatory 






 Emotion focused coping strategies are associated with worse adjustment 
outcomes in IBD. 
 Some evidence for an association between other psychological factors and 
adjustment outcomes.  





Inflammatory bowel disease (IBD) is a chronic long term condition which poses 
significant psychosocial adjustment challenges. The purpose of this review was to 
systematically identify psychological factors related to adjustment in adults with 
IBD with the aim of suggesting evidence based targets that may be modifiable 
though psychological intervention. Twenty five studies met inclusion criteria and 
were included in the systematic review and a narrative synthesis was conducted. 
A wide range of psychological variables were addressed covering six broad 
categories; personality traits, interpersonal traits, stress and coping, emotions 
and emotional control, IBD related cognitions and non IBD related cognitions. The 
most consistent relationship was found between certain emotion focused coping 
strategies and worse adjustment outcomes in IBD. Some evidence also hi-lighted 
a relationship between personality traits (such as neuroticism) perceived stress, 
emotions and emotional control (such as alexithymia) and IBD related cognitions 
(such as illness perceptions) and negative adjustment outcomes. The results of 
this review suggest that interventions to improve adjustment in IBD may benefit 





The two main types of inflammatory bowel disease (IBD) are Crohn’s disease (CD) 
and ulcerative colitis (UC). Both of these conditions affect men and women 
equally, with diagnosis usually occurring between the ages of 10 and 40. The 
incidence and prevalence of IBD is increasing worldwide. The highest reported 
prevalence values for IBD are in Europe (UC, 505 per 100,000 persons; CD, 322 
per 100,000 persons) and North America (UC, 249 per 100,000 persons; CD, 319 
per 100,000 persons) (Molodecky et al, 2012). In Crohn’s disease any part of the 
intestines can become intermittently inflamed, whereas in ulcerative colitis this is 
usually restricted to the colon. This produces a range of unpleasant and disabling 
symptoms including diarrhoea, fatigue, weight loss and pain in the abdomen. The 
course of IBD is idiosyncratic and unpredictable. Its exact aetiology is unknown 
and there is currently no certain cure. The current standard of care in IBD 
treatment is aimed at managing the inflammatory response during flare episodes 
and maintaining remission with an emphasis on adhering to a regular medication 
regime. In severe cases surgery may be required to remove part of or the entire 
large bowel, usually resulting in an ileostomy (Kiebles et al, 2010).  
 
IBD poses numerous challenges for both physical and psychosocial functioning. 
Adults with IBD experience unpleasant and unpredictable symptoms and 
aggressive treatment regimes. In addition they face psychosocial consequences 
including disruptions to their life goals, employment, and social and leisure 
activities (Kemp et al 2012). Psychosocial difficulties are common in IBD when 




populations (Fillpovic et al, 2007). The empirical evidence demonstrates the life 
time prevalence rates of anxiety and depression to be as high as 35.8% (Walker et 
al, 2008). The presence of mood disturbance has also been established as being a 
risk factor for earlier and more active disease (Mittermaier et al, 2004, Graff et al, 
2006).  
 
Psychosocial adjustment in adults with IBD can be influenced by disease and socio 
demographic factors such as remission status, pain severity, relapses per year, 
treatment, extra intestinal manifestations and gender (Petrak et al, 2001, 
Goodhand et al, 2012, Moreno-Jimenez et al, 2007). However, these factors are 
variably associated with adjustment and are often only moderate predictors 
(Mussell et al, 2004, Turnball et al, 1995). Research demonstrates that 
psychological factors are often better predictors of individual differences in 
adjustment and in contrast to clinical or disease factors are potentially adaptable 
through psychological interventions (Kiebles et al, 2010 Mussell et al, 2004, 
Moreno-Jimenez et al, 2007, Dorrian et al, 2009).   
 
A meta-analysis conducted by Timmer and colleagues (2011) concluded that there 
was no evidence that psychological interventions in general enhance emotional 
states, HRQOL and disease activity for adults with IBD. However, there are 
limitations to this review. The authors combined stress management, 
psychodynamic psychotherapy and cognitive behaviour therapy (CBT) studies as 
“psychotherapy” in the meta–analysis, therefore any differential efficacy between 




independently, a more recent review found promising evidence that CBT 
improved mental health in patients with IBD, both immediately following the 
intervention and at 6 months follow up (Knowles et al, 2013).    
 
In addition both reviews have included studies where the majority of participants 
have sub clinical levels of anxiety and depression which is likely to have reduced 
treatment effects. There is also a lack of information given about which 
psychological factors were targeted within interventions and how these factors 
were related to adjustment outcomes. Further work identifying the psychological 
factors that influence adjustment outcomes is warranted in order to identify sub 
groups of patients most likely to benefit from targeted psychological therapy 
(Timmer et al, 2011).  
 
The purpose of this current review is to systematically review existing literature 
which addresses psychological factors that may be associated with, predict or 
explain adjustment outcomes in adults with IBD. The aims are to: a) Identify what 
types of psychological factors have been studied to date; b) Establish which 
psychological variables might serve to explain or predict differences in how well 
people adjust to living with IBD; c) Gain an overview of the strength of evidence 
for relationships between psychological variables and adjustment outcomes in 
IBD; d) Identify common methodological weaknesses in the research, gaps within 
the literature, and directions for future research. 
   




between factors potentially involved in predicting or explaining positive or 
negative adjustment outcomes and the outcomes themselves. Thus, within this 
review the term psychological factors is used to conceptualize potentially 
modifiable factors relating to an individual’s beliefs, attitudes, perceptions, 
thoughts and behaviours that it would be possible to address in a psychological 
intervention. Although personality traits such as neuroticism and interpersonal 
attachment style are not usually considered modifiable targets for psychological 
intervention, the effect of these characteristics on cognitions and behaviour often 
are. These factors are therefore included in this review. The term adjustment 
outcomes pertains to indicators of positive or negative psychosocial adjustment 
such as psychological or emotional wellbeing, social and role functioning, quality 
of life (QOL) and self- reported perceptions of health and well-being. A reliable 
overview of this field will allow clinicians involved in delivering psychological 
interventions to increase their understanding of the factors linked to adjustment 
in IBD, so that these could be targeted in interventions. 
 
Although there have been review papers which have summarised the 
psychosocial issues associated with IBD (e.g. Sajadinejad et al, 2012, Triantafillidis 
et al, 2013, Sainsbury et al, 2006), these have not been systematic, a systematic 









Search strategy and selection criteria 
A search strategy was registered with the International Prospective Register of 
systematic reviews (Prospero: ID CRD42014007435). The systematic review 
protocol and data extraction forms were designed in accordance with the 
preferred reporting items for systematic reviews and meta analyses (Moher et al, 
2009). Electronic databases (Medline, Embase, Web of Science, Cinahl and 
psychinfo) were systematically searched for studies published from inception to 
May 2015, which examined psychological factors relating to adjustment outcomes 
in IBD. Search terms were customised to each database and involved combining 
key word searches for a list of adjustment terms (e.g. 'psychosocial adjustment, 
depression, quality of life), and terms such as 'determin$', 'predict$, correlat$, 
'correlat$, and the term 'Inflammatory bowel disease' 'Crohn's disease' and 
'ulcerative colitis' (Appendix 1).     
 
Inclusion and exclusion criteria 
Studies were included if they met the following criteria: (1) Published empirical 
quantitative research reports that examined relationships between psychological 
factors and adjustment outcomes in people over the age of 18 years with IBD; (2) 
Reported results for IBD participants separately from other conditions.  
 
Studies were excluded if they (1) used qualitative, case report, expert opinion or 
consensus statement; (2) did not use published or appropriate and replicable 




outcomes; (3) did not examine the relationship between psychological factors and 
adjustment outcomes for people with IBD. Uncertainties concerning whether a 




The database searches and study selection were undertaken by two people. The 
titles and abstracts were reviewed by one author (CJ). To enhance rigour 10% of 
all titles discounted at this stage and chosen at random, were independently 
reviewed by a second author (JS), and agreement was reached in all cases. The 
full texts were then screened by CJ and all ineligible papers excluded. Information 
relevant to the research question was systematically extracted and tabulated in 
order to aid comparison and synthesis of the studies. Extracted data comprised 
publication data, country of origin, study design and data analysis methodology, 
sample characteristics, relevant measures, main findings and aspects of 
methodological quality. The extraction process was completed independently by 
two of the authors, CJ and JS, and any disagreements resolved through discussion 
of the study with TC. Where only abstracts were available, or insufficient 
information was reported, authors were contacted via email. Only one paper was 
excluded due to insufficient information being reported and the author remaining 
un-contactable (fig 2. 1).   
 
Data Synthesis  




heterogeneity of the included studies precluded meta-analysis. Therefore, a 
narrative synthesis was conducted guided by the methods described by the 
Centre of Review and Dissemination, 2009. Psychological factors influencing 
adjustment were grouped into conceptually and thematically related constructs 
(e.g. illness perceptions, coping strategies).  
 
 
Elements of study quality were also assessed. A quality scoring methodology was 
devised based on a quality assessment tool which was applicable for both cross 
sectional and longitudinal designs. This had been used in a previously published 
systematic review of psychological correlates of Rheumatoid Arthritis (Matcham et 
al, 2015). The quality score out of 7 was calculated based on the following criteria: 
whether the psychological factor was measured using a validated tool; Yes (score 
1) No (score 0); whether the adjustment outcome were measured using a validated 
tool; Yes (score 1) No (score 0); whether the recruitment strategy was random or 
consecutive; Yes (score 1) No (score 0); whether participants were recruited from 
multiple centres (representing multiple locations not just multiple centres within 
the same city, for example); Yes (score 1) No (score 0); whether eligibility criteria 
were specified; Yes (score 1) No (score 0); whether participation rate was greater 
than 75%; Yes (score 1) No (score 0); whether the study reported it was adequately 
powered; Yes (score 1) No (score 0). Where studies did not report anything for a 
particular eligibility indicator, they were allocated to the no category. Final quality 
scores, together with the information used in their calculation, are shown in table 





2.4: Results of the systematic search and overview of the included studies 
The literature search yielded 658 relevant articles (fig. 2.1). Removal of duplicates, 
title and abstract screening left 39 for full text screening. Fourteen of these did not 
meet our eligibility criteria. The most common reason for exclusion was not 
examining the relationship between psychological factors and adjustment 
outcomes for adults with IBD. Twenty five studies were deemed eligible for 
inclusion in the narrative synthesis. 
Table 2.1 presents the 25 studies included in the review. All but one study was cross 
sectional in design (N=24). Self-report questionnaires were utilised for all the 
psychological factors and adjustment outcomes. Results were typically correlations 
or regression analyses. The majority of sample sizes were between 50 and 150. 
However three had less than 50 (Crane et al 2004, Turnball et al, 1995, Keibles et 
al, 2010) and one more than 1000 (Petrak et al, 2001). Generally samples included 
more women than men. The mean age of participants typically fell between 35 and 
45.  
 
In all studies participants had a diagnosis of IBD which had been assessed by a 
gastroenterologist. Fourteen studies reported mean time since diagnosis for their 
sample. The majority used samples where the patients had been diagnosed on 
average between 5 and 10 years previously (N=12). A few samples had a mean 




























































14 studies excluded 
7 no psychological variable 
measured 
5 no adjustment outcome measured 
1 no analysis between psychological 
variable and adjustment outcome 
I conference abstract  
Reference 





Twelve studies reported mean levels of symptomatic disease activity. The 
majority identified that between 30-40% of their sample was experiencing 
symptomatic disease activity at the time of the study (N=10). A few found less 
than 20% of their sample as having symptomatic disease activity. Only one study 
assessed the level of disease activity objectively through endoscopy and faecal 
calprotectin analysis (Goodhand et al, 2012). All other studies reported 
symptomatic disease activity based on self- report symptom scores. In addition, 
three studies reported the amount of relapses participants had in the past year 
(Moreno-Jiménez et al, 2007, Boye et al, 2008, Inglesias et al, 2012).The most 
frequent setting for patient recruitment was outpatient clinics.   
 
The included studies examined a range of adjustment outcomes. Quality of life 
(QOL) was the most common outcome of interest, however depression, anxiety, 
psychological distress and perceptions of disability were also studied. Only three 
studies reported findings separately for ulcerative colitis and Crohn’s disease 
(Boye et al, 2008, Goodhand et al, 2012, Tabibian et al, 2015). All other studies, 
on finding no significant differences performed their statistical analysis on the 
group as a whole. 
 
Identified psychological variable 
A summary of the psychological variables identified and total sample size 
examining each variable is shown in table 2.2. In total 18 different psychological 
variables were examined, which were categorised into six broad categories. 




emotional processing, IBD related cognitions and non IBD related cognitions. 
The remainder of the results section summarises and synthesises findings 
regarding the relationships between psychological factors (grouped into 
thematically or conceptually-related categories) and adjustment outcomes. 
 
Table 2.1: Studies included in systematic review. 
 
Reference Population 
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A key theme in the adjustment literature is the importance of personality 
factors in mediating the psychosocial impact of chronic physical illness. Over 
the last decade several studies have investigated the influence of personality 
variables such as neuroticism and perfectionism on adjustment outcomes in 
IBD. Each of these constructs is hypothesised to play a role in psychosocial 
wellbeing through its impact on the way an individual reacts to the diagnosis of 
IBD, its symptoms or other stressful events. Neuroticism, for example, is 
characterised by emotional instability and a tendency to interpret situations as 
threatening. Individuals who score high for neuroticism may, therefore, be 
predisposed to making extreme attributions in relation to their IBD and its 
symptoms and experiencing intense emotional reactions as a result (Eysenck et 
al, 1976). Perfectionists tend to strive relentlessly towards unobtainable goals, 
valuing their self-worth in terms of productivity and accomplishments. 
Individuals high in this trait may therefore be more prone to evaluating 
themselves negatively in-light of the disruption caused by IBD to their life goals 
(Flett et al, 2002).  
 
Five studies have investigated the link between three personality traits and 
adjustment outcomes; neuroticism, perfectionism and type D personality (Flett 
et al, 2011, Boye et al, 2008, Moreno-Jiménez et al 2007 Liu et al, 2013, 
Sajadinejad et al, 2012) (Table 2.2). At a cross sectional bivariate level, 
preliminary evidence (1/1) suggests a significant relationship between other 
(r=.50 p< 0.001), and socially prescribed (r=.59 p<0.001) perfectionism and 
reduced psychosocial functioning. Whether this relationship would be 




has a high quality score of 5 as shown in table 2.1.    
 
At a multivariable level after adjusting for socio demographic and clinical 
factors, 100% of results (4/4) show neuroticism (Boye et al, 2008, Moreno-
Jiménez et al 2007 Liu et al, 2013, Sajadinejad et al, 2012) and type D 
personality (1/1) ( β -0.053 p<0.001 Sajadinejad et al, 2012), to be significantly 
associated with a reduced quality of life. Further, neuroticism was specifically 
associated with worse emotional and social functioning, and with reduced 
vitality (Boye et al, 2008, Moreno-Jiménez et al 2007). These studies have 
quality scores of between 3-4 (table 2.1). 
 
The strength of association between neuroticism (p<0.001) and QOL was 
largely consistent and equal to clinical variables (P<0.001) across the five 
studies. Even those studies with small sample sizes found strong associations 
between neuroticism and QOL (e.g. N=58 β .49 P<0.001, Sajadinejad et al, 
2012). The unique variance explained by neuroticism was not given in any of 
these studies. 
 
Interpersonal traits  
Two studies examined the role of attachment style on adjustment outcomes in 
IBD.  Attachment style is a psychological concept that attempts to describe the 
dynamics of interpersonal relationships between humans. It addresses how 
individuals respond within relationships when hurt or perceiving a threat. It is 
conceptualized as secure or insecure, in the form of avoidant or anxious–
ambivalent attachment (Waters et al, 2005). At a multivariate level, after 
controlling for age and recruitment phase, greater anxious attachment (β = 




2014). Attachment avoidance and attachment anxiety also showed significant 
bivariate associations with depression at baseline and follow up in one 
longitudinal study (Maunder et al, 2005).However these studies have a low 
quality score of 2 and 3 respectively. 
 
Stress and coping 
Psychological stress has long been reported anecdotally to increase 
symptomatic disease activity in IBD. Recent empirical advances have provided 
some support for this and proposed that stress may increase gut motility and 
fluid secretion (Mawdsley et al, 2005). According to the stress coping model of 
Lazarus and Folkman (1984), a dominant paradigm in the field of psychosocial 
adjustment to chronic illness, the experience of stress in response to 
difficulties is influenced by the individual’s evaluations and appraisals of the 
stressor and the coping strategies they use to manage it. The following section 
deals first with the appraisal aspect of the model and then the coping aspects. 
 
Perceptions of stress 
As this review is concerned with modifiable psychological factors, we did not 
examine studies that simply investigated the frequency of life events. Included 
studies which investigated stress had to judge the subjective, perceived degree 
of stress reported by the participant.   
 
Four studies examined the role of perceived stress on adjustment outcomes, 
all cross sectional in design (Kiebles et al, 2010, Goodhand et al, 2012, Sewitch 
et al, 2001,Tabibian et al, 2015) (table 2.2). At a multivariate level, 100 % of 




stress and a reduced quality of life, (p=0.01) increased psychological 
distress(r=0.04 P = 0.03), anxiety (β 0.1 P<0.01) and depression (β 0.15 P<0.01). 
Significant covariates across the majority of studies included symptomatic 
disease activity (r= 0.10 P = 0.02) and having a newer diagnosis (r= -0.71 P= 
0.01). A further 50% of results (2/4) found that being female (p = 0.0015) and 
older age (β 0.05 P=0.001) were additional independent correlates of 
depression in CD (Goodhand et al, 2012, Tabibian et al, 2015). Examination of 
study quality (table 2.1) demonstrated that the small number of studies in this 
category were of low-moderate quality with scores between 3-4. 
 
In addition, there was some preliminary evidence that the relationship 
between psychological distress and perceived stress changed depending on the 




Coping strategies refer to the specific efforts, both behavioural and 
psychological, that people employ to master, tolerate, reduce, or minimize 
stressful events (Folkman et al, 1991). Historically coping strategies have been 
measured and categorised in a multitude of ways, however most coping 
theories broadly classify coping attempts as either emotion focused or 
problem focused strategies (e.g. Lazarus et al 1985).  
 
Ten studies considered the relationship between coping strategies and 
adjustment outcomes, all cross sectional in design (Table 2.2). At multivariate 
level after taking sociodemographic and disease variables into consideration, 




relationship between emotion focused coping strategies and reduced quality 
of life, psychological distress, anxiety and depression (Mussell et al, 2004, 
Petrak et al, 2001, Smolen et al, 1993, Seres at al, 2008, Dorian et al, 2009).  
 
There are some differences between studies in the reported amount of 
variance explained by coping strategies. The largest study in this category with 
a sample size of 1322 found that emotion focused coping explained 16% of the 
variance in QOL. In addition, diagnosis showed a significant influence on this 
outcome explaining 9% of the variance (Petrak et al, 2001). The results of the 
majority of studies reported similar findings with emotion focused coping 
explaining a larger proportion of variance in adjustment outcomes than 
disease related or demographic characteristics. In contrast, in a series of 
hierarchical regression models coping did not significantly add to predicting 
adjustment once illness perceptions were controlled for (3% of the variance in 
psychological distress) ( Dorrian et al, 2009). One possible explanation for this 
weaker association may be the choice of a generic list of coping strategies to 
assess coping with IBD. The COPE is designed for use in a variety of situations 
and may omit some important disease-specific coping strategies. A coping list 
tailored to the specific tasks associated with IBD may be more appropriate and 
may produce different results (Dorrian et al, 2009). These studies were all of 
moderate to high quality with scores ranging between 4-5.  
 
No statistically significant relationships between coping, disease type, age of 
onset, gender, symptomatic disease activity, and quality of life were found in 2 





In contrast, the more adaptive emotion focused strategy of optimistic coping 
e.g. thinking positively, related to a better quality of life (β 11.7 P=0.01) in one 
study (Smolen et al, 1993). Further, problem focused coping was linked to a 
reduced quality of life. However, this relationship was solely apparent during 
an active phase of the disease (β 0.02 P<0.00) (Petrak et al, 2001). 
 
Emotion and emotional control 
Psychological variables examining aspects of emotions or emotional processing 
were allocated to this group. These variables include hostile feelings and 
expressed aggression, emotional control, alexithymia and private self- 
consciousness. Eight studies examined the associations between these 
variables and quality of life, all using a cross sectional design. 
 
At a multivariate level, results showed that both alexithymia and private self-
consciousness were significantly associated with negative adjustment 
outcomes. Four studies (4/4), found a significant relationship between 
alexithymia and reduced social, physical and emotional functioning on both 
generic and IBD specific measures of quality of life (Moreno-Jiménez et al, 
2007, Boye et al, 2008, Iglesias-Rey et al, 2012, Verissimo et al, 1998). The 
strength of association between alexithymia and QOL was largely consistent 
across studies with p values ranging from <0.01 to 0.001. In addition Verissimo 
et al, 1998, performed a hierarchical, stepwise multiple regression analysis and 
found that alexithymia scores accounted for an additional 12.4% of the 
variance in predicting quality of life after controlling for socio demographic and 
disease related factors. The majority of results found this trend with 




manifestations, current symptomatic disease activity and number of relapses 
per year being additional independent correlates of negative adjustment 
outcomes. These studies each have a quality score of 4.  
 
Only one study of poor quality considered the relationship between private 
self-consciousness and quality of life .The findings suggested a heightened 
awareness of inner thoughts and feelings was associated with worse QOL, with 
symptomatic disease activity being a further significant covariate (Olbrisch et 
al, 1982).  
 
Mixed evidence was found for the role of expressed aggression and hostile 
feelings in determining adjustment in IBD. Previous research has linked this 
trait to higher levels of subjective illness, poor health habits and interpersonal 
conflicts, which may reduce overall quality of life (Boye et al, 2008). At a 
multivariate level, Boye et al 2008, found expressed aggression and hostility to 
be significantly associated with reduced generic quality of life in Crohn’s 
disease only (β -1.5  p<0.02 Boye et al, 2008 ). This study had a quality rating of 
4.  Another study of poor quality (Lui et al, 2013) found no significant 
relationships between this variable and adjustment outcomes. Symptomatic 
disease activity was a significant covariate of negative adjustment outcomes in 
both studies.  
 
In contrast, one study found having higher active control of emotions to be 
significantly linked to a better quality of life (Verissimo et al, 1998). Emotional 
control scores (ß = 0.261) contributed an additional 5.6% of the variance over 




(ß = –0.094), and alexithymia (ß = –0.277) (R2 = 0.206; F [4, 57] = 3.69, p< 0.01) 
(Verissimo et al, 1998). This study has a quality score of 3. 
 
IBD related cognitions 
Seven studies examined adjustment in relation to IBD cognitions. IBD 
cognitions relate to perceptions or thoughts related to IBD, which may be 
associated with negative adjustment outcomes. The common sense model of 
illness (leventhal et al, 1984) proposes that when faced with a health threat 
individuals construct their own representations or perceptions of their illness 
which then guide their ways of responding, and ultimately their adjustment. 
For example individuals will hold beliefs about responsibility for health 
outcomes. They may believe that either they, others or fate will shape the 
impact of their illness (Mussell et al, 2004). In addition, IBD cognitions can 
relate to concerns about the impact of the disease or being stigmatised or 
alienated due to the nature of IBD symptoms (Kiebles et al, 2010).   
At a multivariate level, feeling stigmatised (1/1) unsupported and 
misunderstood (1/1) and believing that IBD will have serious consequences 
(1/1) were significantly associated with negative adjustment outcomes after 
controlling for illness severity and demographic variables. Current evidence 
suggests that perceived stigma accounts for 10%–22% of the variance in 
health-related quality of life scores, 4%–16% for psychological distress, and 
15% of the variance in anxiety and depression (Taft et al, 2009).This study has a 
quality score of 3. Similar to stigma, perceiving oneself to be misunderstood or 
alienated from one’s social support network when seeking support was 
significantly associated with reduced quality of life (t–2.23 p=<o.o5) (Faust et 




have serious consequences explains a greater proportion of variance in 
psychological distress than demographic or clinical factors (32% as opposed to 
23%) (Dorrian et al, 2007).This study has a quality score of 5, one of the highest 
of any study included in this review.  
 
Conflicting evidence exists for the influence of locus of control on adjustment 
outcomes in IBD at a multivariate level (Boye et al, 2008, Mussell et al 2004). 
Only one study found internal locus of control to be significantly associated 
with a better of quality of life. Whilst a powerful other tendency and chance 
locus of control was linked to a reduced quality of life (Boye et al, 2008). 
Quality scores for these studies ranged between 4-5. 
 
At a bivariate level, symptom tolerance and activity engagement have been 
linked to better adjustment outcomes (kiebles et al, 2010). Whether this 
relationship would be sustained in multivariate analysis is yet to be tested. 
Patient’s knowledge, skill, and confidence in self-health management has also 
shown links to positive adjustment outcomes. However the population was 
comprised entirely of veterans, predominantly older and male, who received 
care in a limited geographical region (Kentucky and Tennessee, USA), thus 
these conclusions may not apply to other clinical IBD populations (Munson et 
al 2009).These studies had quality scores of 3 ( kiebles et al 2010) and 4 
(Munsun et al, 2009). 
 
Non IBD related cognitions 
Two studies examined adjustment in relation to non IBD related cognitions. 




focused on the experience of having IBD such as global self- esteem and 
general hopelessness which may be associated with adjustment outcomes. 
 
At a multivariate level both self- esteem and hopelessness are significantly 
associated with quality of life, albeit in different ways. Self- esteem was most 
strongly associated with positive social functioning on a health related quality 
of life measure (β .35 P=<0.001). Associations were also found between this 
predictor variable and better perceptions of systemic (β 0.20 P=<0.05) and 
emotional functioning (β .28 P=<0.01) (Moreno-Jiménez et al 2007). This study 
has a quality score of 4. In contrast, hopelessness was found to be negatively 
associated with the mental subscale of health related quality of life explaining 
4.9% of the variance found in this outcome (Petrak et al, 2001).This study has a 










Variable  No of studies 
examining 




Personality traits  Neuroticism 5 418 
 Type D 1 58 
 Perfectionism 1 51 
Interpersonal 
traits 
Attachment  2 339 
Stress and coping  Stress  4 578 
 Coping  10 1909 
Emotions and 
emotional control 
Alexithymia 4 787 
 Aggression & hostility 2 189 
 Private self -consciousness 1 143 
 Active restraint of emotions 1 74 
IBD related 
cognitions 
Locus of control 2 181 
 
 
Stigma 1 211 
 Social constraint 1 80 
 Illness perceptions 2 118 
 Acceptance  1 38 
 Adaptive capacities 1 260 
Non IBD related 
cognitions 
Self esteem 1 120 





Summary of main findings  
The aim of this review was to identify studies of psychological variables and 
their associations with adjustment outcomes in adults with IBD. A systematic 
search of the literature identified several psychological correlates of 
adjustment which were grouped into six categories; personality traits, 
interpersonal traits, stress and coping, emotions and emotional control, IBD 
related cognitions and non IBD related cognitions. 
 
The most studied personality trait is neuroticism. Consistently at a multivariate 
level  results show neuroticism to be significantly associated with negative 
adjustment outcomes,   specifically with reduced emotional functioning (Boye 
et al, 2008, Moreno-Jiménez et al 2007 Liu et al, 2013, Sajadinejad et al, 
2012).Neuroticism shows an equal influence on adjustment outcomes as 
clinical variables such as relapses per year and type of treatment. Preliminary 
evidence suggests that Type D personality may have a similar influence on 
outcomes (Liu et al, 2013). Perfectionism is also unhelpful for adjustment, 
however whether this relationship would be maintained when taking socio-
demographic and disease variables into consideration is currently unknown but 
warrants further investigation (Flett et al, 2011). Personality variables are likely 
to be important in understanding the psychological factors that predispose an 
individual to developing unhelpful cognitive and behavioural responses to IBD.  
 
 
Attachment style has also been identified as influencing adjustment to IBD 




reduced quality of life. Understanding insecure attachment in the context of 
relationships with health care staff may be useful in promoting, developing and 
sustaining supportive relationships.  
 
Perceptions of being under stress consistently links to negative adjustment 
outcomes, demonstrating a similar influence to sociodemographic and disease 
related factors  (Kiebles et al, 2010, Goodhand et al, 2012, Sewitch et al, 
2001,Tabibian et al, 2015). Interestingly there is some preliminary evidence 
that social support mitigates the impact stress has on a person’s mental health. 
Understanding obstacles to engaging in social relationships such having an 
insecure attachment style may therefore be important in promoting 
supportive social relationships and ultimately positive adjustment.  
 
Consistently the evidence suggests a significant association between emotion 
focused coping methods and a reduced quality of life and increased 
psychological distress at a multivariate level (Cranes et al, 2003, Kiebles et al, 
2010, Mussell et al, 2004, Petrak et al, 2001, Smolen et al, 1993, Seres at al, 
2008, Dorian et al, 2009, Seres et al 2008, Turnball et al, 1995, Faust et al 
2012).  
 
When considering emotions and emotional control, several studies found an 
association between alexithymia and a reduced quality of life which is 
significant at a multivariate level (Moreno-Jiménez et al, 2007, Boye et al, 
2008, Iglesias-Rey et al, 2012, Verissimo et al, 1998). Alexithymia is defined as 
a difficulty in identifying and describing emotions which can lead to greater 




to be unhelpful for quality of life (Inglesias-Rey et al, 2012). Contradictory 
evidence exists for a link between aggression and hostility and quality of life 
with one finding a relationship (Boye et al, 2008) and one not (Lui et al, 2013). 
Further, at a multivariate level a heightened awareness of inner thoughts and 
feelings was linked to a reduced quality of life in one study (Olbrisch et al, 
1982), whilst scoring higher for emotional control was associated with 
improvements in this outcome in another (Verissimo et al, 1998). Clearly 
further studies are required to elucidate the nature of these relationships. It is 
possible that extreme emotional responses are unhelpful.  
 
Current evidence suggests that several thoughts and perceptions concerning 
IBD link to unhelpful adjustment outcomes. At a multivariate level, feeling 
stigmatised (Taft et al, 2009), socially constrained (Faust et al, 2012), having an 
emotional representation of the illness and believing that it will have serious 
consequences (Dorrian et al, 2007) were all significantly associated with 
psychological distress and a reduced quality of life. In contrast feeling 
optimistic and confident in one’s knowledge and skills to manage health linked 
to an increased quality of life score, albeit in a specific population of veterans 
(Munsun et al, 2009). At a bivariate level acceptance towards the symptoms 
and engagement with valued activities despite them was associated with 
better emotional and social functioning and reduced psychological distress 
(Kiebles et al, 2010). However each of these psychological variables has been 
investigated by only one study. Clearly research in this area is very much in its 






Non IBD related cognitions which appear to be important to adjustment are 
self- esteem which one study linked to better adjustment (Moreno-Jiménez et 
al 2007) and hopelessness which showed associations with poorer outcomes 
(Petrak et al, 2001). 
 
Importantly , the results of our review suggest that even though socio-
demographic and  disease related factors such as lower socioeconomic status, 
gender and symptomatic disease activity play an important role in adjustment, 
psychological variables maintain their significance when controlling for the 
influence of these factors. Overall, psychological variables consistently link to 
worse mental health outcomes whether measured as psychological distress or 
emotional functioning as part of overall quality of life. However, all but one 
study was cross sectional in design without any element of follow up. The lack 
of any longitudinal data means that causal relationships between psychological 
factors and outcomes cannot be established and it is not possible to discern 
which factors are most important for adjustment in IBD. 
 
Psychological model of understanding adjustment in IBD. 
This review sought to systematically review and synthesise the evidence base 
for the psychological correlates of adjustment and consequently we propose a 
psychological model of understanding adjustment to IBD (fig 2.2). This is 
consistent with psychological models of adjustment in other chronic illnesses 
such as multiple sclerosis and rheumatoid arthritis (Dennison et al 2009, 
Matcham et al, 2015). The onset of increased psychological distress and a 
reduction in quality of life and functioning is likely to be associated with a 




This disturbance in mood and quality of life might then be maintained over 
time by disease activity but also by cognitive and behavioural factors. Feeling 
misunderstood or judged because of the symptoms, might lead to a person 
feeling low in mood and employing emotion focused coping strategies such as 
behaviourally disengaging from social activities. The resulting isolation might 
then maintain or exacerbate the low mood. As depression has been identified 
as a risk factor for increased disease activity, this might create a vicious circle 
whereby disease activity leads to a set of thoughts and behaviours which 
trigger more disease activity and vice versa. Disease activity and psychosocial 
functioning are therefore likely to be interrelated and bidirectional. In contrast, 
acceptance and tolerance of symptoms and engaging in meaningful activities, 
feeling confident in skills and abilities to manage health and employing 
optimistic coping strategies may help a person to manage or appraise their 
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Strengths and limitations 
A strength of this review is that it was conducted using a rigorous and 
replicable methodology with abstract screening and data extraction being 
carried out by independent researchers in order to minimise bias. However, 
this review has some limitations. Only studies published in peer reviewed 
journals were considered. The choice of research questions to address in this 
review meant that a broad range of studies were included. This resulted in a 
vast variation both between and within psychological categories which 
precluded meta-analysis, it was, therefore, not possible to formally assess the 
extent of publication bias in a sensitivity analysis or funnel plot.    
 
The quality of studies included varied but was generally low. All but one study 
was cross sectional in design. Therefore, there are limited conclusions which 
can be drawn as to the nature and direction of the relationship between 
psychological variables and adjustment outcomes.     
 
A wide range of validated measures were used in the studies. Disease related 
factors (such as current symptoms, relapses in the past year) examined in this 
review were self-reported in all but one study. It is likely that objective 
measurements of disease activity through endoscopy and faecal calprotectin 
analysis give a more robust indication of disease activity as distress may act as 
a confounder and could potentially lead to inflated reporting of this 
phenomenon. 
 
Most studies used appropriate statistical methods for analysing data and 




Sample size calculations were absent from all but one of the studies included in 
this review and most studies had small sample sizes. Small samples could 
render studies underpowered to detect relationships or mean that positive 
findings might not generalise to larger or different populations. The majority of 
studies described demographic sample characteristics such as age, gender and 
time since diagnosis, although many did not specify details such as 
socioeconomic status or ethnicity making it difficult in some instances to assess 
the representativeness of these samples. 
 
All of the studies reported a recruitment strategy. Five studies used 
consecutive sampling, whilst the rest employed a convenience sample mostly 
from outpatient clinics although a few additionally recruited through patient 
organisations. An advantage of this type of sampling is that is less open to 
selection bias because the participants are likely to be less selected than in 
randomised controlled trials. In addition, all but three studies stated their 
inclusion/exclusion criteria (Table 2.1). On review, selection bias was 
potentially present in two studies whose sample or part of, was recruited 
primarily to participate in stress reduction intervention studies.  
 
A further consideration is the limited number of studies in this area and 
narrow range of psychological variables that have been examined. The findings 
of a recent Meta synthesis of qualitative studies identified fear of embarrassing 
symptoms occurring in public and avoidance and isolation which results from 
this as a major theme in the experience of living with IBD (Kemp et al, 2012). 
Currently no studies have utilised measures that might capture this or have 




relating to psychological factors and adjustment are, therefore, limited by a 
small quantity of studies focused on a limited range of psychological variables, 
not all of which are congruent with the experience of people with IBD as 
identified in the qualitative literature.     
 
Clinical implications of key findings 
The findings of this review may have clinical implications. For example, 
although increased psychological distress and reduced quality of life are 
commonly reported in IBD patients and has been linked to worse outcomes, it 
is not consistently measured as an outcome in clinical practice. It may be 
preferable to include measures of psychosocial adjustment as a routine 
outcome variable because of its relevance to patients, link to increased disease 
activity and potential for treatment. Mood and quality of life can be assessed 
when patients first present to health services and then monitored throughout 
the course of treatment. Early identification and management could prevent 
disturbances in mood and quality of life from negatively influencing outcomes 
for people with IBD. 
 
The results of this review suggest that adjustment is correlated with several 
psychological factors that could be amenable to change. The application of 
cognitive behavioural approaches could help identify any unhelpful 
interactions between symptoms and cognitive and behavioural responses. By 
using strategies such as testing out thoughts and appraisals about symptoms, a 
patient might be encouraged to share their experience with a close friend to 
test the accuracy of their perception that no one will understand. This could 




to decrease disease activity. Preliminary evidence from a recent randomised 
controlled trial suggests that CBT can be useful in improving the quality of life 
of participants with IBD and poor mental health at 6 months (Mikocka et al, 
2015). 
 
Acceptance and tolerance of symptoms and engaging in meaningful activities 
has been linked to positive adjustment in IBD. The development of this type of 
psychological flexibility could be encouraged through the application of 
acceptance and commitment therapy (ACT), which has recently emerged as a 
third wave within the field of CBT. ACT emphasizes observing thoughts and 
feelings as they are, without trying to change them, and behaving in ways 
consistent with valued goals and life directions. This approach has shown some 
promising results in improving outcomes for people with chronic pain but is yet 
to be examined in the context of IBD (Davis et al, 2015).  
.  
A benefit of CBT approaches is that they can be delivered in a variety of ways. 
Staff at IBD clinics could be trained to deliver low intensity interventions such 
as working through CBT based self-help manuals with patients. For more 
severe problems in adjustment high intensity 1:1 CBT may be indicated. 
Pharmacological treatment of emotional symptoms may also be beneficial in 
improving outcomes in IBD. 
 
Recommendations for future research 
Based on the quality assessment of studies included in this review, we can 
make some suggestions for future studies of psychological correlates of 




Studies should have a prospective design so that causal associations and 
mediators can be examined. The sample size should be large enough for a well 
powered statistical analysis and to account for attrition during the course of 
the study. In order to reduce selection bias and increase generalisability 
participants should be recruited consecutively from primary or secondary care 
and from multiple centres. 
 
A model of understanding adjustment in IBD should be based on previous 
theory and evidence taking into account the findings of qualitative studies 
focused on living with IBD.   
New research should expand the range of social, cognitive and behavioural 
factors examined in relation to adjustment over time and the choice of 
measures should be guided by this model. In addition, disease activity should 
be measured objectively through endoscopy and faecal calprotectin analysis 
and subjectively via self -report measures. The associations between these bio-




This review has shown that adjustment to IBD is associated with a number of 
psychological and disease related factors. These relationships have been 
illustrated in the form of a psychological model of understanding adjustment 
to IBD. Longitudinal studies are needed in order to understand the nature of 
adjustment in IBD and any causal relationships with psychosocial factors. The 
range of psychological factors examined in studies should be expanded to 




IBD as identified in qualitative studies. Individuals with IBD are likely to benefit 




2.7: Relevant research published since completion of this review  
Review update 
Prior to submission of this thesis, the original search carried out for this review 
was repeated with the same databases. A limiter was applied to the search to 
only return studies published from May 2015-july 2018. 59 studies were 
initially identified, on screening the titles, 53 were excluded leaving 6 studies of 
potential interest. Inspection of the abstracts led to a further 4 being excluded, 
leaving 2 that were relevant to the reviews research aims and met the original 
inclusion criteria (Please table 2.3).  
 
Both studies were cross sectional in design and examined the association 
between illness perceptions and negative adjustment outcomes. Bivariate and 
multivariate analysis identified that illness perceptions were associated with 
anxiety, depression and poor quality of life. An emotional response to illness 
(e.g. feeling angry or scared about the illness) and illness identify (experiencing 
many symptoms) were found to be the most important illness perceptions in 
this context. One study also found emotion focused coping strategies 
correlated with negative adjustment outcomes. Both studies were low in 
quality. Overall these new studies support the reviews conclusions and the 
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Chapter 3: Theoretical approaches to understanding 
adjustment to IBD 
 
The systematic review of this thesis proposed a psychological model for 
understanding adjustment in IBD which was based on cognitive behavioural 
principles. Cognitive behavioural models of psychopathology are useful 
because they can pinpoint specific psychological processes linked to negative 
adjustment outcomes which can be targeted for intervention using well-
established strategies. This chapter will provide an in-depth consideration of 
the classical CBT model and the more recently developed third wave CBT 
approach acceptance and commitment therapy for understanding 
psychopathology. These frameworks are employed throughout this thesis to 
investigate the psychological factors associated with negative adjustment 
outcomes; anxiety, depression, distress and poor quality of life for people with 
IBD. 
 
The classical CBT model 
A major principle underpinning the classical CBT model of psychopathology is 
that the way an individual interprets and processes information in relation to 
internal or external stimuli determines their emotional and behavioural 
response to it (Knapp et al, 2008). Symptoms of emotional distress are 
proposed to occur when an individual encounters an event which triggers a 
maladaptive belief or dysfunctional assumption. Once activated these extreme 
beliefs are thought to disrupt an individual’s ability to objectively appraise 
events and the process of reasoning is compromised. Systematic cognitive 




beliefs are activated. This disruption to the process of thinking and consequent 
disturbance to mood promotes unhelpful or self-defeating behaviour. In turn 
this behaviour is thought to reinforce and perpetuate unhelpful cognitive and 
emotional processes (Beck et al, 2005).  
A crucial hypothesis of the classical cognitive behavioural model is the notion 
that specific maladaptive beliefs create a vulnerability for the development of 
a particular emotional disorder (Beck, 2005). Depression has been found to be 
associated with cognitive themes of loss and failure. This type of negatively 
biased interpretation has been found universally across all types of depression 
(Haaga et al, 1991).  It is proposed to lead to sadness, hopelessness and social 
withdrawal which serves to perpetuate or exacerbate low mood. For example, 
an individual may receive some minor criticism about a work task which 
activates the belief that they are a failure. This then leads to ruminating over 
past failures and predictions of future ones which impacts on mood and 
motivation, hence plans to meet a friend are cancelled leading to further 
thoughts of being a failure and further rumination, low mood, withdrawal and 
so on.  
 
In contrast “danger orientated beliefs” are hypothesised to provoke anxiety, 
promote selective attention to the perceived threat and catastrophic 
interpretations of it. This then leads to safety behaviours intended to minimise 
or prevent the threat. This type of behaviour is considered by the CBT model to 
perpetuate anxiety as it is perceived as preventative by the individual and 
prevents disconfirmation of the initial threat orientated beliefs (Salkovskis, et 
al, 1999). For example, a person with panic disorder is likely to believe that 




leads to close monitoring of symptoms and safety behaviours such as resting in 
response to an increase in heart rate. The non- occurrence of the feared 
cardiac event is then attributed to the precautions taken rather than 
recognising that the physical sensations associated with anxiety are not in fact 
life threatening. Danger-oriented biases and safety behaviours have been 
found in every phase of information processing (perception, interpretation, 
and recall) across all anxiety disorders (Clark et al, 1999). 
 
The self-perpetuating cycle of cognitive, emotional and behavioural responses 
is central to CBT conceptualisations of psychopathology. Originally constructed 
to explain the psychological processes underlying depression, the CBT model 
has been applied across a range of mental health problems to investigate the 
psychological factors which precipitate and perpetuate symptoms (Deary et al, 
2007).  More recently this model of perpetuation has been utilised in several 
long term physical health conditions to explore if unhelpful cognitive, 
behavioural and emotional responses to disease symptoms influence the 
process of adjustment resulting in disturbances to mood and functioning. 
Feeling embarrassed, preoccupied and catastrophic about symptoms whilst 
engaging in all or nothing behaviour, avoidance and excessive resting have all 
shown associations with negative adjustment outcomes in a range of long term 
conditions including multiple sclerosis (Dennison et al, 2010) and cancer 
(Suleman et al, 2018). In this thesis the classical cognitive behavioural model 
will be utilised to investigate the specific situations, cognitions, emotions and 
behaviour linked to symptoms of anxiety, low mood, psychological distress and 
poor quality of life for people with IBD and any potentially unhelpful 




evaluation of a non-randomised uncontrolled trial of a clinic based CBT 
intervention for improving adjustment outcomes for people with IBD and 
moderate to severe levels of anxiety and depression. 
 
The acceptance and commitment therapy (ACT) model. 
This recently developed third wave CBT approach proposes that psychological 
inflexibility is central to the experience of emotional distress. This 
psychological rigidity is proposed to emerge from six interrelated and 
interacting cognitive and behavioural processes. Experiential avoidance refers 
to attempts by an individual to alter or avoid unwanted thoughts, emotions or 
bodily sensations. These avoidance based strategies are frequently ineffective 
and can serve to increase distress in the long term and prevent the individual 
from engaging in activity they most value. For example an individual may avoid 
an important work opportunity due to feeling anxious about failing at it. 
Although the anxiety is potentially reduced in the short term, it will reoccur 
when faced with a similar situation and the valued opportunity is missed. The 
model suggests that difficult cognitive, emotional or sensory experiences are 
not necessarily problematic in and of themselves. Instead, it suggests that it is 
attempts to avoid these experiences and disengagement from meaningful life 
activities in the service of this avoidance that creates suffering (Hayes et al, 
2006).  
 
Cognitive fusion supports experiential avoidance, it occurs when an individual’s 
thoughts direct their behaviour, rather than choosing behaviour that is 
motivated by valued goals.  In this instance the person will avoid the work 




they are not capable of it, rather than recognising the tendency to have such 
thoughts when faced with a challenging situation. This type of fusion can also 
be identified in conceptualisations of the self, a further core concept 
postulated to underpin psychological inflexibility in the ACT model. Here the 
individual over identifies with and acts on a particular negative description of 
themselves (Hayes et al, 2013). In addition the ACT model hypothesises that 
dwelling on past or future experiences rather than focusing on the here and 
now exacerbates emotional difficulties. This attentional pattern is known to 
exacerbate problems such as trauma (Holman & Silver, 1998), rumination 
(Davis et al 2000), and pain (Schutze et al., 2010). In combination these 
psychological processes disrupt the pursuit of meaningful action towards 
valued goals, instead the individual’s behaviour is driven by the desire to avoid 
distress resulting in self-defeating patterns of behaviour (Hayes et al, 2013).  
 
The ACT model of psychological intervention targets the process of thinking 
rather than the content as would be the case with classical CBT treatment 
protocols. It aims to reduce the behavioural and functional influence of 
thinking by fostering a general process called psychological flexibility. This is  
defined as being open, aware and in contact with the present moment, and 
flexibly engaging in behaviours which facilitate overarching life goals (Hayes et 
al, 2013) ACT sees many forms of distress as a natural consequence of being 
human.  ACT does not explicitly aim to reduce distress but instead aims to 
increase the individual’s ability to undertake meaningful activity in its presence 





Psychological inflexibility and experiential avoidance have been linked to 
negative adjustment outcomes in a range of physical health problems including 
cancer (Hulbert-Wiliams et al, 2016) and chronic pain (McCraken et al, 1998).  
Whilst symptom tolerance and activity engagement has been found to 
correlate with positive adjustment outcomes in one study of people with IBD 
(kiebles et al, 2010). To elucidate further the influence of these factors on 
adjustment outcomes for people with IBD, several measures have been 
selected for inclusion in the cross sectional and prospective study of this thesis 
to capture aspects of the ACT model.  Specifically the acceptance scale adapted 
from the chronic pain acceptance questionnaire (CPAQ) (McCraken et al, 2004) 
was used to measure acceptance beliefs towards symptoms and the beliefs 
about emotions scale (BES) (Rimes et al, 2010) to assess unhelpful beliefs 
about experiencing and expressing negative emotions. These findings will give 
a preliminary indication of the utility of aspects of the ACT model of 
psychological intervention for understanding and improving adjustment 
outcomes for people with IBD.  
 
Multiple models have been proposed in the wider psychological literature to 
explain the variation found in adjustment outcomes for people with long term 
conditions. These include for example; the stress and coping model (Lazarus & 
Folkman et al, 1984) which emphasises the role of coping strategies used by 
individuals to deal with the challenges and tasks imposed by the disease and 
the self-regulatory common sense model of illness representations (Levanthal 
et al, 1984) which highlights the role of attitudes and beliefs about the course 





More recent approaches have attempted to draw together the unique 
elements of each these models into an overarching conceptualisation of 
adjustment to chronic illness. In a recent systematic review of the empirical 
evidence several key processes merged across theories as important for 
facilitating adjustment which included staying as active as the disease 
reasonably allows, recognising and expressing negative emotions, engaging in 
effective self-management and benefit finding in the face of the long term 
condition. Factors which hinder adjustment were not defined (De Ridder et al, 
2008). Increasingly the empirical literature calls for a unified approach to 
investigating the process of adjustment to chronic disease. To bridge the gaps 
between current models, several reviews have suggested that illness specific 
stressors and challenges should be determined empirically and linked to 
specific cognitive, behavioural and emotional responses (Moss-Morris et al, 
2013). CBT models are well suited to conceptualising these factors and the 
relationships between them. Depending on the nature of the psychological 
processes identified as problematic for adjustment in IBD, CBT or ACT based 
psychological interventions can then be developed to target unhelpful 





Chapter 4: A qualitative study exploring the experience of 
people with IBD and elevated symptoms of anxiety and low 





This chapter has been published in psychology & health (full reference below). 




Statement of contributions: I generated the idea for the aims of this study 
which in conjunction with TC was developed into a study protocol. I planned 
and executed the interviews, carried out the data analysis, synthesis and write 
up of the paper. To ensure rigour in this process RO reviewed the analyses, 
themes, sub themes and final template.  Both TC & BH were involved in 
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Background. People with Inflammatory bowel disease (IBD) are at increased 
risk of developing anxiety and low mood. We sought to explore the experience 
of people with IBD and moderate- severe symptoms of anxiety/low mood to 
identify psychological processes which could be targeted in psychological 
interventions, as well as the kind of psychological support preferred.  
Methods: Twenty five participants with IBD and moderate- severe symptoms 
of anxiety/low mood were recruited for interview. Template analysis was 
utilised to analyse interview data. We explored the situations, cognitions and 
behaviour linked to symptoms of anxiety and low mood by people with IBD, as 
well as the kind of psychological help preferred.   
Results: Two themes were identified within participants accounts of symptoms 
of anxiety; “under performance “and “preventing an accident”. Two further 
themes were identified for symptoms of low mood; “lack of understanding” 
and “stigma”. Expertise and understanding was the main theme identified for 
the type of psychological help desired.  
Conclusion: The analysis highlights situations, cognitions and behaviour linked 
to anxiety and low mood by people with IBD and the type of psychological 
support desired. Our findings link to the knowledge and competencies set for 
psychological therapist working with long- term conditions.  
 
Key words: Inflammatory bowel disease, anxiety, depression, cognitive 






Inflammatory bowel disease (IBD) including Crohn’s disease and ulcerative 
colitis, is a long term disease with no known cause or exact cure. 
Iintermittently the intestines become swollen and inflamed leading to periods 
of debilitating symptoms which include diarrhoea, fatigue and pain in the 
abdomen. The fluctuating episodic nature of IBD has been reported to disrupt 
employment, social and leisure activities, relationships and psychological well- 
being (Restall et al, 2016, Kemp et al, 2012). The empirical evidence suggests 
the life time prevalence rates of anxiety and depression for people with IBD is 
as high as 35.8% (Walker et al, 2008). The presence of disturbance to mood has 
also been identified as an independent risk factor for more frequent disease 
activity and is associated with a reduced quality of life (Mittermaier et al, 2004, 
Graff et al, 2006, Mikocka-Walus et al, 2016). 
 
Although disease related factors such as remission status, frequency of 
relapse, pain severity, and extra intestinal manifestations have been linked to 
psychological adjustment in IBD, evidence suggests that psychological factors 
have a comparable influence (Jordan et al, 2016). A recent systematic review 
found that emotion focused coping strategies, extreme perceptions of the 
illness and of being stressed were significantly associated with worse mental 
health outcomes, and this was maintained when controlling for the influence 
of clinical factors (Jordan et al, 2016). However this body of quantitative 
research has been criticised for failing to capture the full experience of living 
with IBD. Qualitative studies have reported that people with IBD fear 
embarrassing symptoms occurring in public and describe feeling isolated, yet 




2012). These qualitative findings arguably provide a richer illustration of the 
burden of living with IBD from the patients perspective but currently offer no 
insight into how these experiences link to symptoms of anxiety and low mood.  
 
Despite this gap in understanding a range of psychological approaches to 
enhance emotional states, for adults with IBD have been developed and 
tested. Initially psychodynamic and stress management approaches were 
trialled with limited efficacy (Timmer et al, 2011). More recently cognitive 
behaviour therapy has shown some promising results for improving the mental 
health of adults with IBD post intervention and at 6 month follow up (Knowles 
et al, 2013). However, apparent across all studies is a lack of information given 
about which psychological processes were targeted within interventions and 
how these factors were related to disturbances in mood (Timmer at al, 2011). 
A pre-requisite for establishing effective and targeted interventions is a more 
thorough understanding of the cognitive and behavioural responses linked to 
psychological adjustment in IBD. This has been demonstrated in the 
development of CBT interventions specifically for multiple sclerosis (MS), 
where the intervention was in part based on insights gained through 
qualitative exploration of the adjustment process (Dennison et al, 2012). For 
adults with IBD this is of particular importance as they have been reported to 
express a higher need for psychological support than other chronic disease 
populations. Further, this need is associated with worries about the disease 
and symptoms of anxiety rather than with medical variables (Miehsler et al, 





The goal of this mixed method study is therefore to explore and report the 
experience of adults with IBD and moderate to severe symptoms of anxiety 
and low mood. Our aim is to hi-light commonalities of experience and 
illuminate psychological processes which it would be possible to target in 
psychological interventions. It is envisaged that our findings will not only 
contribute to the content of future psychological interventions but also 
provide knowledge that will support psychological therapists in achieving the 
competencies required to deliver it.   
 
Specifically our primary research aims were to 1) investigate the specific 
situations, thoughts, perceptions, appraisals, beliefs and behaviour that people 
with IBD describe as linked to their symptoms of anxiety and low mood 2) 
explore the type of psychological help or support people with IBD and elevated 
symptoms of anxiety and low mood would like as part of routine medical care. 
A secondary aim was to consider our findings in relation to the knowledge 
associated with the competencies set for psychological therapists delivering 




A mixed method research design was adopted for this study. A qualitative 
approach with in-depth semi-structured face to face interviews was used to 
explore the experiences of adults with IBD who reported moderate to severe 




respectively (Spitzer et al, 2006, Spritzer et al, 1999). Individual rather than 
group interviews were chosen as participants may have been reluctant to fully 
disclose personal and sensitive information in a group setting due to fears 
about judgement or confidentiality. Data were analysed using template 
analysis as detailed by King et al (2017), a technique which is well suited to 
answering practical research questions in real world settings. Further, it is 
compatible with the neo- positivist position assumed by this study in that we 
aimed to report the reality evident in the data in relation to participant’s 
experience of symptoms of anxiety and low mood and drew on CBT theory to 
inform constructs within our analysis (King et al, 2017). This mixed methods 
study was nested within a larger epidemiological study measuring illness 
perceptions, anxiety, depression, quality of life and functioning over a 3 month 
period.  
 
Patient and public involvement 
People with inflammatory bowel Disease (IBD) were actively involved in 
formulating the design and conduct of this study. Consultation was sought 
from two individuals with IBD for developing the participant information sheet, 
invitation to participate letter and topic guide for the qualitative interviews. 
Ways to maximise participation and recruitment were also discussed and 
resulted in the qualitative interviews being offered via telephone/skype in 
order to reduce burden for participants. Further, as discussed below the 
interview schedule was piloted with two patients prior to the study 
commencing and a small group of participants reviewed our findings and 





Participants were recruited through an IBD clinical service in South East 
London, United Kingdom. Initially people over the age of 18 with a confirmed 
diagnosis of IBD where invited to take part in a cohort study measuring illness 
perceptions, anxiety, depression, quality of life and functioning over a 3 month 
period. A total of 150 people participated in this study, on its completion 
participants were asked to indicate their willingness to be interviewed. 
Following the initial analysis of demographic data, interested respondents 
were organised into subgroups based on their anxiety and depression scores. 
We then reviewed the pool of participants with scores in the moderately 
severe to severe range for symptoms of anxiety and/or low mood on the GAD7 
and PHQ9 questionnaires (n=42) (Spitzer et al, 2006, Spritzer et al, 1999). To 
capture the diverse impact of IBD we purposely selected individuals of varied 
age, ethnicity and gender for each threshold score within the moderately 
severe to severe range On this basis we selected 33 people for inclusion in the 
interview group. Of these 3 were not contactable, 2 arranged an interview but 
were subsequently not contactable and 3 changed their minds about 
participating. Thus the analysed sample consisted of 25 participants. 
 
Procedure 
 Interviews were offered via telephone, Skype or face to face for flexibility and 
to lessen any potential burden to participants. All participants selected to meet 
with the lead author (CJ) in person within the clinical service with the interview 
being scheduled to coincide with their routine medical appointments. 




following measures to establish current levels of anxiety, low mood and 
disease activity and these are reported in table 1; the generalised anxiety 
disorder 7 measure (GAD7), a self- report questionnaire which measures key 
symptoms of generalised anxiety disorder. Scores in the 10- 14 range advocate 
a moderate level of symptoms, whilst 15 and above implies severe (Spitzer et 
al, 2006). Symptoms of low mood were measured by the patient health 
questionnaire, a multiple choice self -report inventory (PHQ9). Scores in 15-19 
range signpost moderate symptoms of low mood, a score of 20 or more, 
severe (Spritzer et al, 1999). Current levels of symptomatic disease activity 
were measured by the Harvey Bradshaw Index (HBI) (Harvey et al, 1980) for 
participants with Crohn’s disease and the Simple Clinical Colitis Activity Index 
for participants with ulcerative Colitis (SCCAI) (Warmsley et al, 1998). The score 
derived from the HBI is based on 5 items that assess general well-being, 
abdominal pain, number of liquid stools per day, abdominal mass, and 
complications or extra intestinal manifestations. The score derived from the 
SCCAI is based on 6 items that assess daytime and night time bowel 
movements, urgency, and presence of blood in the stool, general well-being, 
and extra intestinal manifestations. Scores of <5 on the HBI and <3 on SCCAI 
are considered to suggest remission (Higgins et al, 2005).  
 
Subsequently a one to one interview was conducted which typically lasted for 
45 minutes. All interviews were conducted in English and followed a semi-
structured schedule. Once the interviews were completed participants were 
given the opportunity to ask questions and were provided with information 
regarding accessing psychological services. All participants completed consent 




investigator and took place from August 2015-Feb 2016. This study was 
approved by the NRES committee London-Bloomsbury (REC reference 
12/LO/1510). 
  
Data collection  
As this study focuses specifically on the experience of adults with IBD and 
elevated symptoms of anxiety and low mood an interview guide was 
constructed by the authors which focused on the following areas (1) situations 
or events which the person felt  most anxious or depressed about, such as 
specific symptoms of the disease or situations which were difficult because of 
it (2) the meanings, appraisals and cognitions that were experienced about 
such events, as well as consequent emotional and behavioural responses (3) 
the type of emotional or psychological help or support the person would like to 
receive as part of routine medical care. Key interview questions included “Tell 
me what you feel anxious/ low about?” Can you tell me some of the things that 
go through your mind when you feel anxious or low in mood? What do you do 
when you feel anxious or low to cope with the situation?  What help or 
support would you like with this as part of your IBD treatment & care? The 
interview schedule was piloted with two patients prior to the study 
commencing and no amendments were found to be necessary as a result.  
Data analysis  
All interviews were transcribed verbatim and analysed by the principal author 
(CJ) using template analysis (King et al, 2017), assisted by Nvivo version 10 




because it is suited to studies with particular applied concerns which need to 
be incorporated into the analysis. Commonly the first procedural step involves 
identifying some potential “A priori” themes which are pertinent to the 
research question and expected in the data. Given the aims of this study, our 
initial template for analysis was organised around 1) symptoms of anxiety and 
associated situations, beliefs and behaviour 2) symptoms of low mood and 
associated situations, beliefs and behaviour 3) the type of psychological help 
wanted. Interview transcripts were analysed on a manifest level where visible 
and obvious components of the text relating to these broad domains were 
identified, coded and grouped into meaningful clusters. Consequently several 
subthemes were identified within each “A priori “theme. These detailed 
situations participants described as sources of symptoms of anxiety and/or low 
mood as well as specific cognitive and behavioural responses to these. As we 
aimed to hi-light commonalities in experience features in the data were 
considered a subtheme if they occurred across four or more transcripts. Data 
not fitting any themes or subthemes was placed in its own category and then 
reanalysed. No further themes were identified as a result. To ensure rigour, 
the final template was reviewed by two of the authors (CJ & RO). Themes and 
subthemes were verified through discussion and with reference to examples 
found in the qualitative data. Any disagreements were resolved through 
discussion with TC.  CJ is an experienced psychological therapist with an 
interest in understanding and treating distress in IBD. Both RO and TC are 
experienced qualitative researchers and clinicians with an interest in 
understanding distress in long term conditions. The final template is presented 






We followed the approach of Creswell and Miller (2000) to strengthen the 
credibility of our findings. Firstly to minimise the risk of researcher bias a 
consistent interview process was adhered to. Secondly, all themes are 
illustrated with rich descriptive quotes which were taken directly from raw 
data. Finally, a small group of participants reviewed our findings and 
considered their relevance and accuracy. No amendments were requested as a 




A total of twenty five individuals, 11 males and 14 females participated in this 
study. Eleven had a diagnosis of Crohn’s disease and fourteen ulcerative colitis. 
Based on self- report scores derived from the Harvey- Bradshaw index of 
Crohn’s disease activity (HBI) and Simple Clinical colitis activity index (SCCAI) 
the majority of the participants were currently in remission. The mean age of 
participants was 36.5 years (range 22-68 years), mean time since diagnosis was 
5 years (range 1-20years). The participants reported a range of ethnicities. All 
participants scored in the moderate to severe range for depressive symptoms 
on PHQ9 (range from 11-20) and/ or symptoms of generalised anxiety disorder 
on GAD7 (Range 11-21) at the time of interview. Demographic, psychological 





Table 4.1. Sampling Characteristics  
 
 Total (n=25) % 








































Ulcerative colitis 14 56% 
Crohn’s disease 11 44% 
Symptomatic disease activity 
































Depression ( PHQ9) 
Moderate (15-19) 













To align with the focus of this study our analysis concentrated on three main 
areas; 
1. Symptoms of anxiety and the situations, appraisals, beliefs and 
behaviour linked to these emotional experiences by people with IBD. 
2. Symptoms of low mood and the situations, appraisals, beliefs and 
behaviour linked to these emotional experiences by people with IBD. 
3.  The type of psychological support wanted.   
These overarching themes, and their component subthemes will now be 
described and discussed with the use of illustrative quotes.  
 
1. Symptoms of anxiety 
 The majority of participants associated their symptoms of anxiety with 
concerns about their ability to function at work due to episodic disease 
activity. Anxiety was also linked to attempts to influence or manage the onset 
of symptoms. Participants were particularly anxious about preventing an 
accident when out in public and this promoted a range of behavioural 
responses designed to minimise the probability of this occurring.  
 
Underperformance at work 
Participants reported being anxious that either absence or reduced functioning 
in the work setting   due to symptomatic disease activity, would result in their 




being concerned that they would be side-lined into a lesser role or at worse 
sacked or made redundant, although there was no objective feedback to 
suggest this. The financial impact should this happen was identified frequently 
as a major source of anxiety for participants. For example one participant said; 
“It’s stressful when it comes to work and my finances. I am a self- employed 
actress and I really worry about the impact being ill is going to have on this. If I 
get sick and take time off, or last minute I can’t make it in then people will 
think I am unreliable and won’t offer me any further work.  It goes on 
reputation a lot and if mine becomes sketchy I don’t know want will happen. If 
I don’t get paid you can imagine, how I will pay my mortgage and all that” (P1, 
age 47, UC) 
Participants described an all or nothing behavioural response to these 
cognitions. This entailed working extended hours and taking on more whilst 
feeling well, to compensate in advance for future periods of reduced 
functioning due to illness. For example one participant said;  
“When I think a flare might be coming on I do as much work as I can before , 
get as much done as possible because I know I might need to stop soon and 
take time off ” (P2, 40 CD). 
This boom or bust behaviour was described by participants as having negative 
consequences in that it led to tiredness or fatigue which was cited as a further 
risk factor for underperformance at work. Participants frequently described a 
pattern of cycling between periods of excessive occupational activity followed 




“I exhaust myself to get as much done as I can if I am feeling ok, I then worry 
about how I am going to get on with all my work when I am so exhausted after 
doing so much. I feel like I am going to slip even further behind, I but I have to 
stop , rest, do nothing for a bit  before I can get on with any more” (P13, 43 
UC) 
IBD symptoms has been reported to disrupt work activities in previous 
qualitative studies (Devlin et al, 2014). Our findings link this experience to 
specific concerns about the consequences of underperformance in the work 
place and to feelings of anxiety. This was reported to motivate an all or nothing 
behavioural response which was thought to be unhelpful for energy levels and 
perpetuated concerns about occupational underperformance. These 
psychological processes could be addressed in a psychological intervention and 
a more helpful behavioural response could lead to a reduction in anxiety and 
more consistent energy levels.  
 
Preventing an accident 
The accessibility of toilets was described by participants as a significant source 
of anxiety which persisted even when a flare episode had subsided. 
Participants reported panicking when they were in a situation where toilet 
accessibility was obstructed or absent or when considering future situations 
where this might be the case. In both examples, this particular anxiety was 
described as being an overwhelming experience that it was difficult to 




“I have a job where I am dealing with staff and students all day long, face to 
face. So I find myself in the middle of conversations thinking what if I need the 
toilet, how will I get out of this meeting? As soon as I think that I can’t focus 
any more I am just thinking about needing to get out, dreading anyone being in 
the toilet, I get really panicked about this”  (P7, UC, age 34) 
In order to manage these anxieties participants reported multiple behavioural 
strategies intended to manage or minimise anxiety about the occurrence of an 
accident in public. These included avoiding or restricting the use of public 
transport or where possible opting for transport that provided a sense of being 
more in control such as cycling. For example one participant said; 
 “I won't get  on the tubes, I started to cycle to work as that way I can stop if I 
need to”  (P9 aged 24 CD) 
 Having knowledge of the whereabouts of toilets and carrying spare clothes in 
case of “an accident” was another way that participants described managing 
their anxiety in this situation. In addition participants described getting up 
extra early in order to extend the time available to use the toilet in the 
mornings before leaving the house and reported restricting both what and 
when they ate. For example one participant described; 
“I just don’t eat through the day and only eat in the evenings to avoid possible 
accidents. If there is nothing in there then there is nothing that can come out is 
my thinking”. (P11 age 48 UC) 
On occasions participants described avoiding leaving the house. This was 
reported as a last resort strategy when feeling overwhelmed by the 




house. Participants reported that this had negative consequences for their 
mood as they were concerned that this would leave them susceptible to 
becoming socially isolated. For example one participant described; 
  “I  just don’t go out some times, sometimes because I am not feeling well or 
am tired or just can’t face the anxiety of going out, getting prepared and not 
knowing what my bowels might do, I feel low  then, stuck in the house, it 
worries me that I might end up a bit isolated” (P12 Age 62 CD) 
Clearly participants go to considerable lengths to manage or minimise their 
anxiety about toilet access both in the moment and in anticipation of future 
situations. An unintended consequence of continuing to plan journeys around 
toilet locations or carry spare clothes beyond a flare episode seems to be that 
it maintains focus and attention on the feared event. Maintaining close 
proximity to toilets and having concerns about an accident occurring in public 
has been identified as part of the burden of living with IBD in several previous 
qualitative studies. Our findings link this behaviour and concern with 
symptoms of anxiety and indicates specific behavioural responses which it may 
be beneficial to target in a psychological intervention to reduce anxiety.  
 
2. Symptoms of low mood  
Perceiving that others misunderstood IBD was reported by participants as a 
source of low mood which often led to social withdrawal. Where participants 
believed others were familiar with the illness this was often reported to lead to 
fears about judgement and stigma. In both examples illustrated below, 
perceiving others to hold negative and inaccurate judgements seems to be 




Lack of understanding from others 
The vast majority of participants linked feeling low in mood with perceiving a 
lack of understanding from their family members, friends and employers.  
Frequently interviewee’s reported that IBD was mistaken for irritable bowel 
syndrome which they felt underestimated the severity of their condition. As a 
result participants reported that they often felt that others were dismissive of 
their symptoms and lacked empathy towards them. In response to this 
participants reported withdrawing socially; for example one participant said; 
“With friends I don’t think they understand that it’s not IBS, and that its 
chronic it will always come and go. Nobody understands so I just don’t bother 
talking about it or seeing people, it’s miserable, I feel low” (P7, UC, age 34)  
This behavioural response was linked to low mood by participants. By 
withdrawing from friends the opportunity for social support is reduced and the 
perception “that no one understands” is likely to remain intact. The resulting 
isolation is reported to be unhelpful for mood as it perpetuates feeling low. 
IBD has been found to impact on relationships in previous qualitative studies. 
Our findings link this experience to low mood and highlights the perceptions 
and appraisals about others which motivate social withdrawal. To improve 
mood these appraisals could be tested for accuracy by increasing social activity 









Some participants also linked feeling low in mood with concerns that they 
would be stigmatised and alienated by others due to the nature of the 
symptoms of IBD being focused around the bowels. Participants were 
particularly concerned that others would think they were unclean and as a 
consequence would avoid them or not want them involved in food 
preparation.  For example one participant described; 
“I am not the person you want preparing food. It’s the difference between the 
charity shop and a designer boutique. If you go to a charity shop you might 
touch things and then use hand gel, I am the charity shop, it’s depressing”   
(P12, UC age 29) 
Behaviourally participants described a range of strategies intended to 
overcompensate for these concerns. Participants described appearing well 
groomed to others  as a necessity and reported going to great lengths to 
demonstrate high levels of personal hygiene, for example one participant 
reported; 
 “I make a big effort to show them that I am washing my hands before I 
prepare food or touch anything” (P21, UC age 50) 
For some participants concerns about stigma extended to their consideration 
of prospective romantic relationships as IBD was seen as a major obstacle to 
establishing a relationship. Concerns often focused on whether the disease 
rendered them unattractive to others for example; 
“I can’t imagine anyone finding me attractive what with this. Who wants a 




Participants described how this often meant they avoided disclosing their 
diagnosis for some time or underplayed the impact of their symptoms. This 
potentially contributes to the perception that others misunderstand IBD. 
Testing out the accuracy of appraisals linked to feeling misunderstood and 
stigmatised may therefore be central to a psychological intervention targeting 
low mood in IBD.   
 
3. Psychological support: Expertise and understanding 
Overwhelmingly participants described that they would like some support 
from a professional with specialised knowledge of IBD, its symptoms and 
emotional impact. Interviewee’s reported wanting to make sense of the illness, 
their emotions and coping strategies. For example one participant said; 
 “A professional to talk to who knows about the illness, gets it. To help me 
work out some of this stuff. Help me think through decisions I am making, 
work out what helps and what doesn’t. Someone to share it with I guess and 
get some feedback” (P25, CD age 45). 
Participant accounts highlight a motivation to adjust to the demands dictated 
by IBD and a desire for professional support to achieve this. Knowledge of IBD 
and its biopsychosocial impact was identified as crucial for the psychological 
therapist providing such support and we anticipate that our findings might be 
useful for developing this. Given that participants in our study cited feeling 
misunderstood as source of low mood, familiarity with IBD may be essential for 




Some participants reported that talking to other people with IBD in a group 
setting was useful as it helped to normalise the experience of IBD and reduce 
the sense of being alone, for example one interviewee said; 
“It helps to talk and to know that there are others that are experiencing the 
same. Talking to others has been useful, I joined a support group and that was 
useful” (P8, UC age 42). 
This suggests that there may be advantages to delivering a psychological 
intervention in a group format. It could provide participants with a shared 
experience which may counteract the social isolation frequently described by 
participants in our study as a consequence of symptoms of anxiety and low 
mood.  
 
4.5: Discussion  
The results of our analysis link symptoms of anxiety for people with IBD to 
concerns about occupational underperformance and having an accident in a 
social situation. Within each of these domains distinct cognitive and 
behavioural responses have been described by participants and are illustrated 
in figure 4.1. Participants main behavioural response to concerns about the 
consequences of reduced occupational functioning was to increase their 
workload in order to compensate in advance for future periods of sickness. 
This type of boom or bust behaviour whereby sustained periods of excessive 
activity are followed by episodes of withdrawal has been linked to fatigue in 
several long term conditions such as multiple sclerosis (Skerrett et al, 2006). 




which was perceived as a further risk factor for occupational 
underperformance. Adopting an all or nothing behavioural response in this 
context may therefore be unhelpful for people with IBD in that it may 
precipitate or maintain fatigue which could perpetuate concerns about 
underperforming and maintain anxiety levels. In addition this may influence 
the course of IBD as elevated levels of anxiety and stress have been linked to 
more frequent disease activity in several longitudinal studies (Camara et al, 
2009, Mokoka-Walus et al 2016).  
 
A prevalent concern for the vast majority of participants was preventing the 
occurrence of an accident in public. This is consistent with the results of 
several previous studies exploring the lived experience of people with IBD 
(Dudley-Brown, 1996, Burger, 2005, Hall et al, 2005). Importantly the results 
from our study suggest that it is the perception or recognition that a toilet is 
inaccessible that triggers feelings of anxiety, rather than symptoms or 
sensations originating from the bowels. In response to this anxiety participants 
described a wide range of behaviours from changing modes of travel and 
carrying spare clothes to adjusting eating habits. Coping behaviours such as 
these which are intended to manage the anxiety and prevent the feared event 
occurring have been identified in a range of anxiety disorders and are referred 
to as safety seeking behaviours (Salkovskis, et al, 1998).  Although arguably 
helpful in the short term, over prolonged period’s safety seeking behaviours 
have been found to amplify anxiety by maintaining attention and focus on the 
feared event and preventing a realistic appraisal of it. In the context of IBD, a 
flare up in disease activity might initially necessitate a hyper vigilance towards 




toilets. Once symptoms begin to subside this selective attention to symptoms 
may be less useful and serve to focus the individual’s attention on the feared 
event and provoke feelings of anxiety. As anxiety has been associated with 
increased bowel frequency in several studies (Gorard et al, 1996), this may 






Figure 4.1: Thematic map of cognitive, behavioural responses linked to 
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Feeling misunderstood and stigmatised was linked to symptoms of low mood 
by participants in this study. Participants described thinking that others would 
find them less attractive as a potential partner and would not want them 
involved in food preparation given the nature of their IBD symptoms. In 
response to these concerns participants described overcompensating by 
demonstrating excessive cleanliness, a behaviour likely to focus attention and 
perpetuate preoccupation with this concern. Perceptions of stigma have been 
linked to depression in one previous study (Taft et al, 2009). In response to 
thinking that others misunderstood their illness participants described 
cancelling social plans. This pattern of behavioural disengagement was 
apparent across other subthemes identified in our analysis as participants also 
reported withdrawing from social events to prevent accidents occurring in 
public. In all cases participants described feeling low in mood as a 
consequence. Behavioural withdrawal and avoidance has long been associated 
with low mood in the wider psychological empirical literature and is considered 
to be a perpetuating factor for depression (Ferster, 1973). Multiple 
quantitative studies of the psychological correlates of IBD have also linked this 
type of behaviour to poor psychological health (Seres et al, 2008, Dorian et al, 
2009 Mussell et al, 2004, Petrak et al, 2001). Reducing activity levels in 
response to the many concerns and challenges posed by IBD is therefore likely 
to be unhelpful for mood. As depression has been found to lead to earlier and 
more frequent relapse in IBD, it is possible this behavioural response may also 
exert an indirect influence on disease activity and vice versa (Mikoka-Walus et 






Overall our analysis highlights the situations, cognitions and behaviours linked 
to symptoms of anxiety and low mood by people with IBD and we have 
hypothesised some potentially unhelpful interactions between these factors. 
Anxiety related responses appear catastrophic and lack acceptance whilst 
responses related to low mood were more characterised by hopelessness and 
withdrawal. Encouragingly cognitive and behavioural responses are potentially 
modifiable factors which it is possible to address in a psychological 
intervention and the vast majority of participants in our study stated a desire 
for psychological support. Significantly, our findings suggest a strong 
preference for this to be delivered by a compassionate practitioner who can 
draw on specialised knowledge of the key symptoms of IBD and their impact 
on functioning and mental health, with a focus on building coping strategies. 
 
Transdiagnostic cognitive behavioural therapy (TD-CBT) would be well suited 
to promoting more adaptive responses in order to restore disruptions to 
mood. This approach is based on traditional cognitive behavioural principles 
with a particular emphasis on the way people respond to their emotions. 
Strategies include psychoeducation to introduce the main components of an 
emotional experience, namely thoughts, physical sensations and behaviour 
and the reciprocal relationships between these domains. This three 
component model is then employed across sessions to recognise and track 
emotional experiences. This enables the individual to understand their 
responses to emotional triggers and situations and assess the short and long 
term consequences of their emotion driven behaviour. Where behaviour is 
identified as unhelpful the individual can work towards acting in alternative 




trains by participants in our study. A common behavioural response was to 
stay close to the toilet and monitor its occupation. On consideration, this might 
be recognised as unhelpful in that it maintains attention and focus on the 
feared event and amplifies feelings of anxiety. An alternative response might 
therefore be to sit slightly further away and focus attention on a more neutral 
activity thus lessening preoccupation and anxiety. Mindfulness and attention 
training exercises are employed to encourage such present focused awareness 
and support the development of alternative adaptive emotional responses. A 
recent meta-analysis which included 24 RCT’s found that transdiagnostic CBT 
treatments outperformed control conditions for reducing anxiety and 
depression and improving quality of life (Newby et al, 2014).  
Finally, our findings suggest that Psychological therapists working with this 
group would require advanced skills in conducting bio-psychosocial 
assessments in order to gain a clear picture of the differing psychological 
processes impacting on mood and levels of anxiety. Recently in the UK, a 
national curriculum was established to ensure efficacy in the delivery of 
psychological therapies for anxiety and depression in long term health 
condition. Our findings link to and support a range of competencies set out to 













The findings of this study may therefore have clinical and training implications. 
To the authors knowledge this is the first time that anxiety and depression has 
been linked to differing yet specific aspects of IBD and with distinct cognitive 
and behavioural responses. Psychological therapists will be able to draw on 
these findings to increase their competency in working with this group of 
people. 
 
 Further these insights could assist clinicians working in IBD services with early 
detection of disturbances to mood for people with IBD and encourage referrals 
to psychological services for appropriate support and treatment. This may 
prevent poor mental health from negatively influencing outcomes for people 
with IBD. Pharmacological treatment of emotional symptoms may also be 
beneficial (Jordan et al 2016). 
 
Future directions for research 
Our findings provide a framework which could be utilised in future studies. The 
themes participants identified as sources of anxiety and low mood along with 
the cognitive, behavioural and emotional responses to these should be 
measured in quantitative studies exploring the psychological factors linked to 
psychosocial adjustment for people with IBD. The findings of this study could 
also be utilised to inform the content of psychological interventions to improve 
mental health outcomes for people with IBD and to help psychological 





Table 4.2: Results linked to therapist competencies. 
 
Theme and findings relevant to competency 
 
Knowledge associated with competencies 
identified in the national curriculum for long 
term conditions 
 Ability to draw on knowledge of specific 
psychological process that contribute to the 
development and maintenance of distress, 
depression and anxiety, such as:  
Theme: Symptoms of anxiety:  
Sub theme: preventing an accident. 
 
Selective attention to symptoms and toilet 
accessibility.  
-  Attentional processes that increase 
the perceived severity and 
pervasiveness of sensations and 
symptoms  
  
Theme: Symptoms of anxiety:  
Sub theme: preventing an accident. 
Safety seeking behaviours: changing modes of 
transport carrying spare clothes, restricting 
what to eat and when. Mapping out the 
location of toilets. 
-  Safety seeking behaviours which are 
understandable in the short-term, but 
which (in the long-term) tend to 
strengthen unhelpful beliefs, increase 
preoccupation and exacerbate concern  
 
Theme: Symptoms of anxiety:  
Subtheme: underperforming at work: I will be 
sacked.   
Sub theme: preventing an accident: what if the 
toilet is inaccessible?    
Catastrophizing and/or worry (“preparing for 
the worse”) which in turn primes negative ideas 
and increases preoccupation and may lead to 
procrastination 
Theme:  Symptoms of anxiety  
Sub theme:  underperformance at work: 
cancelling plans to rest. 
Sub Theme: preventing an accident: reduction 
in social activity. 
 
Theme: Symptoms of depression  
Sub Theme: lack of understanding: social 
withdrawal. 
Unhelpfully restrictive behaviour, such 
as generalised withdrawal from 
physical activity or from role-related 
activity (such as relationships, work, 
and hobbies), leading to impaired 
mood, confirmation of unhelpful 
beliefs, reduced self-efficacy and 
disengagement from rewarding 
activities. 
Theme: Symptoms of anxiety  
Subtheme: under performance at work: Boom 
or bust behaviour  
All or nothing (“boom or bust”) behaviours 
(undertaking activities beyond the level of 
which the person is physically or psychologically 
capable, resulting in symptom surges (e.g. 
fatigue, pain) and leading to more negative 
appraisal 
Theme: Expertise & understanding: 
knowledgeable  about IBD, understanding, 
supportive    
Ability to reflect upon the assumptions and 
expectations that people with LTHC may have 
about being referred for assessment and 









This study does however have some potential limitations. Our participants had 
all taken part in an online survey measuring illness perceptions, anxiety, 
depression, quality of life and functioning and may therefore be more 
motivated to pursue psychological or emotional support. It is arguable that our 
deductions are therefore based on a specific cohort of adults with IBD which 
may not be generalizable to the wider population, although our findings are 
congruent with, and build on those of previous studies.   
 
4.6: Conclusion 
Our analysis of participant accounts illustrates that concerns pertaining to 
underperformance and preventing an accident link to symptoms of anxiety 
whilst low mood was associated with a lack of understanding and stigma. In 
each of these domains distinct cognitive and behavioural responses were 
described by participants. Participants in our study stated a desire for 
psychological support delivered by a professional with specialised knowledge 
of IBD to evaluate and build their coping strategies. Practitioners will be able to 
draw on the findings of this study in order to understand the specific 
psychological processes that contribute to the development and maintenance 





Chapter 5: Psychological factors and their associations with 




Background. To extend and deepen current understanding of the psychological 
factors linked to negative adjustment outcomes, this study aimed to 
investigate the types of cognitive, behavioural and emotional responses 
associated with, and predictive of negative adjustment outcomes; anxiety, 
depression, general psychological distress and poor health related quality of 
life for adults with inflammatory bowel disease.   
Methods: Two hundred and twenty two adults with IBD completed measures 
at baseline of which 170 completed outcome measures again at 3 month 
follow up. A cross sectional and prospective analysis was carried out to explore 
the  associations between cognitive, emotional and behavioural responses 
assessed at baseline and anxiety, low mood, general psychological distress and 
poor quality of life assessed at baseline and 3 month follow up, when taking 
sociodemographic and disease related factors into account.   
Results: A range of unhelpful cognitive, emotional and behavioural responses 
were found to be  associated with baseline cases of anxiety, depression, 
general psychological distress and poor quality of life for adults with 
inflammatory bowel disease, when taking sociodemographic and clinical 
factors into account. In addition, a range of these responses were found to 
increase the risk of being a case of anxiety, depression, general psychological 




Conclusion:  A differing range of cognitive, behavioural and emotional 
responses to IBD were identified as linked to and predictive of disturbances to 
mood and health related quality of life.  The results suggest different 
psychological factors may need to be targeted in a psychological intervention 
for different outcomes and for different IBD types. A third wave CBT approach 
such as acceptance and commitment therapy may be best suited to treating 
disturbances to the process of adaption in IBD given the nature of the cognitive 








The literature review of this thesis (Chapter 2) systematically identified 
psychological factors related to adjustment in adults with IBD. Emotion 
focused coping strategies, personality traits (such as neuroticism), perceived 
stress, emotions and emotional control (such as alexithymia) and IBD related 
cognitions (such as illness perceptions) were all found to link to negative 
adjustment outcomes. Importantly, the results of this review suggested that 
even though sociodemographic and disease related factors such as gender and 
symptomatic disease activity played an important role in adjustment, 
psychological variables maintained their significance when controlling for the 
influence of these factors. All but one study included in this review was cross 
sectional in design. The lack of any longitudinal data meant that causal 
relationships between psychological factors and outcomes could not be 
established and it was not possible to discern which factors were most 
important for the process of adjustment in IBD (Jordan et al, 2016).   
 
A further consideration identified in this review was the limited number of 
studies in this area and the broad array of psychological variables that have 
been examined. The conclusions relating to psychological factors and 
adjustment were therefore limited by a small quantity of studies focused on a 
diverse range of psychological variables. Despite these limitations a cognitive 
behavioural model of understanding psychological adjustment in IBD was 
suggested. It was proposed that the onset of psychological distress and 
reduced quality of life and functioning was likely to be associated with a trigger 
such as the onset of symptoms at the start of a flare episode of IBD and that 




over time by disease activity but also by cognitive and behavioural responses. 
Further, this review concluded that future studies should expand the range of 
cognitive, emotional and behavioural factors examined in relation to 
adjustment outcomes and employ a prospective design to assess these 
associations over time (Jordan et al, 2016). A meta-synthesis of qualitative 
studies reported that people with IBD fear embarrassing symptoms occurring 
in public and describe becoming isolated as a result, yet these psychological 
responses have not been explored in quantitative studies. These qualitative 
findings provided an illustration of the burden of living with IBD from the 
patient’s perspective but offered no insight into how these experiences linked 
to symptoms of anxiety, low mood, distress or poor health related quality of 
life (Kemp et al, 2012).  
 
The qualitative study of this thesis (Chapter 4) explored the cognitive, 
emotional and behavioural responses to IBD symptoms which individuals 
specifically linked to their symptoms of anxiety and low mood. This was in 
order to illuminate psychological processes which could be targeted during a 
clinic based cognitive behaviour therapy (CBT) intervention (chapter 6). 
Catastrophizing, a lack of acceptance, being preoccupied with symptoms and 
all or nothing behaviour were linked to anxiety by participants, as were 
unhelpful behavioural responses to manage the fear of having bowel 
symptoms when out socially. Behavioural withdrawal and avoidance were 
major themes identified in participant accounts of low mood (Jordan et al, 
2017). These findings not only provided further support for the cognitive 
behavioural model of adjustment to IBD proposed in the literature review but 




quantitative study.  
 
The study reported in this chapter aimed to build on the findings of the 
literature review (chapter 2) and qualitative study (chapter 4) by expanding the 
range of cognitive, behavioural and emotional responses to IBD symptoms 
examined in relation to negative adjustment outcomes; anxiety, depression, 
general psychological distress and poor quality of life. This exploration of a 
wider range of psychological responses was intended to enrich current 
empirical understanding of the psychological factors linked to negative 
adjustment in IBD and potentially provide insight into the type of CBT 
approach best suited to improving the process of adaptation.   
 
The classical CBT model of emotional distress proposed by Beck (1976) 
postulates that maladaptive or extreme beliefs contribute to the development 
of emotional distress. This distress is then perpetuated by unhelpful cognitive, 
emotional, physical and behavioural responses. Treatment techniques such as 
behavioural experiments are utilised to modify extreme beliefs about illness or 
to test out alternative behavioural responses to ultimately reduce distress or 
improve quality of life.   
 
More recently developed CBT approaches such as Acceptance and 
commitment therapy (ACT) conceptualise emotional distress as the result of 
psychological rigidity which leads to a failure to engage behaviourally with 
valued and meaningful activities. Experiential avoidance (e.g. avoiding or trying 
to get rid of unwanted experiences) and cognitive fusion (e.g. becoming 




promote and sustain psychological rigidity.  ACT targets different change 
processes to traditional CBT. It does not attempt to directly modify the content 
of extreme beliefs for example through behavioural experiments. Instead it 
aims to reduce the behavioural impact of unhelpful thinking processes. 
Mindfulness based strategies are utilised to facilitate an attitude of acceptance 
towards unwanted experiences and a present moment focus. Further, a range 
of values based exercises are employed to identify meaningful activities to 
participate in to achieve valued life goals (Graham et al, 2016). 
 
Psychological measures of cognitive, behavioural and emotional responses to 
IBD symptoms to be examined in the current study were therefore selected on 
the basis that they captured 1) the factors identified as important for 
adjustment in the literature review, or qualitative study, 2) had empirical links 
to adjustment outcomes in other chronic long term conditions or 3) measured 
aspects of the CBT or ACT model of emotional distress. Hence the irritable 
bowel syndrome –behavioural responses questionnaire (IBS-BRQ) was chosen 
and adapted for use with people with IBD as it measures specific behavioural 
strategies for managing bowel symptoms (Reme et al, 2010). The cognitive 
behavioural responses to symptoms questionnaire (CBRQ) (Ryan et al, 2018) 
was selected because it assesses avoidance of activities due to shame, 
embarrassment or fear, as well as beliefs about symptom severity, 
preoccupation with symptoms and all or nothing and resting behaviour. These 
unhelpful cognitive and behavioural responses to symptoms have been linked 
to poorer adjustment outcomes in several long term conditions including 





The Literature review and ACT model of emotional distress suggests that the 
role of acceptance beliefs towards symptoms warranted further exploration. 
Only one cross sectional study identified in the review examined acceptance 
and found it to be associated with better adjustment outcomes (Kiebles et al, 
2010). The Acceptance scale adapted from the chronic pain acceptance 
questionnaire (CPAQ) (McCraken et al, 2004) was therefore used to measure 
this psychological factor. 
 
Aspects of emotional processing were linked to poorer psychosocial outcomes 
in IBD in the literature review, particularly a heightened awareness of feelings 
and difficulties in describing and expressing these (Moreno-Jiménez et al, 
2007, Boye et al, 2008, Iglesias-Rey et al, 2012, Verissimo et al, 1998, Olbrisch 
et al, 1982). To elucidate this relationship further a questionnaire to assess 
unhelpful beliefs about experiencing and expressing negative emotions was 
included in this study. These types of belief have been linked to distress in 
other physical health populations and are thought to perpetuate clinical 
problems by delaying the individual from seeking help or support (Cramer et al, 
2005, Rimes et al, 2010). According to the ACT model, unhelpful beliefs about 
experiencing and expressing negative emotions are likely to have implications 
for emotion regulation and the acceptance of unpleasant emotional 
experiences (Rimes et al, 2010).  
 
To address the methodological weaknesses identified in previous studies by 
the literature review, this current study utilised a cross sectional and 






To extend and deepen current understanding of the psychological factors 
linked to negative adjustment outcomes, this study’s first aim was to 
investigate the types of cognitive, behavioural and emotional responses 
associated with negative adjustment outcomes; anxiety, depression, general 
psychological distress and poor health related quality of life in adults with 
inflammatory bowel disease at a cross sectional level. The second aim of this 
study was to explore if these cognitive, behavioural and emotional responses 
were associated with an increased risk of having anxiety, depression, 
psychological distress and poor health related quality of life at three month 
follow up in a prospective analysis.  
 
Hypothesis 
It was expected that unhelpful beliefs about experiencing and expressing 
negative emotions (BeS), unhelpful behavioural responses to gastrointestinal 
symptoms (IBS-BRQ), a lack of acceptance beliefs towards symptoms (CPAQ), 
avoiding exercise due to a fear it will make symptoms worse (CBSQ: FA), 
believing symptoms are damaging (CBSQ:D), focusing on symptoms (CBSQ: SF), 
excessive resting to manage symptoms (CBSQ: AR), all or nothing behaviour 
(CBSQ: AL) and avoidance of activities due to embarrassment about symptoms 
and worries about how others will judge symptoms (CBSQ: EA), would be 
associated with baseline (Time 1) cases of anxiety, depression, psychological 
distress and poor health related quality of life, when taking sociodemographic, 
disease related and clinical variables into account. Further, it was anticipated 




associated with an increased risk of being a case of anxiety, depression, 
general psychological distress and poor health related quality of life at three 
month follow up (Time 2). 
 
5.3: Material and methods 
Study design 
Firstly, associations between psychological, sociodemographic, disease related 
and clinical factors assessed at baseline (Time 1) and cases of anxiety, 
depression, general psychological distress and poor health related quality of 
life assessed at baseline (Time 1) were explored cross sectionally.  
 
Secondly, for study participants who completed measures at three months 
follow up (Time 2) an additional prospective analysis was utilised to investigate 
the associations between psychological, sociodemographic, disease related 
and clinical factors assessed at baseline (Time 1) and cases of anxiety, 
depression, general psychological distress and poor health related quality of 
life assessed at 3 month follow up (Time 2). The findings of the cross sectional 




All patients of an IBD clinical service nested within a gastroenterology 
department of a hospital in the south east London area of the UK and all 




participate in this study. Potential participants were eligible to take part if they 
were aged 18 years or over with a diagnosis of inflammatory bowel disease 
(IBD) which had been confirmed by a gastroenterologist.  
 
Data collection 
Participants were contacted in writing and provided with information about 
the study and invited to complete a set of online questionnaires at two time 
points; baseline (Time 1) and three month follow up (Time 2). Potential 
participants were also given the option of requesting paper versions of the 
online questionnaires to promote inclusion of those unfamiliar with or unable 
to access the internet. An identical recruitment strategy was followed for both 
the clinical service and patient organisation. At baseline, data was collected on 
demographic and general characteristics (gender, age, ethnicity, marital status, 
years in education, age of diagnosis, work status, health problems other than 
IBD and type of IBD). Questionnaires measuring cognitive and behavioural 
factors, symptoms of anxiety and depression, health related quality of life and 
symptomatic disease activity were also included (details provided below). 
Three months later (Time 2) participants were invited to repeat the 
questionnaires measuring anxiety, depression, psychological distress and 
health related quality of life. Data collection took place between November 
2014 and January 2017.  
 
Time 1 and Time 2: Outcomes assessed at baseline and 3 month follow up 
Probable symptoms of anxiety, depression and general psychological distress 




variables for this study according to scores on the hospital anxiety and 
depression scale (Zigmond et al, 1983). This 14 item self-report questionnaire 
measures levels of anxiety (HADSA: seven items) and depression (HADSD: 
seven items) over the past week. Each item is assessed on a 4 point Likert scale 
e.g. “I feel tense or wound up’” 0 (not at all) to 3 (most of the time). Scores for 
each subscale range from 0 to 21, with higher scores indicating greater 
symptoms of anxiety or depression. A score of ⩽7 points is considered “no 
case,” 8–10 “possible case,” and ⩾11 “probable case” for the presence of 
anxiety or depression symptoms (Norton et al, 2013). Any participant scoring 
11 or more on the HADSA or HADSD at baseline (Time 1) or 3 month follow up 
(Time 2) was therefore considered to be a moderate anxiety or depression 
case in the cross sectional and prospective analysis.  
 
General psychological distress at baseline (Time 1) and 3 month follow up 
(Time 2) was assessed by the total overall score on the Hospital anxiety and 
depression scale (HADS-T), with a score of 15 or more being indicative of the 
probable presence of psychological distress (Zigmond et al, 1983, Norton et al, 
2013). Any subject scoring 15 or more at baseline was therefore considered to 
be a psychological distress case in the cross sectional analysis. Participants 
scoring in the same range at 3 month follow up (Time 2) were considered to be 
cases of general psychological distress in the prospective analysis. 
 
Health related quality of life was assessed at baseline (Time 1) and 3 month 
follow up (Time 2) by the Short Inflammatory Bowel Disease Questionnaire 




assesses the impact of IBD symptoms as well as general wellbeing and 
emotional status over the last two weeks. Each item is assessed on a seven 
point Likert scale e.g. “How often during the last 2 weeks have you had to 
delay or cancel a social engagement because of your bowel problems?”  1 (all 
of the time) to 7 (not at all). Total scores range from 10 to 70, with a higher 
score indicating a better QOL. There are no published validated cut-off values 
for the SIBDQ which indicate a “normal” quality of life. Using Huaman et al’s 
(2010) estimated value for the IBDQ-36 (209 in the range 36–252) and a 
previous study as a guide (Swart et al, 2013), a cut off of 56 in the range 7–70 
was used to estimate a cut-off for the SIBDQ. Participants with a score of 56 or 
less were therefore considered to be a poor quality of life case in the cross 
sectional and prospective analysis. 
 
Time 1: Potential predictor variables assessed at baseline (Time 1) 
Patient Characteristics & disease related factors  
Gender, age, marital status, ethnicity, years spent in education, work status, 
type of IBD (Crohn’s disease (CD) or ulcerative colitis (UC)), age at diagnosis, 
comorbidity (other health problems) and self-reported levels of current 
symptomatic disease activity were assessed at baseline. Data on disease 
activity was assessed by the Harvey-Bradshaw Index (HBI) (Harvey et al, 1980) 
for patients with CD and via the Simple Clinical Colitis Activity Index (SCCAI) for 
patients with UC (Walmsley et al, 1998). The score derived from the HBI is 
based on 5 items that assess general well-being, abdominal pain, number of 
liquid stools per day, abdominal mass and complications or extra-intestinal 




assess daytime and night time bowel movements, urgency, presence of blood 
in the stool, general well-being, and extra-intestinal manifestations. Higher 
scores indicate more severe symptoms, with scores of <5 on the HBI and <3 on 
SCCAI considered to suggest remission (Higgins et al, 2005). 
 
Beliefs about emotions scale (BES) (Rimes & Chalder, 2010) 
This 12 item questionnaire measures beliefs about the unacceptability of 
experiencing and expressing negative emotions such as “it is a sign of 
weakness if I have miserable thoughts” and “if I have difficulties I should not 
admit them to others”.  Each item on the scale is measured on a seven point 
Likert scale ranging from 0 (Totally disagree) to 6 (Totally agree) with a higher 
total score being indicative of more negative beliefs about emotions (Rimes et 
al, 2010). This measure showed high internal consistency in this study 
(Cronbach’s α 0.9). 
 
Acceptance scale adapted from the chronic pain acceptance questionnaire 
(CPAQ) (McCraken et al, 2004)  
The 20-item CPAQ-revised was designed to measure acceptance of pain 
(McCraken et al, 2004). It measures beliefs about the pursuit of life activities 
regardless of pain e.g. “I am getting on with the business of living no matter 
what my level of pain is” and about avoidance and control of pain e.g. “I would 
gladly sacrifice important things in my life to control this pain better”. The 
items on the CPAQ are rated on a 7-point scale from 0 (never true) to 6 (always 
true). Higher scores indicate higher levels of acceptance. For this study the 
scale was adapted to reflect the variability of symptoms in IBD, hence the word 




living no matter what my level of symptoms  is”. Internal consistency for this 
measure was high in this study (Cronbach’s α 0.9). 
 
Irritable bowel syndrome- behavioural responses questionnaire (IBS-BRQ) 
(Reme at al, 2010) 
The Irritable bowel syndrome – behavioural responses questionnaire was 
developed to assess potentially unhelpful behaviours associated with 
symptoms of diarrhoea, constipation and abdominal bloating. The scale 
incorporates two subscales (1) avoidance behaviour such as “when I go out I 
always know where the nearest toilet is” and (2) assesses safety seeking 
behaviours which are coping behaviours intended to reduce anxiety and 
prevent the threat from occurring e.g. “I eat specific foods to help me open my 
bowels less”. The scale has 26 items, each rated on a Likert scale from 1 
(never) to 7 (always), indicating how persistently the particular behaviour is 
carried out. The total score, calculated by summing the responses to the 28 
items, ranges from 29 to 203. For this study the terminology of the scale was 
adapted to reflect the diagnosis of IBD (changing IBS to bowel problems on the 
scale where relevant e.g. “I avoid certain social situations because of my bowel 
problems”). Internal consistency for both subscales of this measure in this 
study were high (IBS-BRQ: avoidance:  Cronbach’s α 0.9, IBS-BRQ: safety 
seeking: Cronbach’s α 0.8). 
 
Cognitive & behavioural responses to symptoms (CBRQ) (Skerett et al, 2006) 
Cognitive and behavioural responses to symptoms were assessed by the 
Cognitive and Behavioural Responses to Symptoms Questionnaire (CBRQ) 




version incorporating two behavioural and four cognitive subscales (Ryan et al, 
2018). The cognitive subscales include 1) fear avoidance which focuses on 
avoidance of exercises due to fear of worsening symptoms (e.g. “I am afraid 
that I will make my symptoms worse if I exercise”), 2) damage beliefs which 
measures the belief that symptoms and their severity reflects true damage to 
the body (e.g. “the severity of my symptoms must mean there is something 
serious going on in my body”), 3) embarrassment avoidance which quantifies 
avoidance of social situations due to feelings of shame about symptoms and 
concerns about others opinion of symptoms  (e.g. “I am ashamed of 
symptoms, I worry others will think badly of me because of my symptoms”) 
and 4) symptom focusing which assesses attentional focus towards symptoms  
(e.g. “when I am experiencing symptoms it is difficult for me to think of 
anything else”). The two behavioural subscales consist of 1) all-or-nothing 
behaviour which measures the tendency to engage in periods of high activity 
resulting in overextension and subsequent prolonged periods of resting (e.g. “I 
tend to do a lot on a good day and rest on a bad day”) and 2) resting behaviour 
which is characterised by excessive resting and avoidance of activity (e.g. “I 
stay in bed to control my symptoms”). Each CBRQ item is measured on a five-
point Likert scale, scored from 0 (strongly disagree) to 4 (strongly agree), 
where a higher subscale score indicates more unhelpful cognitions and 
behaviours. Internal consistency for each subscale was high (Cronbach’s α 
ranging from 0.8 to 0.9). 
 
Hospital anxiety and depression scale (Zigmond and Snath, 1983) 
Symptoms of anxiety and depression were assessed at baseline by the hospital 




adjustment outcomes at 3 month follow up (Time 2). HADSA and HADSD 
scores were included in the prospective analysis as continuous data. 
  
Health related quality of life (Irvine J, 1989) 
Health related quality of life was assessed at baseline by the Short 
Inflammatory Bowel Disease Questionnaire (SIBDQ) (Irvine J, 1989). As a 
potential predictor of negative adjustment outcomes at 3 month follow up 




Data analysis was performed using Stata SE 19 (Statacorps, 2017). Initial 
inspection of the data collected at baseline (Time 1) revealed 11 cases were 
missing 8 items on the HADSA (anxiety) & HADSD (depression) subscales of the 
hospital anxiety and depression scale (HADS). 23 cases were missing at least 2 
items of the Short inflammatory bowel disease questionnaire (SIBDQ), 11 cases 
were missing between 1 and 10 items on all subscales of the cognitive 
behavioural responses to symptoms questionnaire (CBRQ), 11 were missing 17 
items on the Chronic pain acceptance questionnaire (CPAQ), 9 were missing at 
least 2 items on the Beliefs about emotions scale (BeS) and for measures of 
disease activity in ulcerative colitis 2 cases were missing 1 item on the SCCAI 
and for Crohn’s disease 5 cases were missing 2 items on the HBI. For data 
collected at 3 month follow up (Time 2), 3 cases were missing all 14 items on 
HADS (anxiety, depression and general psychological distress) and 4 cases were 
missing all 11 items of the SIBDQ measure. Therefore, when at least 75% of 




used in order to substitute a total score. Where more than 25% of data items 
was missing from any one subscale, a score was not computed and that 
participant was excluded from analyses involving that variable. 
 
Histograms, kurtosis and skew statistics were consulted to check the 
distribution of all continuous data assessed at baseline (Time 1) and 3 month 
follow up (Time 2). This suggested that data had a bimodal distribution with  
participants having either particularly low or high scores for the following 
measures at time 1; HADSA (anxiety)  W=0.966 df =210 p<0.001, HADSD 
(depression), W= 0.961 df=210 p<0.01, HADS-T (psychological distress) 
W=0.963 df=210 p<0.01, SIBDQ (HRQOL) W=0.975 df=200 p<0.001,  CBRQ 
subscales (cognitive behavioural response  to symptoms subscales); damage 
beliefs W=0.985 df=212 p=0.03, all or nothing W=0.986 df=210 p=0.03, 
avoidance resting W=0.969 df=211 p=0.001, symptomatic disease activity; HBI 
(Crohn’s disease) W=0.968 df=114 p=0.007 & SCCAI (ulcerative colitis) 
W=0.948 df=101 p=0.001.  At three month follow up (Time 2) data continued 
to show a bimodal distribution for measures of anxiety (HADSA), depression 
(HADSD), distress (HADS-T) and quality of life (SIBDQ)  (HADSA W=0.975 
df=166 p=0.004, HADSD W=0.950 df=166 p-<0.0001 , HADS-T W=0.960 df=166 
p=0.0001, SIBDQ W=0.962 df=165 p<0.001).  
 
Therefore outcome measures for anxiety (HADSA), depression (HADSD), 
psychological distress (HADS-T) and health related quality of life (SIBDQ) 
assessed at baseline (Time 1) and 3 month follow up (Time 2) were 




two clear groupings. Logistic regression was selected as the method of analysis 
to estimate associations between potential predictor variables measured at 
baseline (Time 1) and probable cases of anxiety, depression, distress and poor 
health related quality of life assessed at baseline (Time 1) and 3 month follow 
up (Time 2). Logistic regression generates odds ratios which describe the 
increase or decrease in the odds of being in one outcome category when the 
value of the independent variable increases by one unit. It also allows for the 
impact of covariate or confounding variables to be determined (Tabachnik & 
Fidell, 2001).    
 
Participants were classified as a moderate case of anxiety and/or depression at 
baseline (Time 1) and 3 month follow up (Time 2) if they scored 11 or more on 
the relevant subscale of the hospital anxiety and depression scale and a case of 
psychological distress was indicated by a HADS total score of 15 or more. A 
case of poor health related quality of life was categorised by a score of 56 or 
less on the short inflammatory bowel disease questionnaire (SIBDQ). Potential 
predictor variables were entered into the analysis as continuous data as 
logistic regression does not assume independent variables are normally 
distributed (Acock et al, 2016).  
 
Correlation analysis was utilised to explore the relationship between 
psychological measures assessed at baseline (Time 1) in this study. Pearson’s 
correlation coefficient and p values indicated that these measures were highly 
and statistically significantly correlated with each other (Table 5.1). Time 1 




(SIBDQ) were included in this analysis as continuous data as they were to be 
entered into the prospective analysis as potential predictor variables.  
Table 5.1: Correlations between psychological measures assessed at baseline 
(Time 1) 
Key :T1 HADSA: Time 1  hospital anxiety and depression scale: anxiety, T1 HADSD: Time 1 hospital anxiety and depression 
scale: depression, T1SIBDQ: Time 1 Short Inflammatory bowel disease questionnaire, BES: beliefs about emotions scale, 
CPAQ: acceptance scale adapted from the chronic pain acceptance questionnaire, IBSBRQ: irritable bowel syndrome 
behavioural response questionnaire, CBRQ: cognitive behavioural responses questionnaire, FA: fear avoidance, D: damage 





























































































 p= 0.001  
0.35  
p<.0001 



























p<0.0001   
0.26 




















































p<0.0001    
0.54 
p<0.0001    
0.45 







Multicolinearity arises from highly correlated predictor variables and can lead 
to unstable estimates of odds ratios in multivariable logistic regression 
analysis. In addition it can lead to inaccurate results about which predictors are 
redundant in the presence of others. This can be a challenge for psychological 
research as there is often some conceptual overlap between differing 
measures of psychological constructs. Variable selection or reduction 
techniques are often used to overcome this problem but these strategies to 
assess variable importance are also influenced by multicollinearity. Optimal 
variable selection is therefore difficult in standard logistic regression modelling 
where predictor variables are highly and statistically significantly correlated 
(Midi et al, 2010). Consequently in this study psychological measures showing 
statistically significant associations with adjustment outcomes were not 
entered collectively into a multivariable model.  
 
For the cross sectional analysis and prospective analysis, univariable analysis 
was performed to assess the associations between sociodemographic, disease 
related and clinical variables assessed at baseline (Time 1) and each outcome 
assessed at baseline (Time 1) (anxiety, depression, distress, poor health related 
quality of life) and at 3 month follow up (Time 2). Potential psychological 
predictor variables assessed at baseline (Time 1) were also tested one by one 
with each outcome assessed at baseline (Time 1) and 3 month follow up (Time 
2) and then adjusted for each sociodemographic, disease related or clinical 
factor (such as age or level of symptomatic disease activity) which showed a 
statistically significant association with that outcome (equal to or less than 
0.10). This significance level was chosen as more traditional levels such as 0.05 




In addition, descriptive statistics were generated to analyse baseline 
characteristics of study participants at Time 1. Chi –squared tests were 
performed to assess for any statistically significant differences between 
participants with ulcerative colitis or Crohn’s disease on baseline data. For 
continuous psychological measures with a skewed distribution the two sample 
Wilcoxon rank sum (Mann Whitney) test was used to test for significant 
differences between the two types of IBD. The two sample t tests were 
performed for variables that were normally distributed.  
 
For the prospective analysis, descriptive statistics were generated to analyse 
baseline characteristics of study completers (completed measures at baseline 
& follow up) and non –completers (only completed baseline measures). Chi –
squared tests were performed to assess any statistically significant differences 
between 1) study completers and non-completers and 2) study completers 
with Crohn’s disease and ulcerative colitis on baseline data. For continuous 
psychological measures with a skewed distribution the two sample Wilcoxon 
rank sum (Mann Whitney) test was used to test for significant differences 
between 1) study completers and non-completers and 2) study completers 
with Crohn’s disease and ulcerative colitis. The two sample t tests were 
performed for variables that were normally distributed. Further, as the number 
of participants across age bands was unevenly distributed with few aged 18-24 
years or over 75 years, the age categories were collapsed into 3 bandings to 
create more equal groups; under 35 years, 35-54 years, 55 years and over, for 







This study was approved by the NRES committee London-Bloomsbury (REC 
reference 12/LO/1510). A copy of the patient information sheet and consent 
form are provided in appendix 4. 
 
5.4.1: Results: Cross sectional analysis.  
Participants  
At baseline (Time 1) questionnaires were completed by 222 participants. Table 
5.2 reports baseline data on the socio-demographic and clinical characteristics 
of participants by IBD type (including X2, t-tests statistics, df & p values). The 
sample was composed of 104 people with ulcerative colitis, of which 73% were 
female. The majority were British (67%), under 35 years in age (41%), living 
with their partners (56%), educated to a post graduate level (37%), in paid 
work (71%), had other health problems alongside their diagnosis of ulcerative 
colitis (54%) and were reporting symptoms of disease activity indicative of 
relapse (52.9%). The remaining 118 participants had a diagnosis of Crohn’s 
disease of which 72% were female. The majority of this group were also British 
(75%), aged between 35-54 years (49%), living alone (51%), educated to a post 
graduate level (27%) and in paid work (60%). In addition, the majority were 
experiencing other health problems (61%) as well as Crohn’s disease and were 
reporting symptoms of disease activity indicative of relapse (60.2%). 
Preliminary analysis identified there were no statistically significant differences 
between participants with ulcerative colitis and those with Crohn’s disease on 









UC CD X2, P value & t-tests & df 
N=222 104 (46.8%) 118 (53.2%)  
Female:  n % 76 (73%) 85 (72%) Pearson chi2(1) =   0.03   p = 0.86 
Marital status: n % 










Pearson chi2(4) =   4.52   p = 0.34 
Ethnicity :n % 
1=English/Welsh/Scot 
2=Mixed multiple 
















Pearson chi2(22) =  22.63   p = 0.48 
Age: n %  
1=Under 35 
2=35-54  












Pearson chi2(6) =  10.01   p = 0.12 
Work status: n % 
1=Paid work  









Pearson chi2(8) =  12.52   p = 0.13 
Comorbidity: n % 










Pearson chi2(1) =   1.05   p = 0.31 
Source: n %  
1=NHS Clinic 









Pearson chi2(1) = 0.49   p = 0.48 
Disease activity: relapse 













(Different measures so could not 
be compared)  






T(218)= 1.21  p = 0.23 
Years in education:  M, 
(SD), (range) 
16,  (4.21), 
(3-47) 
15, (5.83),       
(3-47)  





Baseline Scores of psychological variables by IBD type 
Comparisons between participants with ulcerative colitis and Crohn’s disease 
on baseline measurements of psychological variables demonstrated some 
statistically significant differences (Table 5.3). Participants with Crohn’s disease 
had higher mean scores for; symptoms of anxiety (HADSA), unhelpful beliefs 
about experiencing negative emotions (BeS), resting (CBRQ: R) and all or 
nothing (CBRQ: AL) behavioural subscales of the cognitive behavioural 
responses to symptoms questionnaire. Further participants with Crohn’s 
disease had lower scores for health related quality of life (SIBDQ).  
 
 
Table 5.3: Comparisons between participants with ulcerative colitis and  
Crohn’s disease on baseline measurements of psychological measures (Time 
1). 
Key :T1 HADSA: Time 1  hospital anxiety and depression scale: anxiety, T1 HADSD: Time 1 hospital anxiety and depression 
scale: depression, T1SIBDQ: Time 1 Short Inflammatory bowel disease questionnaire, BES: beliefs about emotions scale, 
CPAQ: acceptance scale adapted from the chronic pain acceptance questionnaire, IBS-BRQ: irritable bowel syndrome 
behavioural response questionnaire, A: avoidance behaviour, S: safety seeking behaviour, CBRQ: cognitive behavioural 
responses questionnaire, FA: fear avoidance beliefs, D: damage beliefs, SF: symptom focusing, R: resting behaviour, AL: all 
or nothing behaviour, EA: embarrassment avoidance beliefs 
Measures( n=222) UC: mean (SD) or 
median (n=104) 
CD: mean (SD) or 
median   (n=118) 
Two sample t tests & 
Rank sum stats 
T1 HADSA  7.0  9.0 Z=-1.9 p=0.05  
T1 HADSD  5.0 6.0  Z=-1.0 p=0.30 
T1 SIBDQ 50 44 Z=2.7 p<0.01  
BES 35.8 (13.4) 41.4 (15.1) T(205)=-2.8 p=<0.01 
CPAQ 48.39 (14.2) 45.7 (14.6) T(207)=1.3 p=0.19 
IBS-BRQ: A 54.9 (21.3) 52.5 (21.9) T(202)=0.78 p=0.44 
IBS-BRQ: S 51.2 (13.5) 48.4 (14.3) T(202)=1.43 p=0.15 
CBRQ : FA 11  (4.4) 12.1  (4.3) T(209)=-1.4 p=0.16 
CBRQ: D  12.0 13.0 Z=-0.3 p=0.8 
CBRQ: SF 14.9 (5.7) 14.6 (5.1) T(208)=0.4 p=0.69 
CBRQ: R  10.0 12.0 Z=-2.4 p=0.02  
CBRQ: EA 11.5 (4.9) 12.3 (4.9) T(210)=-1.1 p=0.28 




Distribution of cases of anxiety & depression, HRQOL and general 
psychological distress assessed at baseline (Time 1) by IBD type. 
Based on scores on the hospital anxiety and depression scale (Zigmond & 
Snath, 1983), at baseline (Time 1) 28.8% of participants with ulcerative colitis 
and 37.3% with Crohn’s disease were probable cases of anxiety. 14.4% of 
participants with ulcerative colitis and 11.9% of participant with Crohn’s 
disease reported scores indicative of probable cases of depression. Based on 
total HADS scores, 39.4% of participants with ulcerative colitis and 51.3% of 
those with Crohn’s diseases had scores indicative of being a probable case of 
general psychological distress. Scores for health related quality of life on the 
Simple inflammatory bowel disease questionnaire (SIBDQ) (Irvine, 1989) at 
baseline suggest that 67.3% of participants with ulcerative colitis and 75.4% of 
participants with Crohn’s disease were cases of poor quality of life (Table 5.4). 
These differences in the distribution of cases of anxiety, depression, 
psychological distress and poor health related quality of life between the IBD 





Table 5.4:  Time 1 cases of anxiety, depression, psychological distress and 
health related quality of life by disease type. 
N=222 UC CD X2 & p value 
n (% ) cases of 
Anxiety (scoring 11 

















Pearson chi2(1) =   2.61   p = 0.11 
n (%)  cases of 
depression (scoring 





















Pearson chi2(1) =   0.18   p = 0.67 
n (%) Cases of 
general 
psychological 
distress (scoring > 15 
on HADST) 
Yes  





















Pearson chi2(1) =   2.45   p = 0.12 
n (%) Cases of poor 
quality of life 



























Sociodemographic, clinical and psychological factors assessed at baseline 
(Time 1) associated with cases of anxiety at baseline (Time 1).  
Based on the univariable analysis (Table 5.5) sociodemographic and clinical 
variables assessed at baseline (Time 1) significantly associated with cases of 
anxiety at baseline (Time 1) were gender, age, years in education and 
symptomatic disease activity in ulcerative colitis and Crohn’s disease.  
 
Table 5.5: Univariable analysis: Sociodemographic & disease related & clinical 
factors assessed at time 1 associated with time 1 cases of moderate anxiety 
























Cases Unadjusted odds ratio, 
(95% CI) and p value 
Gender: 1=Female  






0.61  (0.31 -1.16) p = 0.01  
Age: 1=Under 35 yrs. 
          2=35-55 yrs. 








0.71 (0.38- 1.31) p = 0.27 
0.36 (0.15- 0.88) p = 0.02  
Marital status: 1=Living with partner  





0.94 (0.53- 1.65) p = 0.83     
Ethnicity: 1=English/ Welsh/ Scottish/               
                       Northern Irish           
                    2=Mixed/multiple 
                    3=Asian/Asian British 
                    4= Black British  














          
6.24 (0 .54- 1.76)  p = 0.14     
2.34  (0.49 -11.17) p = 0.29      
1.78  (0.48-  6.60) p = 0.39      
 
Comorbidity: 1=Yes  






1.13  (0.64- 1.10) p = 0.68  
Clinical & sociodemographic  factors 
(continuous data) 
Mean &  (SD) Unadjusted odds ratio, 
(95% CI) and p value 
Disease activity : Ulcerative colitis   4.6  (3.6) 1.35  (1.17- 1.57) p =  0.01   
Disease activity : Crohn’s disease  6.9  (4.5) 1.08  (0 .99- 1.18) p = 0.09 
Age of Diagnosis  29.9 (12.8) 1.01  (0.98-  1.03) p = 0.84 




Univariable analysis identified statistically significant associations between all 
psychological measures assessed at baseline (Time 1) and cases of anxiety at 
baseline (Time 1) when unadjusted for sociodemographic or clinical variables 
(Table 5.6). Adjusting for age, gender or years in education had little impact on 
the majority of these relationships except for beliefs about emotions (BeS). 
After adjusting for years spent in education, unhelpful beliefs about 
experiencing and expressing negative emotions (BeS) were associated with 
reduced odds of being a case of anxiety at baseline (Time 1).   
Adjusting for symptomatic disease activity reduced or eliminated some 
relationships, particularly for participants with CD. For the CD group, after 
adjusting for disease activity, time 1 cases of anxiety were associated with 
unhelpful beliefs about experiencing and expressing negative emotions (BeS), a 
lack of acceptance beliefs towards symptoms (CPAQ), avoidant and safety 
seeking  behavioural responses to gastrointestinal symptoms (IBS-BRQ: A, IBS-
BRQ: S), symptom focusing (CBRQ: SF), resting behaviour (CBRQ: R), all or 
nothing behaviour (CBRQ: AL), as well as embarrassment avoidance beliefs 
(CBRQ: EA). For the UC group, after adjusting for disease activity, time 1 cases 
of anxiety were associated with unhelpful beliefs about experiencing and 
expressing negative emotions (BeS), a lack of acceptance beliefs towards 
symptoms (CPAQ), avoidant behavioural responses to gastrointestinal 
symptoms (IBS-BRQ: A), damage beliefs (CBRQ; D), symptom focusing beliefs 
(CBRQ: SF), resting behaviour (CBRQ: R), all or nothing behaviour (CBRQ: AL), 
and embarrassment avoidance beliefs (CBRQ: EA).  
Each psychological factor was then entered on its own into a multivariable 




clinical variables (gender, age, years in education and disease activity) to 
further test associations with time 1 cases of anxiety. For the UC group, the 
significant associations did not change (Table 5.7). For the CD group the 
relationship between resting behaviour, safety seeking  behavioural responses 
to gastrointestinal symptoms (IBS-BRQ; S)  and time 1 cases of anxiety were no 






Table 5.6: Univariable and multivariable analysis: Psychological variables 
assessed at time 1 associated with time 1 cases of moderate anxiety (= >11 on 





odds ratio p 
value and 












































 (1.03-1.08)  
p<0.01 
0.93  
(0.87-0 .99)  
p=0.02 
1.07 
 (1.02-1.11)  




























p<0.001   
1.04  
(1.02-1.05) 
p<0.001   
1.04  
(1.02-1.05) 
p<0.001   
1.04  
(1.02-1.05) 
p<0.001   
1.03 




p<0.001    













 (0.99-1.09)   
p<0.08 
1.04  
(1.01-1.07)   
p<0.01 



















p=0.54    
CBRQ: D 1.17 
 (1.05-1.30) 






p<0.01   
1.16  
(1.04-1.29) 






p=0.45   
CBRQ: SF 1.24 
 (1.15-1.33) 









p<0.01   
1.31 
 (1.14-1.51) 
p<0.01   
1.19 
 (1.08-1.31) 




















p=0.04    



































p<0.01   
Key:  BES: beliefs about emotions scale, CPAQ: acceptance scale adapted from the chronic pain 
acceptance questionnaire, IBS-BRQ: irritable bowel syndrome behavioural response questionnaire, 
A: avoidance behaviour, S: safety seeking behaviour, CBRQ: cognitive behavioural responses 
questionnaire, FA: fear avoidance beliefs, D: damage beliefs, SF: symptom focusing, R: resting 




Table 5.7: Multivariable analysis: Each psychological factor assessed at time 1 
associated with time 1 cases of moderate anxiety (=>11 on HADSA) on its 
own in a gender, age, years in education and symptomatic disease activity 
adjusted model (UC). 
 
 
Table 5.8: Multivariable analysis: Each psychological factor assessed at time 1 
associated with time 1 cases of moderate anxiety (=>11 HADSA) on its own in 








Odds ratio, (confidence interval) & p value for each 
psychological factor in its own gender, age, years in 
education, disease activity (UC) adjusted model. 
BeS 1.08 (1.03-1.13) p<0.01 
CPAQ 0.76 (0.66-0.87) p<0.001 
IBS-BRQ: A 1.03 (1.01-1.05) p=0.04 
IBS-BRQ: S 1.04 (0.99-1.09) p=0.08 
CBRQ: Fear avoidance  1.14 (0.97-1.34) p=0.13 
CBRQ: Damage beliefs  1.25 (1.02-1.52) p=0.03 
CBRQ: Symptom focusing 1.34 (1.14-1.57) p<0.001 
CBRQ: Resting 1.24 (1.09-1.41) p<0.001 
CBRQ: All or nothing  1.14 (1.01-1.30) p=0.04 
CBRQ: Embarrassment avoidance 1.21 (1.06-1.38) p<0.01 




Odds ratio, (confidence interval) & p value for each 
psychological factor in its own gender, age, years in 
education, disease activity (CD) adjusted model 
BeS 1.06 (1.02-1.10) p<0.01 
CPAQ 0.95 (0.92-0.99) p=0.02 
IBS-BRQ: A 1.03 (1.01-1.05) p=0.03 
IBS-BRQ: S 1.03 (0.99-1.07) p=0.08 
CBRQ: Fear avoidance  0.99 (0.87-1.13) p=0.93 
CBRQ: Damage beliefs 0.99 (0.82-1.19) p=0.89 
CBRQ: Symptom focusing 1.19 (1.07-1.33) p<0.01 
CBRQ: Resting  1.04 (0.96-1.12) p=0.37 
CBRQ: All or nothing  1.16 (1.03-1.31) p=0.01 




Sociodemographic, clinical and psychological factors assessed at baseline 
(Time 1) associated with cases of depression at baseline (Time 1)  
Based on the univariable analysis (Table 5.9) there were no sociodemographic 
or clinical variables assessed at baseline (Time 1) which were significantly 
associated with cases of depression at baseline (Time 1). Measures of 
symptomatic disease activity for ulcerative colitis and Crohn’s disease were 
significantly associated with this outcome. 
 
Table 5.9: Univariable analysis: Sociodemographic & clinical factors assessed 










Cases Unadjusted odds ratio, (95% CI) and 
p value 
Gender: 0=Female  






0.63 (0.24-1.64) p=0.34      
Age: 1=Under 35 yrs. 
          2=35-55 yrs. 








0.74 (0.31-1.76) p=0.49    
0.80 (0.27-2.44) p=0.70 
Marital status:  Living with partner =1 






0.60 (0.27-1.32) p=0.21 
Ethnicity: 1=English / Welsh / Scottish 
                  2=Mixed/multiple 
                  3=Asian/Asian British 
                  4= Black British  









   
5.22 (0.43-63.3) p=0.19     
1.12 (0.49-11.17) p=0.29 
1.03 (0.48-6.60) p=0.39      
 
Comorbidity: 1=Yes  






1.88 (0.81-4.36) p=0.14 
Clinical factors (continuous data) Mean &  (SD) Unadjusted odds ratio, (95% CI) and 
p value 
Disease activity: Ulcerative colitis     4.64       (3.6) 1.46 (1.20-1.77) p<0.001 
Disease activity: Crohn’s disease    6.98       (4.5) 1.21 (1.06-1.37) p<0.01      
Age of Diagnosis  29.92     (12.8) 1.02 (0.99-1.05) p=0.27     




Univariable analysis found statistically significant associations between all 
psychological variables assessed at baseline (Time 1) and baseline (Time 1) 
cases of depression when unadjusted for symptomatic disease activity (Table 
5.10). After adjusting for symptomatic disease activity in the UC group, time 1 
cases of depression were associated with unhelpful beliefs about experiencing 
and expressing negative emotions (BeS), a lack of acceptance beliefs towards 
symptoms (CPAQ) and resting behaviour (CBRQ: R). For the CD group after 
adjusting for disease activity, time 1 cases of depression were associated with 
a lack of acceptance beliefs towards symptoms (CPAQ), avoidant and safety 
seeking behavioural responses to gastrointestinal symptoms (IBS-BRQ: A, IBS-
BRQ:S), symptom focusing (CBRQ: SF), resting behaviour (CBRQ: R) and 
embarrassment avoidance beliefs (CBRQ: EA). Individual psychological factors 
were not tested further in separate multivariable models as there were no 
additional significantly associated sociodemographic or clinical variables to 





Table 5.10: Univariable and multivariable analysis: Psychological variables 
assessed at time 1 associated with time 1 cases of moderate depression 





ratio p value and  


















BeS 1.05 (1.02-1.09) 
p<0.01  
1.08 (1.02-1.14) 
p=0.01      
1.03 (0.99-1.07) 
p=0.21    
CPAQ 0.89 (0.85-0.925) 
p<0.001   
0.87 (0.80-0.95) 
p=0.002   
0.89 (0.84-0.95) 
p=0.001 












CBSQ: FA 1.22 (1.08-1.40) 










p=0.32    
CBRQ: SF 1.18 (1.08-1.29) 





CBRQ: R 1.17 (1.09-1.24) 
p<0.001 
1.14 (1.03-1.27) 
p=0.02   
1.11 (1.01-1.22) 
p=0.03   





p=0.22   





p<0.01    
Key:  BES: beliefs about emotions scale, CPAQ: acceptance scale adapted from the chronic pain 
acceptance questionnaire, IBS-BRQ: irritable bowel syndrome behavioural response questionnaire, 
A: avoidance behaviour, S: safety seeking behaviour, CBRQ: cognitive behavioural responses 
questionnaire, FA: fear avoidance beliefs, D: damage beliefs, SF: symptom focusing, R: resting 





Sociodemographic, clinical and psychological factors assessed at baseline 
(Time 1) associated with cases of general psychological distress at baseline 
(Time 1)  
Univariable analysis (Table 5.11) identified age, years in education, comorbidity 
and symptomatic disease activity for both UC and CD assessed at baseline 
(Time 1) were significantly associated with cases of psychological distress at 
baseline (Time 1).  
Univariable analysis found statistically significant associations between all 
psychological variables assessed at time 1 and time 1 cases of psychological 
distress when unadjusted for sociodemographic, clinical or disease related 
variables (Table 5.12). Adjusting for age, years in education or comorbidity had 
minimal impact on these relationships except for safety seeking behavioural 
responses to gastrointestinal symptoms  (IBS-BRQ: S). After adjusting for years  
in education, unhelpful safety seeking behaviour reduced the odds of being a 





Table 5.11: Univariable analysis: Sociodemographic & clinical factors assessed 




For the UC group, after adjusting for symptomatic disease activity, time 1 cases 
of general distress were associated with unhelpful beliefs about emotions 
(BeS), lack of acceptance beliefs towards symptoms (CPAQ), avoidant 
behavioural responses to gastrointestinal symptoms (IBS-BRQ: A), Symptom 
focusing (CBRQ; SF), resting behaviour (CBRQ: R) and all or nothing behaviour 
(CBRQ: AL). For the CD group, time 1 cases of general  distress were associated 
with unhelpful beliefs about experiencing and expressing negative emotions 
(BeS), lack of acceptance beliefs towards symptoms  (CPAQ), avoidant  and 
safety seeking behavioural responses to gastrointestinal symptoms (IBS-BRQ), 
symptom focusing (CBRQ: SF), resting behaviour (CBRQ: R) and embarrassment 
avoidance beliefs  (CBRQ: EA). 
Socio- demographic & clinical variables. 
 
Non cases Cases Unadjusted odds ratio, 
(95% CI) and p value   
Gender:0=Female  






 0.89 (0.49-1.63) p=0.7 
Age: 1=Under 35 yrs. 
          2=35-55 yrs.  








0.83 (0.46-1.52) p=0.55     
0.49 (0.22-1.10) p=0.08    
Marital status: Living with partner =1 






0.75 (0.43-1.29) p=0.29     
Ethnicity: 1=English / Welsh / Scottish         
                  2=Mixed/multiple 
                  3=Asian/Asian British 









              
1.78 (0.48-6.60) p=0.39      
1.34 (0.28-6.30) p=0.71   
2.14 (0.61-7.50) p=0.23   
Comorbidity: 1=Yes  






1.66 (0.96-2.89) p=0.07     
Clinical factors ( continuous data) Mean &  (SD) Unadjusted odds ratio, 
(95% CI) and p value 
Disease activity : Ulcerative colitis   4.64       (3.63) 1.38 (1.20-1.61) p<0.001      
Disease activity : Crohn’s disease  6.98       (4.45) 1.09 (0.099-1.19) p=0.06 
Age of Diagnosis  29.92    (12.81) 1.01 (0.99-1.03) p=0.29      




Table 5.12: Univariate and multivariate analysis: Psychological variables 
assessed at time 1 associated with time 1 cases of distress (=>15 HADST), 






p value and  












































only    
n=118) 





p<0.001      
1.07  
(1.04-1.09) 






p<0.01   
1.06  
(1.03-1.10) 
p<0.001     





p<0.001    
0.88  
(0.85-0.92) 










IBS-BRQ: A 1.03  
(1.02-1.05) 
p<0.001     
1.03  
(1.02-1.05) 












p<0.01   


















CBRQ: FA  1.15  
(1.06-1.25) 

































p=0.53   











p<0.001      
1.21  
(1.08-1.35) 












p<0.001   
1.15  
(1.09-1.22) 
p<0.001   
1.19  
(1.08-1.32) 




CBRQ: AL  1.15  
(1.08-1.22) 





















p<0.001   
1.19 
(1.10-1.27) 










 Key:  BES: beliefs about emotions scale, CPAQ: acceptance scale adapted from the chronic pain acceptance questionnaire, 
IBS-BRQ:  irritable bowel syndrome behavioural response questionnaire, A: avoidance behaviour, : S safety seeking 
behaviour, CBRQ: cognitive behavioural responses questionnaire, FA: fear avoidance beliefs, D: damage beliefs, SF: 




Each psychological factor was then entered on its own in a multivariable model 
with all statistically significant sociodemographic, clinical and disease related 
variables (age, years in education, comorbidity and disease activity) to further 
test associations with time 1 cases of general distress. For the UC group the 
relationship between avoidant behavioural responses to gastrointestinal 
symptoms and distress was no longer significant (Table 5.13). For the CD group 
the relationship between resting behaviour and Time 1 cases of distress was no 
longer significant. All other associations remained largely unchanged (Table 
5.14). 
 
Table 5.13: Multivariable analysis: Each psychological factor assessed at time 
1 associated with time 1 cases of distress (=>15 HADST) on its own in an age, 









Odds ratio, (confidence interval) & p value for each 
psychological factor in its own gender, age, years in 
education, disease activity (UC) adjusted model. 
BeS 1.08 (1.03-1.14) p<0.001 
CPAQ 0.83 (0.75-0.91) p<0.001 
IBS-BRQ: A 1.03 (0.99-1.05) p=0.07 
IBS-BRQ: S 1.03 (0.98-1.09) p=0.18 
CBRQ: Fear avoidance  1.14 (0.98-1.34) p=0.09 
CBRQ: Damage beliefs  1.10 (0.93-1.29) p=0.26 
CBRQ: Symptom focusing 1.21 (1.08-1.36) p<0.001 
CBRQ: Resting  1.22 (1.08-1.37) p<0.001 
CBRQ: All or nothing  1.16 (1.02-1.32) p=0.02 




Table 5.14: Multivariable analysis: Each psychological factor assessed at time 
1 associated with time 1 cases of distress (=>15 HADST) on its own in an age, 








Odds ratio, (confidence interval) & p value for each 
psychological factor in its own gender, age, years in 
education, disease activity (CD) adjusted model. 
BeS 1.07 (1.03-1.11) p<0.001 
CPAQ 0.92 (0.88-0.96) p<0.001 
IBS-BRQ: A 1.02 (1.01-1.04) p=0.04 
IBS-BRQ: S 1.04 (1.00-1.07) p=0.05 
CBRQ: Fear avoidance  0.99 (0.87-1.15) p=0.91 
CBRQ: Damage beliefs  0.97 (0.82-1.14) p=0.67 
CBRQ: Symptom focusing 1.23 (1.11-1.37) p<0.001 
CBRQ:  Resting 1.06 (0.97-1.14) p=0.21 
CBRQ: All or nothing  1.09 (0.98-1.21) p=0.09 




Sociodemographic, clinical and psychological factors assessed at baseline 
(Time 1) associated with cases of poor health related quality of life at 
baseline (Time 1)  
Univariate analysis found no statistically significant relationships between any 
sociodemographic variables assessed at baseline and cases of poor health 
related quality of life at baseline (Time 1). Clinical and disease related factors 
linked to baseline (Time 1) cases of poor quality of life included having a 
comorbid health problem alongside the diagnosis of IBD and symptomatic 
disease activity for both ulcerative colitis and Crohn’s disease (Table 5.15).  
 
Table 5.15: Univariable analysis: Sociodemographic & clinical factors assessed 
at time 1 associated with time 1 cases of poor health related quality of life 
(=<56 SIBDQ).  
 
Socio- demographic & clinical 
variables. 
 
Non cases Cases Unadjusted odds ratio,(95% CI) 
and p value 
Gender :0=Female  






1.18 (0 .62-2.26) p=0.61   
Age: 1=Under 35 yrs. 
          2=35-55 yrs.  








0 .91(0.47-1.71) p=0.74     
0.48 (0.22-1.05) p=0.67   
Marital status: 1=Living with partner  






1.37 (0.78-2.42) p=0.28     
Ethnicity:   1=English / Welsh / Scottish 
                    2=Mixed/multiple 
      3=Asian/Asian British 









              
1.01 (0.43-63.3) p=0.19     
1.70 (0.32-9.17) p=0.54      
1.87 (0.56-6.25) p=0.31      
Comorbidity: 1=Yes  






1.83 (1.01- 3.31) p=0.05    
Sociodemographic & Clinical factors 
(continuous data) 
        Mean &  (SD) Unadjusted odds ratio, (95% CI) 
and p value 
Disease activity : Ulcerative colitis           4.64       (3.63) 1.37 (1.16-1.62) p<0.001      
Disease activity : Crohn’s disease          6.98       (4.45) 1.33 (1.15-1.54) p<0.001   
Age of Diagnosis        29.92     (12.81) 1.01 (0.98-1.03) p=0.86     




At a univariate level all psychological variables when unadjusted for clinical and 
disease related factors showed statistically significant relationships with time 1 
cases of poor quality of life (Table 5.16). Adjusting for comorbidity had no 
impact on these relationships but adjusting for symptomatic disease activity 
reduced or eliminated some of these associations. In the UC group, after 
adjusting for symptomatic disease activity time 1 cases of poor health related 
quality of life were significantly associated with lack of acceptance of 
symptoms (CPAQ) and symptom focusing (CBSQ: SF). For the CD group after 
adjusting for symptomatic disease activity time 1 cases of poor health related 
quality of life showed statistically significant relationships with a lack of 
acceptance beliefs towards symptoms, safety seeking behavioural responses to 
gastrointestinal symptoms (IBS-BRQ), resting behaviour (CBSQ: AR) and 





Table 5.16: Univariable and multivariable analysis: Psychological variables 
assessed at time 1 associated with time 1 cases of poor health related quality 


























(CD group only 
n=118) 
BeS 1.04 (1.02-1.07) 
p<0.001      
1.04 (1.02-1.07) 




p=0.07    







p=0.01   





p=0.08    
1.02 (0.99-1.05) 
p=0.16 








CBRQ: FA 1.18 (1.08-1.29) 
p<0.001 
1.17 (1.07-1.28) 
p=0.001   
1.10 (0.95-1.27) 
p=0.20   
1.11 (0.96-1.28) 
p=0.16 
CBRQ: D 1.13 (1.02-1.30) 
p=0.020 
1.13 (1.02-1.26) 




p=0.32   
CBRQ: SF 1.13 (1.06-1.20) 
p<0.001 
1.14 (1.07-1.21) 




p=0.18   
CBRQ: R 1.14 (1.07-1.22) 






p=0.03   
CBRQ: AL  1.14 (1.07-1.22) 







CBRQ: EA 1.23 (1.14-1.32) 
p<0.001   
1.22 (1.13-1.32) 
p<0.001   
1.10 (0.98-1.22) 
p=0.10   
1.21 (1.06-1.38) 
p<0.01    
Key:  BES: beliefs about emotions scale, CPAQ: acceptance scale adapted from the chronic pain 
acceptance questionnaire, IBS-BRQ: irritable bowel syndrome behavioural response questionnaire, 
A: avoidance behaviour, S: safety seeking behaviour, CBRQ: cognitive behavioural responses 
questionnaire, FA: fear avoidance beliefs, D: damage beliefs, SF: symptom focusing, R: resting 





Each psychological factor was then entered on its own in a multivariable model 
with all statistically significant sociodemographic, clinical and disease related 
variables (comorbidity and disease activity) to further test associations with 
time 1 cases of poor quality of life.  For both groups, the significant 
associations between psychological factors and baseline health related quality 






Table 5.17: Multivariable analysis: Each psychological factor assessed at time 
1 associated with time 1 cases of poor health related quality of life (=<56 
SIBDQ) on its own in a comorbidity and symptomatic disease activity 





Table 5.18: Multivariable analysis: Each psychological factor assessed at time 
1 associated with time 1 cases of poor health related quality of life (=<56 
SIBDQ) on its own in a comorbidity and symptomatic disease activity 
adjusted model (CD). 




Odds ratio, (confidence interval) & p value for 
each psychological factor in its own comorbidity 
& disease activity (UC) adjusted model. 
BeS 1.01 (0.97-1.05) p=0.61 
CPAQ 0.93 (0.89-0.98) p<0.01 
IBS-BRQ: A 1.02 (0.99-1.05) p=0.10 
IBS-BRQ: S 1.04 (0.99-1.09) p=0.07 
CBRQ: Fear avoidance  1.09 (0.95-1.26) p=0.22 
CBRQ: Damage beliefs  1.09 (0.94-1.25) p=0.25 
CBRQ: Symptom focusing 1.15 (1.04-1.27) p<0.01 
CBRQ: Resting 1.05 (0.96-1.15) p=0.29 
CBRQ: All or nothing  1.06 (0.95-1.19) p=0.32 
CBRQ: Embarrassment avoidance 1.10 (0.98-1.23) p=0.09 




Odds ratio, (confidence interval) & p value for 
each psychological factor in its own comorbidity 
& disease activity (CD) adjusted model. 
BeS 1.04 (0.99-1.09) p=0.13 
CPAQ 0.95 (0.90-0.99) p=0.02 
IBS-BRQ: A 1.02 (1.99-1.05) p=0.016 
IBS-BRQ: S 1.07 (1.02-1.13) p=0.01 
CBRQ: Fear avoidance  1.10 (0.95-1.27) p=0.20 
CBRQ: Damage beliefs  1.10 (0.92-1.32) p=0.30 
CBRQ: Symptom focusing 1.07 (0.97-1.19) p=0.17 
CBRQ: Resting 1.12 (1.01-1.25) p<0.01 
CBRQ: All or nothing  1.06 (0.94-1.19) p=0.36 




5.4.2: Results: Prospective analysis  
Baseline comparisons of characteristics for study completers (Time 1 & Time 
2 measures) and non –completers (Time 1 measures only). 
 
The baseline questionnaires were completed by 222 participants with IBD, of 
which 170 completed the follow up questionnaires at 3 month follow up 
(response rate 76.6%). Table 6.9 reports baseline data on socio-demographic, 
clinical and psychological variables for participants who completed time 1 & 2 
measures (study completers) and those who completed time 1 measures only 
(non- completers). There were no relevant statistically significant differences 
between groups on sociodemographic or clinical variables. Further, there were 
no statistically significant differences between groups on the majority of 
baseline measures of psychological variables except that participants who 
completed time 1 & time 2 measures (study completers) had higher mean 
scores for embarrassment avoidance and damage beliefs on the cognitive 





Table 5.19: Comparisons of sociodemographic and clinical variables assessed 
at baseline (Time 1) between participants who completed measures at time 1 
(non- completers) and those who completed measures at time 1 and time 2 
(study completers). 
 
 Sociodemographic, clinical 




(n=170)   
Response rate: 
76.6% 
X2 and p values 










Pearson chi2(1)=0.14     p=0.71 










Pearson chi2(1)=2.46     p= 0.12 
Marital status: n (%) 
1=Living with partner 







Pearson chi2(6)=10.05   p=0.12 
Ethnicity: n (%) 
1=English / Welsh / Scottish 
/ Northern Irish / British 
2=Mixed multiple 














Pearson chi2(23)=30.61 p=0.13 
Age: n (%) 
1=Under 35 yrs. 
2=35-55 yrs.  









Pearson chi2(2)=4.35     p=0.13 
 
Work status: n (%) 
Paid work 







Pearson chi2(8)=4.22     p=0.84 









Pearson chi2(1)=0.08     p=0.78 









Pearson chi2(1)=0.33     p=0.57 
Age of diagnosis (years), 
mean (SD), (range).  
28.65 (11.35), (3-67) 30.30,(3.22), (3-75) T(218)=-0.80                    p=0.42 
Years in education (years), 
mean (SD), (range).  
15, (4.4), (3-47) 15.7 (5.4),(3-47) 
 






Table 5.20: Comparisons of psychological variables assessed at baseline (Time 
1) between participants who completed measures at time 1 (non-completers) 
and those who completed measures at time 1 & time 2 (study completers). 
Psychological factor  Non completers 
 n=52  
 
M (SD) or median   
Completers (n=170)   
(Response rate: 
76.6%) 
M (SD) or median  
Wilcoxon rank sum and t-tests & 
p values 
Time 1 HADSA    7.00   8.00  z = 0.01  Prob > |z| = 0  .99 
Time 1 HADSD   6.00   6.00  z = 0.43  Prob > |z| = 0 .67 
Time 1 SIBDQ 44.00 47.50  z = -1.65 Prob > |z| = -0.09 
BES 38.06, (15.02) 38.91, (14.44) T(205)=-0.35 p=0.73  
CPAQ  45.33, (13.20) 47.45, (14.76) T(207)=-0.87 P=0.38 
IBS-BRQ: A 56.80, (22.10) 52.60, (15.30) T(203)= 1.18 p=0.24 
IBS-BRQ: S 52.60, (15.30) 48.90, (13.50) T(203)= 1.65 p=0.10 
CBRQ: FA    4.96, (2.99)    5.52, (2.46) T(220)=-1.14 p=0.16 
CBRQ: D   8.00   8.00  z =  -1.93 Prob > |z| =   0.06 
CBRQ: SF    6.07, (3.51)   6.91, (3.15) T(220)=-0.10 p=0.92 
CBRQ: R   3.00    3.00  z =  -0.20 Prob > |z| =   0.84 
CBRQ: AL   4.00    5.00  z =  -0.61 Prob > |z| =   0.54 




The 170 participants who completed measures at baseline (Time 1) and 3 
month follow up (Time 2) constitute the sample for the prospective analysis. 
Seventy nine had a diagnosis of ulcerative colitis of which 67% were female. 
The majority were British (76%), aged between 35-54, living with a partner, 
educated to a post graduate level (42.3%), in paid work, had other health 
problems alongside IBD (55%) and were reporting symptomatic disease activity 
indicative of relapse (61.3%). The remaining 91 had a diagnosis of Crohn’s 
disease of which 72.5% were female. The majority were British (78.5%), aged 
between 35-54 ( 42.9%), living with a partner (50.5%), educated to a post 
graduate level (30%), in paid work (72.5%), had other health problems (60.4%) 




There were no statistically significant differences between people with Crohn’s 
disease and ulcerative colitis on baseline sociodemographic or clinical variables 
(Table 5.21).  
Table 5.21: Sociodemographic, clinical and disease related characteristics of 
participants completing T1&T2 measures (study completers) by IBD type.  
 UC CD X2, t-tests & p values 
N=170 79 (46.5%) 91 (53.5%)  









Pearson chi2(1) =   0.68   p = 0.41 
Marital status: n % 






46 (50.5%)  
45 (49.5%) 
Pearson chi2(4) =   4.75   p = 0.31 
Ethnicity :n % 
1=English/Welsh/Scott/etc.  
2=Mixed multiple =2 





  5 (6.3%) 




  5 (5.5%) 
  5 (5.5%) 
Pearson chi2(5) =   5.82   p = 0.32 
Age: n %  
1=Under 35 
2=35-54  









Pearson chi2(2) =   2.15   p = 0.34 
Work status: n % 
1=Paid work  







Pearson chi2(8) =  11.54  p = 0.17 
Comorbidity: n % 








Pearson chi2(1) =   0.49   p = 0.49 
. 
Source ; n %  
1=NHS Clinic 







Pearson chi2(1) =   0.01   p = 0.90 
Disease activity relapse (<3 











(Different measures so could not 
be compared) 
 










t(167)= -1.28 p=0.20 
Years in education:  M, (SD), 
(range) 






Baseline Scores of psychological variables by IBD type 
Comparisons between study completers with ulcerative colitis and Crohn’s 
disease on baseline measurements of psychological variables demonstrated 
some statistically significant differences (Table 5.22). Participants with Crohn’s 
disease had higher mean scores for unhelpful beliefs about experiencing 
negative emotions (BeS), Fear avoidance (CBSQ: FA) and all or nothing (CBSQ: 
AL) behavioural subscales of the cognitive behaviour responses to symptoms 
questionnaire. Further participants with Crohn’s disease had lower scores for 
health related quality of life (SIBDQ).  
Table 5.22: Comparisons between study completers with ulcerative colitis 
and Crohn’s disease on baseline measurements of psychological measures 
(Time 1). 
Measures( n=170) UC: mean (SD) or 
median (n=79) 
CD: mean (SD) or 
median   (n=91) 
Wilcoxon rank sum , t tests & p 
values 
T1HADSA   8.32 (4.96), 7.5   9.29 (4.66), 9 z =  -1.51     Prob > |z| =   0.13 
T1HADSD    6.00 (3.61), 6    5.76 (4.61), 5  z =  -0.88     Prob > |z| =   0.38 
T1SIBDQ  48.69 (12.40), 50 44.44 (10.65),44 z =   2.35    Prob > |z| =   0.02 
BES 35.86 (13.63) 41.65 (14.67), T(159) =2.579 p=0.01 
CPAQ 46.92 (14.51) 43.64 (13.88) T(163 =)-1.48 p=0.14 
IBS-BRQ: A 44.40 (20.5) 41.90 (21.5) T(167)=-0.77 p=0.44 
IBS-BRQ: S 47.20 (17.4) 43.80 (18.6) T(167) =1.24 p=0.22 
CBRQ: FA   5.11 (2.28)   5.94 (2.49) T(167)=--2.42  p=0.03 
CBRQ: D   8.19 (2.25), 8.5   8.00 (2.21), 8 z =   0.37     Prob > |z| =   0.71 
CBRQ: SF   7.00 (3.21)   6.97 (2.97) T(166)=-0.05 p=0.93 
CBRQ: R    3.42 (3.00), 3   3.98 (2.53), 4 z =  -1.85     Prob > |z| =   0.06 
CBRQ: AL    4.19 (3.31), 3.5   5.58 (3.35), 6 z =  -2.78     Prob > |z| =   < 0.01 
CBRQ: EA   7.13 (2.84)   7.54 (3.08) T(167)=0.89   p=0.37 
 Key : HADSA: hospital anxiety and depression scale: anxiety,  HADSD: hospital anxiety and 
depression scale: depression, SIBDQ: Short Inflammatory bowel disease questionnaire, BES: beliefs 
about emotions scale, CPAQ: acceptance scale adapted from the chronic pain acceptance 
questionnaire, IBS-BRQ: irritable bowel syndrome behavioural response questionnaire, A: avoidance 
behaviour, S: safety seeking behaviour, CBRQ: cognitive behavioural responses questionnaire,   FA: 
fear avoidance beliefs, D: damage beliefs,  SF: symptom focusing,  R: resting behaviour, AL: all or 




Distribution of anxiety & depression, HRQOL, general psychological distress 
at 3 month follow up (Time 2). 
At 3 month follow up (Time 2) based on scores on the hospital anxiety and 
depression scale (>11 on HADSA & HADSD) 26.6% of those with ulcerative 
colitis and 37.4% of participants with Crohn’s disease represented probable 
cases of anxiety and 20.3 % of participants with ulcerative colitis and 19.8% of 
people with Crohn’s disease reported scores indicative of probable cases of 
depression. Based on total HADS scores 30.4% of participants with ulcerative 
colitis and 42.9% of those with Crohn’s diseases had scores indicative of a 
probable case of general psychological distress. Scores for health related 
quality of life on the Simple inflammatory bowel disease questionnaire (SIBDQ) 
at 3 month follow up (Time 2) suggest that 69.2% of participants with 
ulcerative colitis and 87.9% of participants with Crohn’s disease were cases of 
poor quality of life (Table 5.23). The differences in the distribution of cases of 
anxiety and depression for the different types of IBD were not statistically 
significant. The CD group was, however, more likely to report being a case of 
psychological distress and poor health related quality of life than the UC group 





Table 5.23: Time 2 cases of anxiety, depression, psychological distress and 
health related quality of life by disease type. 
N=170 UC CD X2 & p value 
n (% ) cases of 
Anxiety at time 2 
















Pearson chi2(1) = 2.09    p=0.15 
n (%)  cases of 
depression at time 2 
















Pearson chi2(1) = 0.01    p=0.91 
N (%) Cases of 
general 
psychological 
distress at time 2 




















Pearson chi2(1) = 10.94  p=0.001 
N (%) Cases of poor 
quality of life at 
time 2 (scoring  56 















Pearson chi2(1) = 7.44    p=0.01 
 
 
Sociodemographic, clinical and psychological factors assessed at baseline 
(Time 1) associated with cases of anxiety at 3 month follow up (Time 2)  
Based on the univariable analysis (Table 5.24), sociodemographic and clinical 
variables assessed at baseline (Time 1) significantly associated with cases of 
anxiety at 3 month follow up (Time 2) were gender, age and disease activity for 





Table 5.24: Univariate analysis: Sociodemographic & clinical factors assessed 




Socio- demographic & clinical 
variables. 
Non cases Cases  Unadjusted odds ratio with 95% CI 











0.34 (0.15-0.76)   p=0.01 
Age :  
1=Under 35 yrs. 
2=35-55 yrs.  











0.78 (0.39-1.59)   p=0.50 
0.40 (0.15-1.05)   p=0.06 
Marital status  










1.31 (0 69-2.51)   p= 0.407   
Ethnicity 
1=English / Welsh / Scottish 
2=Mixed/multiple 
3=Asian/Asian British 













0.89 (0.88-8.89)   p=0.19 
0.66 (0.13-3.33)   p=0.62 












1.27 (0.66-2.44)  p=0.48 
Sociodemographic & Clinical 
factors (continuous data) 
Mean & (SD) Unadjusted odds ratio, (95% CI) and 
p value 
Disease activity : 
Ulcerative colitis  
4.53    (3.68) 1.38 (1.15-1.65) p=0.001  
 
Disease activity : 
Crohn’s disease  
6.63    (3.36) 1.15 (1.04-1.28) p=0.01 
Age of Diagnosis 30.30    (13.22) 0.99 (0.97-1.02) p=0.77  




Univariable analysis identified statistically significant associations between all 
psychological measures assessed at time 1 and time 2 cases of anxiety when 
unadjusted for sociodemographic or clinical variables (Table 5.25). Adjusting 
for age or gender had little impact on these relationships. However the 
associations between some psychological variables assessed at time 1 and time 
2 cases of anxiety were reduced or eliminated when symptomatic disease 
activity was adjusted for. For the UC group, after adjusting for disease activity 
time 2 cases of anxiety were associated with time 1 anxiety (HADSA), 
depression (HADSD), lower quality of life (SIBDQ), lower levels of acceptance 
beliefs towards symptoms (CPAQ), avoidant behavioural responses to 
gastrointestinal symptoms (IBS-BRQ: A), fear avoidance beliefs (CBRQ: FA), 
damage beliefs (CBRQ; D), symptom focusing (CBSQ: SF), resting behaviour 
(CBRQ: R) and all or nothing behaviour(CBRQ: AL). For the CD group, after 
adjusting for disease activity time 2 cases of anxiety were associated with 
baseline anxiety (HADSA), lower levels of acceptance beliefs (CPAQ), avoidant 
and safety seeking behavioural responses to gastrointestinal symptoms (IBS-
BRQ), symptom focusing (CBRQ: SF), all or nothing behaviour (CBRQ: AL) and 





Table 5.25: Univariable and multivariable analysis: Psychological variables 
assessed at time 1 associated with time 2 cases of moderate anxiety (=>11 





with 95% CI 



























































































































































































Key : HADSA: hospital anxiety and depression scale: anxiety,  HADSD: hospital anxiety and depression scale: depression, 
SIBDQ: Short Inflammatory bowel disease questionnaire, BES: beliefs about emotions scale, CPAQ: acceptance scale 
adapted from the chronic pain acceptance questionnaire, IBS-BRQ: irritable bowel syndrome behavioural response 
questionnaire, A: avoidance behaviour, S: safety seeking behaviour, CBRQ: cognitive behavioural responses questionnaire,   
FA: fear avoidance beliefs ,  D: damage beliefs,  SF: symptom focusing,  R: resting behaviour,  AL: all or nothing behaviour, 




Each psychological factor was then entered on its own in a multivariable model 
collectively with all statistically significant sociodemographic and clinical 
variables to further test associations with time 2 cases of anxiety. For the UC 
group, the relationships between fear avoidance beliefs and all or nothing 
behaviour and time 2 cases of anxiety were no longer significant (Table 5.26). 
For the CD group, symptom focusing was no longer a significant predictor of 
time 2 anxiety (Table 5.27).  
 
Table 5.26: Multivariable analysis: Each psychological factor assessed at time 
1 associated with time 2 cases of moderate anxiety (=>11 HADSA) on its own 
in a gender, age and symptomatic disease activity adjusted model (UC). 
 
  
Independent predictors Adjusted for gender, age and disease activity : 
Odds ratio, confidence interval and p value  
 (UC group) 
T1HADSA 1.40  (1.15-0.49)    p =< 0.01 
T1HADSD 1.60  (1.22-2.08)   p=<0.01 
T1SIBDQ  0.86  (0.79-0.94)   p=< 0.01 
BeS 1.04  (0.99-1.09   p=0.13 
CPAQ 0.93  (0.87-0.99)  p= 0.02 
IBS-BRQ: A 1.04  (1.00-1.09)  p=0.04 
IBS-BRQ: S 1.06  (0.98-1.14)  p=0.13 
CBRQ: Fear avoidance  1.28  (0.93-1.76)  p= 0.12 
CBRQ: Damage beliefs  1.60  (1.04-2.44)  p=  0.03 
CBRQ: Symptom focusing 1.55  (1.12-2.17)  p=0.01 
CBRQ: Resting 1.31  (1.03-1.68)  p= 0.03 
CBRQ: All or nothing  1.24  (0.98-1.57)  p=0.08 




Table 5.27: Multivariable analysis: Each psychological factor assessed at time 
1 associated with time 2 cases of moderate anxiety (=>11 HADSA) on its own 
in a gender, age and symptomatic disease activity adjusted model (CD) 
 
 
Sociodemographic, clinical and psychological factors assessed at baseline 
(Time 1) associated with cases of depression at 3 month follow up (Time 2) 
Univariable analysis identified no significant associations between any 
sociodemographic variables assessed at baseline (Time 1) and cases of 
depression assessed at three month follow up (Time 2). Statistically significant 
associations were identified between disease activity in ulcerative colitis and 
Crohn’s disease and cases of depression at 3 month follow up (Time 2) (Table 
5.28)   
Univariable analysis identified statistically significant associations between the 
majority of psychological measures (all except for damage beliefs (CBSQ: D) 
and embarrassment avoidance beliefs (CBSQ: EA)) assessed at time 1 and time 
2 cases of depression when unadjusted for clinical variables (Table 5.29). 
Independent predictors Adjusted gender, age and symptomatic disease 
activity Adjusted Odds ratio, confidence interval 
and p value  ( CD group) 
T1HADSA 1.28  (1.11-1.48)  p<0.01 
T1HADSD 1.12  (0.98-1.29)  p=0.09 
T1SIBDQ  0.97  (0.92-1.02)  p=0.25 
Bes 1.02  (0.99-1.06)  p=0.21 
CPAQ 0.96  (0.92-0.99)  p=0.02 
IBS-BRQ: A 1.04  (1.01-1.06)  p<0.01 
IBS-BRQ: S 1.07  (1.03-1.12)  p<0.01 
CBRQ: Fear avoidance  1.21  (0.98-1.49)  p=0.08 
CBRQ: Damage beliefs  1.14  (0.93-1.40)  p=0.21 
CBRQ: Symptom focusing 1.17  (0.99-1.39)  p=0.62 
CBRQ: Resting 1.15  (0.95-1.41)  p=0.16 
CBRQ: All or nothing  1.34  (1.12-1.60)  p<0.01 




Adjusting for symptomatic disease activity significantly reduced or eliminated 
the majority of these relationships. For the UC group after adjusting for 
symptomatic disease activity time 2 cases of depression were associated with 
time 1 anxiety (T1HADSA), and depression (T1HADSD). For the CD group, after 
adjusting for symptomatic disease activity, time 2 cases of depression were 
associated with time 1 anxiety (T1HADSA), depression (T1HADSD), and poor 
quality of life (T1SIBDQ). Individual psychological factors were not tested 
further in separate multivariable models as there were no additional 
significantly associated sociodemographic or clinical variables to collectively 





Table 5.28: Univariate analysis: Sociodemographic & clinical factors assessed 
















Cases  Unadjusted odds ratio with 












0.51 (0.22-1.34)   p=0.19 
Age :  
1=Under 35 yrs. 
2=35-55 yrs.  











0.91 (0.39-2.09)   p=0.83 
0.75 (0.26-2.17)   p=0.60 
Marital status  










0.59 (0.27-1.26)   p= 0.17 
Ethnicity 
1=English / Welsh / Scottish /etc.  
2=Mixed/multiple 
3=Asian/Asian British 













1.78 (0.17-18.26) p=0.63 
1.01 (0.20-5.30)   p=0.71   












0.89 (0.42-1.92)   p=0.78 
Sociodemographic & Clinical factors 
(continuous data) 
Mean & (SD) Unadjusted odds ratio, (95% 
CI) and p value 
Disease activity: Ulcerative colitis  4.53       (3.68) 1.39 (1.15-1.68)   p=0.001 
Disease activity: Crohn’s disease  6.63       (3.36) 1.21 (1.06-1.38) p=0.003 
Age of diagnosis 30.30     (13.22) 1.01 (0.98-1.04) p=0.55 




Table 5.29: Univariable and multivariable analysis: Psychological variables 
assessed at time 1 associated with time 2 cases of moderate depression 
(=>11 HADSD) (unadjusted and adjusted). 
 
Key : HADSA: hospital anxiety and depression scale: anxiety, HADSD: hospital anxiety and 
depression scale: depression, SIBDQ: Short Inflammatory bowel disease questionnaire, BES: beliefs 
about emotions scale, CPAQ: acceptance scale adapted from the chronic pain acceptance 
questionnaire, IBS-BRQ: irritable bowel syndrome behavioural response questionnaire, A: avoidance 
behaviour, S: safety seeking behaviour, CBRQ: cognitive behavioural responses questionnaire,   FA: 
fear avoidance beliefs, D: damage beliefs, SF: symptom focusing, R: resting behaviour,  AL: all or 




Unadjusted odds ratio 
with 95% CI and p value: 
(Whole sample n =170)  
Adjusted for disease 
activity UC (UC group 
only n= 79) 
Adjusted for disease 
activity T2CD (CD group 
only n=91 ) 
T1 HADSA 1.26 (1.14-1.38) p<0.001 1.22 (1.04-1.42) p=0.02 1.18 (1.03-1.34) p=0.001 
T1 HADSD 1.37 (1.22-1.54) p<0.001 1.39 (1.12-1.73) p<0.01 1.22 (1.03-1.45) p=0.02 
T1 SIBDQ .922 (.886-.959) p<0.001 0.96 (0.89-1.03) p=0.29 0.95 (0.89-1.02) p=0.04 
BES  1.04 (1.01-1.07) p=0.007 1.02 (0.97-1.07) p=0.42 1.03 (0.99-1.07) p=0.18 
CPAQ 0.95 (0.92-0.98) p=0.002 0.97 (0.92-1.03) p=0.34 0.97 (0.93-1.01) p=0.17 
IBS-BRQ: A 1.03 (1.03-1.05) p=<0.01 1.02 (0.98-1.07) p=0.31 1.01 (0.99-1.04) p=0.44 
IBS-BRQ: S 1.07 (1.03-1.11) p<0.001 1.06 (0.98-1.14) p=0.14 1.04 (0.99-1.09) p=0.07 
CBRQ: FA 1.34 (1.13-1.59) p=0.001 1.18 (0.88-1.59) p=0.26 1.18 (0.92-1.52) p=0.20 
CBRQ: D 1.10 (0.92-1.30) p=0.295 0.96 (0.67-1.38) p=0.82 0.01 (0.79-1.27) p=0.98 
CBRQ: SF 1.20 (1.05-1.38) p=0.008 1.17 (0.90-1.51) p=0.24 1.03 (0.86-1.25) p=0.73 
CBRQ: R  1.22 (1.07-1.40) p=0.003 1.07 (0.87-1.32) p=0.53 1.09 (0.87-1.35) p=0.45 
CBRQ: AL  1.20 (1.07-1.35) p=0.002 1.05 (0.86-1.28) p=0.62 1.12 (0.93-1.36) p=0.23 




Sociodemographic, clinical and psychological factors assessed at baseline 
(Time 1) associated with cases of general psychological distress at 3 month 
follow up (Time 2). 
Univariable analysis identified statistically significant associations between 
gender, comorbid health problems, years in education and symptomatic 
disease activity for both UC and CD assessed at baseline (Time 1) and cases of 
general psychological distress assessed at 3 month follow up (Time 2) (Table 
5.30). Univariable analysis identified statistically significant associations 
between all-time 1 psychological measures except for damage beliefs (CBRQ: 
D) and time 2 cases of general psychological distress when unadjusted for 
sociodemographic or clinical variables (Table 5.31). Adjusting for gender, 
comorbidity or years in education had minimal impact on these relationships, 
however adjusting for symptomatic disease activity reduced or eliminated 





Table 5.30: Univariate analysis: Sociodemographic & clinical factors assessed 






Socio-demographic variables   Non cases Cases Unadjusted odds ratio with 











0.40 (0.20-0.8)     p=0.01 
Age :  
1=Under 35 yrs. 
2=35-55 yrs.  











1.10 (0.56-2.17)   p=0.78 
0.60 (0.26-1.43)   p=0.25 
Marital status  









0.97 (0.53-1.77)   p= 0.92 
Ethnicity 
1=English / Welsh / Scottish / etc. 
2=Mixed/multiple 
3=Asian/Asian British 













1.97 (0.27-14.63) p=0.51 
0.39 (0.26-14.63) p=0.40 











1.99 (1.07-3.74)   p=0.03 
Sociodemographic & Clinical factors 
(continuous data) 
Mean & (SD) Unadjusted odds ratio, (95% 
CI) and p value 
Disease activity: Ulcerative colitis:  4.53    (3.68) 1.37   (1.15-1.62)   p<0.001 
Disease activity: Crohn’s disease  6.63    (3.36) 1.21   (1.07-1.36)   p=0.002 
Age of diagnosis 30.30  (13.22) 1.01   (0.990-1.04) p=0.25 




After adjusting for symptomatic disease activity for the UC group, time 2 cases 
of  general psychological distress were associated with time 1 anxiety 
(T1HADSA), time 1 depression (T1HADSD), time 1 poor health related quality of 
life (T1SIBDQ), unhelpful beliefs about emotions (BeS), lower levels of 
acceptance beliefs towards symptoms (CPAQ) and all or nothing behaviour 
(CBRQ: Al). For the CD group, time 2 cases of  general psychological distress 
were associated with baseline anxiety, (T1HADSA), baseline depression 
(T1HADSD), poor health related quality of life (T1SIBDQ), lower levels of 
acceptance beliefs towards symptoms (CPAQ), avoidant and safety seeking  
behavioural responses to gastrointestinal symptoms (IBS-BRQ: A & S) and all or 





Table 5.31: Univariable and multivariable analysis: Psychological variables 
assessed at time 1 associated with time 2 cases of general psychological 




odds ratio with 







































































































































































































































































Each psychological factor was then tested individually in a multivariable model 
with all statistically significant sociodemographic and clinical variables included 
(gender, comorbidity, years in education and symptomatic disease activity) to 
further test associations with time 2 cases of general psychological distress. For 
the UC group, the relationships between time 1 anxiety (HADSA), depression 
(HADSD), poor health related quality of life (T1SIBDQ) and lower levels of 
acceptance beliefs towards symptoms (CPAQ) and time 2 cases of 
psychological distress remained significant whilst unhelpful beliefs about 
experiencing and expressing negative emotions (BES) and all or nothing 
behaviour did not (Table 5.32). For the CD group the relationships between 
time 1 anxiety (T1HADSA), depression (T1HADSD), avoidant and safety seeking 
behavioural responses to gastrointestinal symptoms (IBS-BRQ) and all or 
nothing behaviour (CBRQ: AL) and time 2 cases of general psychological 
distress retained their significance but baseline poor health related quality of 
life (T1SIBDQ) and lower levels of acceptance beliefs towards symptoms 





Table 5.32: Multivariable analysis: Each psychological factor assessed at time 
1 associated with time 2 cases of general psychological distress (=>15 HADST) 
on its own in a gender, years in education, comorbidity, symptomatic disease 
activity adjusted model (UC) 
Independent predictors Adjusted for gender, yrs. in education , comorbidity & 
disease activity : Odds ratio, confidence interval and p value  
 (UC group) 
T1 HADSA 1.38  (1.13-1.69)  p=0.001 
T1 HADSD 1.48  (1.18-1.85)  p=0.001 
T1 SIBDQ  0.81  (0.73-0.92)  p=0.001 
BeS 1.05  (0.99-1.10)  p=0.081 
CPAQ 0.94  (0.88-0.99)  p=0.03 
IBS-BRQ: A 1.03  (0.92-1.05)  p=0.24 
IBS-BRQ: S 1.04  (0.97-1.01)  p=0.26 
CBRQ: Fear avoidance  1.08  (0.81-1.43)  p=0.60 
CBRQ: Damage beliefs  1.07  (0.79-1.46)  p=0.68 
CBRQ: Symptom focusing 1.24  (0.97-1.58)  p=0.09 
CBRQ: Resting 1.07  (0.86-1.33)  p=0.55 
CBRQ: All or nothing  1.18  (0.93-1.48)  p=0.17 
CBRQ: Embarrassment avoidance 0.97  (0.75-1.15)  p=0.49 
 
 
Table 5.33: Multivariable analysis: Each psychological factor assessed at time 
1 associated with time 2 cases of general psychological distress (=>15 HADST) 
on its own in a gender, years in education, comorbidity, symptomatic disease 
activity adjusted model (CD) 
 
Independent predictors Adjusted for gender, years in educations,  comorbidity  and 
disease activity : Odds ratio, confidence interval and p value  
 (CD group) 
T1HADSA 1.28   (1.10-1.51)   p=0.002 
T1HADSD 1.21   (1.01-1.44)   p=0.04 
T1SIBDQ  0.95   (0.89-1.01)   p=0.09 
BeS 1.02   (0.98-1.06)   p=0.35 
CPAQ 0.96   (0.92-1.00)   p=0.07 
IBS-BRQ: A 1.03   (1.01-1.05)   p=0.01 
IBS-BRQ: S 1.05   (1.01-1.10)   p=0.02 
CBRQ: Fear avoidance  1.12   (0.91-1.39)   p=0.29 
CBRQ: Damage beliefs  1.20   (0.96-1.50)   p=0.12 
CBRQ: Symptom focusing 1.12   (0.94-1.33)   p=0.19 
CBRQ: Resting 1.11   (0.90-1.37)   p=0.31 
CBRQ: All or nothing  1.35   (1.11-1.64)   p<0.01 




Sociodemographic, clinical and psychological factors assessed at baseline 
(Time 1) associated with cases of poor health related quality of life at 3 
month follow up (Time 2). 
Univariable analysis identified statistically significant associations between age 
and symptomatic disease activity for both UC and CD assessed at baseline 
(Time 1) and cases of poor health related quality of life at 3 month follow up 
(Time 2) (Table 5.34). 
Table 5.34: Univariable analysis: Sociodemographic & clinical factors assessed 
at time 1 associated with time 2 cases of poor health related quality life 
(=<56 SIBDQ)  
 
 
Socio-demographic variables  Non cases Cases Unadjusted odds ratio with 95% 
CI and p value: 

























0.64   (0.26-1.60)   p=0.34 
0.31   (0.11-0.83)   p=0.02 
Marital status  
Living with Partner =1 







1.02   (0.48-2.14)   p=0.96 
Ethnicity 
















1.25   (0.13-12.58) p=0.85 
0.31   (0.11-0.83)   p=0.51 
3.76   (0.46-31.10) p=0.22 










1.62   (0.77-3.40)   p=0.21 
Sociodemographic & Clinical 
factors (continuous data) 
Mean & (SD) Unadjusted odds ratio with  95% 
CI and p value 
Disease activity: Ulcerative 
colitis:  
4.53      (3.68)  
1.18   (1.0-1.38)     p=0.05 
Disease activity: Crohn’s disease 6.63      (3.36) 1.39  (1.10-1.77)    p=0.007 
Age of diagnosis 30.30  (13.22) 0.90  (0.96-1.02)    p=0.44 




Univariable analysis identified statistically significant associations between 
time 1 anxiety (T1HADSA), depression (T1HADSD), poor health related quality 
of life (T1SIBDQ), unhelpful beliefs about experiencing negative emotions 
(BeS), lower levels of acceptance beliefs towards symptoms (CPAQ), avoidant 
and safety seeking behavioural responses to gastrointestinal symptoms (IBS-
BRQ) and all or nothing behaviour (CBSQ: Al) and time 2 cases of poor health 
related quality of life when unadjusted for sociodemographic or clinical 
variables (Table 5.35). Adjusting for age had minimal effect on these 
associations. Adjusting for symptomatic disease activity had a significant 
impact on the majority of relationships.  
After adjusting for symptomatic disease activity, time 2 cases of poor quality of 
life were not significantly associated with any psychological measures assessed 
at baseline for the UC group (Table 5.35). For the CD there were significant 
relationships with time 1 depression (T1HADSD) and poor health related 
quality of life (T1SIBDQ). These associations remained unchanged when each 
psychological factor was tested on its own in a multivariable model which 





Table 5.35: Univariable and multivariable analysis: Psychological variables 
assessed at time 1 associated with time 2 cases of poor quality of life (=<56 
SIBDQ) (unadjusted and adjusted) 
 
Key : HADSA: hospital anxiety and depression scale: anxiety, HADSD: hospital anxiety and 
depression scale: depression, SIBDQ: Short Inflammatory bowel disease questionnaire, BES: beliefs 
about emotions scale, CPAQ: acceptance scale adapted from the chronic pain acceptance 
questionnaire, IBS-BRQ: irritable bowel syndrome behavioural response questionnaire, A: avoidance 
behaviour, S: safety seeking behaviour, CBRQ: cognitive behavioural responses questionnaire,   FA: 
fear avoidance beliefs, D: damage beliefs, SF: symptom focusing, R: resting behaviour,  AL: all or 




ratio with 95% CI 
and p value: 
(Whole sample 
n=170) 
Adjusted for age 










(CD group only 
n=91) 
T1 HADSA 1.16 (1.05- 1.28) 
p=0.003 
1.15 (1.04-1.27)  
p<0.01 
1.06 (0.92-1.20)  
p=0.47 
1.11 (0.92-1.33)  
p=0.28 
T1 HADSD 1.27 (1.12-1.44)  
p<0.001 
1.26 (1.11-1.44)  
p<0.001 
1.05 (0.90-1.24)  
p=0.46 
1.54 (1.12-2.11)  
p=0.01 
T1  SIBDQ 0.91 (0.87-0.95)  
p<0.001 
0.91 (0.86-0.95)  
p<0.001 
0.97  (0.91-1.02) 
p=0.21 
0.87 (0.91-1.26)  
p=0.03 
BES 1.02 (0.99-1.05)  
p=0.01 
1.02 (1.00-1.05)  
p=0.02 
0.99 (0.95-1.03)  
p=0.59 
1.02 (0.96-1.07)  
p=0.64 
CPAQ  0.96 (0.94-0.99)  
p=0.01 
0.97 (0.94-0.99)  
p=0.02 
0.99 (0.90-1.05)  
p=0.97 
0.96 (0.90-1.01)  
p=0.13 
IBS BRQ: A 1.03 (1.01-1.05)  
p<0.01 
1.02 (1.01-1.04)  
p=0.02 
1.01 (0.99-1.04)  
p=0.62 
1.03 (0.99-1.06)  
p=0.23 
IBS-BRQ: S  1,03 (1.01-1.06)  
p=0.02 
1,03 (1.01-1.06)  
p=0.04 
1.01( 0.96-1.05)  
p=0.84  
1.05 (0.99-1.11)  
p=0.10 
CBRQ: FA 1.07 (0.91-1.24)  
p=0.42 
1.05 (0.90-1.23)  
p=0.52 
0.73 (0.55-0.96)  
p=0.12 
1.25 (0.92-1.69)  
p=0.15 
CBRQ: D 0.88 (0.74-1.05)  
p=0.15 
0.84 (0.69-1.01)  
p=0.06 
0.96 (6.76-1.20)   
p= 0.70 
0.67 (0.43-1.05)  
p=0.06 
CBRQ: SF 1.08 (0.96-1.22)  
p=0.20 
1.05 (0.93-1.19)  
p=0.41 
1.02 (0.87-1.20)  
p=0.79 
1.10 (0.87-1.39)  
p=0.41 
CBRQ: R  1.09 (0.94-1.25)     
p =0.26 
1.04 (0.89-1.20)  
p=0.61 
0.94 (0.77-1.15)  
p=0.54 
1.03 (0.77-1.37)  
p=0.86 
CBRQ: AL  1.14 (1.01-1.28)  
p=0.03 
1.12 (0.99-1.27)  
p=0.06 
1.13 (0.94-1.40)  
p=0.17 
0.94 (0.75-1.19)  
p=0.60  
CBRQ: EA 1.06 (0.94-1.20)  
p=0.36 
1.05 (0.93-1.19)  
p=0.45 
0.94 (0.78-1.12)   
p= 0.47 





Table 5.36: Multivariable analysis: Each psychological factor assessed at time 
1 associated with time 2 cases of poor quality of life (=<56 SIBDQ) on its own 




Table 5.37: Multivariable analysis: Each psychological factor assessed at time 
1 associated with time 2 cases of poor quality of life (=<56 SIBDQ) on its own 
in an age and symptomatic disease activity adjusted model (CD) 
 
  
Independent predictors Adjusted for age and disease activity : Odds ratio, 
confidence interval and p value  
 (UC group) 
T1(HADSA 1.03   (0.90-1.17)   p= 0.68 
T1HADSD 1.02   (0.88- 1.18)  p= 0.82 
T1SIBDQ  0.98   (0.93-1.04)   p= 0.57 
BeS 0.99   (0.95- 1.03)  p=0.64 
CPAQ 1.01   (0.97- 1.06)  p= 0.59 
IBS-BRQ: A                         1.01  (0.98- 1.02)  p= 0.86 
IBS-BRQ: S 1.01   (0.95-1.05)   p=0.96 
CBRQ: Fear avoidance  0.90   (0.76-1.07)   p=0.25 
CBRQ: Damage beliefs  0.83   (0.64-1.05)   p=0.13 
CBRQ: Symptom focusing 0.92   (0.76-1.12)   p= 0.40 
CBRQ: Resting 0.89   (0.73-1.12)   p= 0.33 
CBRQ: All or nothing  1.12   (0.92-1.38)   p= 0.27 
CBRQ: Embarrassment avoidance 0.84   (0.67-1.04)   p=0.17 
Independent predictors Adjusted for  age and disease activity : Odds ratio, 
confidence interval and p value  
 (CD group) 
T1(HADSA 1.10  (0.91- 1.33)  p=0.33 
T1HADSD 1.63  (1.14- 2.35)  p=<0.01 
T1SIBDQ  0.87  (0.77-0.99)   p= 0.03 
BeS 1.02  (0.96- 1.08)  p=0.53 
CPAQ 0.96  (0.91-1.02)   p=0.17 
IBS-BRQ: A 1.02  (0.99-1.05)   p=0.23 
IBS-BRQ: S  1.04  (0.98-1.10)   p=0.17 
CBRQ: Fear avoidance  1.20  (0.87-1.64)   p=0.26 
CBRQ: Damage beliefs  0.67  (0.42-1.05)   p=0.08 
CBRQ: Symptom focusing 1.08  (0.85-1.37)   p=0.51 
CBRQ: Resting 0.98  (0.72-1.35)   p=0.92 
CBRQ: All or nothing  0.95  (0.75-1.22)   p=0.70 





As hypothesised this study found that unhelpful cognitive, emotional and 
behavioural responses were associated with baseline (Time 1) cases of anxiety, 
depression, general psychological distress and poor quality of life for adults 
with inflammatory bowel disease, when taking sociodemographic and clinical 
factors into account. In addition, a range of these responses were found to 
increase the risk of being a case of anxiety, depression, general psychological 
distress or poor health related quality of life at three month follow up (Time 2). 
The results will now be discussed in more detail.  
 
Anxiety 
The prevalence of probable cases of anxiety in this study was approximately 
30% for the UC group and 37% for the CD group at baseline (Time 1) and 3 
month follow up (Time 2). This is similar to the 31.6% reported in the empirical 
literature for life time prevalence rates of anxiety in this population (Walker et 
al, 2008). 
 
The cross sectional analysis identified baseline cases of anxiety to be 
associated with a largely similar range of psychological responses for both the 
UC and CD group. After adjusting for significant sociodemographic and clinical 
factors, time 1 cases of anxiety for both groups were associated with; believing 
it to be unacceptable to experience and express negative emotions (BeS), 
lacking acceptance beliefs towards symptoms (CPAQ), thinking a lot about 




behavioural responses to symptoms such as knowing the whereabouts of the 
nearest toilets or carrying spare clothes (IBS-BRQ: A) and overdoing things on a 
good day when symptoms were minimal (CBRQ: AL). For the UC group only, 
perceiving symptoms to be a sign that something serious was happening 
physically (CBRQ: D) and resting to manage symptoms (CBRQ: R) were also 
significantly linked to time 1 anxiety. This is consistent with the findings of 
previous cross sectional studies which have linked anxiety to more severe 
perceptions of the illness and to emotion focused coping strategies (Knowles 
et al, 2011, Goodhand et al, 2012, Tribbick et al, 2015, Rochelle et al, 2012).   
 
At 3 month follow up (Time 2), anxiety continued to show associations with 
unhelpful cognitive, emotional and behavioural responses with some 
similarities and differences apparent between groups. A lack of acceptance 
beliefs towards symptoms were a significant risk factor for anxiety at time 2 for 
both the UC and CD groups. This unhelpful cognitive response has been linked 
to anxiety in several long term conditions including chronic pain (McCracken et 
al, 1998) and chronic obstructive pulmonary disease (Uchmanowicz et al, 
2006). 
  
For the CD group, baseline anxiety, feeling ashamed of symptoms or worried 
about others opinions of them (CBRQ: EA), overdoing things on a good day 
when symptoms were minimal (CBRQ: AL), and avoidant and safety seeking 
behavioural responses to gastrointestinal symptoms were also significant 
predictors of anxiety at 3 month follow up (Time 2).  




which arises from the perception of serious threat and is carried out in order to 
avert the feared catastrophe. It is perceived as preventative by the individual 
and is focused on the imagined negative consequences of the threat. It is 
considered by the cognitive behavioural approach to be an important factor in 
the maintenance of anxiety disorders as it promotes a hypervigilance towards 
the feared event and prevents disconfirmation of threat related cognitions 
(Salkovskis et al, 1998).   
 
Safety seeking behavioural responses to gastrointestinal symptoms which were 
found to increase the risk of anxiety at 3 month follow up (Time 2) in this study 
included strategies such as avoiding staying away from home overnight or 
frequently visiting the toilet and finding it unnecessary. According to the CBT 
model, these behaviours in combination with avoidant behavioural responses 
(e.g. always knowing the whereabouts of the nearest toilet) would be intended 
to prevent the occurrence of perceived shame or social judgement which is 
anticipated in responses to the occurrence of symptoms in public. Although a 
flare up in disease activity might have initially necessitated some of these 
responses such as staying home, once  symptoms begin to subside this may be 
less useful as it maintains focus on the feared event, prevents a realistic 
appraisal of its occurrence and consequences and maintains anxiety. Engaging 
in excessive activity to get tasks finished when symptoms are at their least 
intrusive and perhaps least embarrassing would also make sense in this 
context. As anxiety has been associated with increased bowel frequency in 
several studies (Gorard et al, 1996), this may further cloud appraisals and 




For the UC group, baseline levels of anxiety (HADSA) and depression (HADSD), 
perceiving symptoms to be a sign that something serious is happening 
physically (CBRQ: D) and thinking a lot about these symptoms (CBRQ: SF), 
whilst resting to control them (CBRQ: R), increased the risk of being a case of 
anxiety at 3 month follow up (Time 2). According to the cognitive behavioural 
model of anxiety, the perception of symptoms being dangerous is likely to 
promote a hypervigilance towards them (Clark et al, 1999). Behavioural 
responses such as resting would represent attempts to minimise or control the 
danger and the anxiety experienced about it. The inactivity created by this 
behavioural response may be particularly unhelpful for mood as it provides 
further opportunity to focus on symptoms without distraction leading to 
further severe evaluations, more anxiety, more resting and so on. 
Furthermore, as behavioural withdrawal has long been associated with low 
mood in the wider psychological empirical literature and is considered to be a 
perpetuating factor for depression, this behaviour may link to and exacerbate 
baseline levels of depression (Ferster, 1973).  
 
The findings of this study suggest that specific cognitive and behavioural 
responses to symptoms are linked to the experience and risk of developing 
anxiety for people with IBD. In addition baseline levels of anxiety and 
depression were identified as important predictors of subsequent anxious 
symptomology. No previous studies have utilised a cognitive behavioural 
model to explore the psychological factors linked to anxiety or included any 







In this study the prevalence of cases of depression at baseline (Time 1) was 
14% for the UC group and 12% for the CD group. At 3 month follow up (Time 2) 
it was approximately 20% for both groups. This is somewhat less than the 
lifetime prevalence rate of 27% reported in the empirical literature (Walker et 
al, 2008). 
 
Cross sectional analysis identified that baseline cases of depression were 
associated with a range of unhelpful cognitive and behavioural responses 
which showed some similarity and variation by IBD type. After adjusting for 
clinical variables, time 1 cases of depression were significantly associated with 
a lack of acceptance beliefs towards symptoms (CPAQ) for both UC and CD 
groups. This psychological factor was also significantly associated with anxiety 
at baseline and at 3 month follow up for both groups. One previous study 
found a cross sectional association between acceptance towards the 
symptoms, engagement with valued activities and better emotional and social 
functioning in IBD (Kiebles et al, 2010).  
 
Other unhelpful cognitive and behavioural responses were also linked to time 
1 cases of depression but these varied by diagnosis. For the CD group feeling 
ashamed of symptoms and worried about others opinions of them (CBRQ: EA), 
thinking constantly about symptoms (CBRQ: SF), excessively resting to control 




gastrointestinal symptoms (IBS-BRQ: A, S) were significantly associated with 
time 1 cases of depression.  
 
The cognitive behavioural model of depression proposes that low mood is 
linked to extreme beliefs about personal loss and failure which leads to social 
withdrawal. This reduction in social activity is thought to perpetuate low mood 
by reducing the individual’s exposure to situations which would usually provide 
a sense of pleasure and mastery and promote wellbeing (Beck et al, 1976). For 
the CD group, responding to feelings of shame about symptoms and worries 
about others opinions of them by resting or avoiding social situations may 
therefore be particularly unhelpful for mood in several ways. It is likely to 
prevent the individual from evaluating the accuracy of their perceptions 
pertaining to others reactions to their symptoms, maintaining feelings of 
shame and promoting further social withdrawal. The resultant lack of 
engagement in valued activities would then provide further opportunity to 
focus on symptoms and could maintain or exacerbate feelings of depression.  
 
 For the UC group, believing it to be unacceptable to experience negative 
emotions and express these to others (BeS) and excessive resting or napping to 
control symptom (CBRQ: R) were significantly associated with baseline 
depression. These findings suggest that dysfunctional assumptions about the 
self (BeS) rather than Illness specific cognitions are relevant to depression for 
this group. The cognitive behavioural model proposes that individuals who 
believe that anger, fear or sadness should not be experienced or shared may 




from others. Unhelpful beliefs about emotions have been linked to negative 
adjustment outcomes in other long term condition including multiple sclerosis 
(Dennison et al, 2010). Further, the CBT model would hypothesise that the 
reduction in valued and stimulating activities brought about by resting 
behaviour may serve to reinforce low mood (Forester et al, 1973). 
 
At 3 month follow up (Time 2) cases of depression were not associated with 
any of these illness specific cognitive, emotional or behavioural responses 
assessed at baseline for either group. The risk of being a case of depression at 
3 month follow up was significantly increased by baseline anxiety and 
depression for both the UC and CD groups and with baseline poor health 
related quality of life for the CD group only. Initial disturbances to mood and 
health related quality of life are therefore significant risk factors for the 
development of subsequent depressive symptomology. 
 
It is possible that the absence of any associations between psychological 
measures and time 2 cases of depression in this study are a result of the 
psychological concepts measured. These may have failed to capture the 
psychological processes pertinent to this mood disorder. Several studies have 
identified feeling misunderstood, stigmatised and alienated due to IBD 
symptoms to be associated with symptoms of depression (Jordan et al, 2017, 
Kemp et al, 2012, Taft et al, 2009).  Further, low self-esteem and hopelessness 
have been linked to reduced emotional functioning in this population in two 




longitudinal studies may benefit from including measures focused on assessing 
stigma, hopelessness and dysfunctional assumptions related to the self. 
 
General psychological distress  
In this study the prevalence of cases of general psychological at baseline (Time 
1) was approximately 30% for the UC group and 43% for the CD group. At 3 
month follow up this had increased to 40% for the UC and 50% for the CD 
group. Previous studies have reported prevalence rates of approximately 30% 
(Dorrian et al, 2009). 
 
At time 1 cases of general psychological distress were associated with a range 
of unhelpful cognitive, emotional and behavioural responses. For both groups, 
believing it to be unacceptable to experience and share negative emotions 
(BeS), a lack of acceptance beliefs towards symptoms (CPAQ) and thinking 
excessively about symptoms (CBRQ: SF) were important. For the UC group 
only, excessive resting to manage symptoms (CBRQ: R) and a tendency to 
overdo things on a good day (CBRQ: Al) were also significant. For the CD group 
feeling ashamed of symptoms (CBRQ: EA) and avoiding going out overnight or 
only doing so with spare clothes and a knowledge of the nearest toilet (IBS-
BRQ: A, S) were additional factors linked to distress. 
 
Baseline (Time 1) levels of anxiety (T1HADSA) and depression (T1HADSD) were 
significant risk factors for distress at 3 month follow up (Time 2) for both 




symptoms to be important in the development of subsequent 
psychopathology. For the CD group, behavioural responses to managing 
symptoms (IBS-BRQ & CBSQ: AL) were also important predictors. For the UC 
group cognitive responses (CPAQ) were associated with an increased risk. 
 
Previous studies that have explored the psychological factors associated with 
distress have not conducted separate analyses for UC and CD groups. At a 
cross sectional level, perceptions of stress, severe predictions about the 
consequences of IBD and behavioural disengagement have all been linked to 
general psychological distress (Dorian et al, 2009). Whether these associations 
vary across IBD type or are linked to an increase risk of distress over time has 
not currently been considered in the empirical literature. The findings of this 
study suggest that at 3 month follow up (Time 2), the risk of distress was 
significantly increased by baseline disturbance to mood for both groups; 
unhelpful cognitive responses in UC and unhelpful behavioural strategies for 
CD.  
 
Health related quality of life  
In this study, at baseline the prevalence of probable cases of poor health 
related quality of life was approximately 67% for participants with UC and 69% 
of those with Crohn’s disease. This is consistent with previous studies that 
reported rates of 70% (Swart et al, 2013, Huaman et al, 2010). At 3 month 
follow up this had increased to 75% for the UC group and 88% for the CD 




At baseline after adjusting for significant sociodemographic and clinical 
variables, poor health related quality of life was associated with some 
unhelpful cognitive responses to symptoms; a lack of acceptance beliefs for 
both groups, thinking a lot about symptoms (CBSQ: SF) for the UC group and 
feeling embarrassed or ashamed about symptoms (CBRQ: EA) for the CD 
group. In addition, safety seeking behavioural responses to gastrointestinal 
symptoms such as checking stools for abnormalities (IBS-BRQ: S) and resting to 
control symptoms (CBRQ: R) were also significantly associated with this 
outcome for the CD group. Once again behavioural responses were found to 
be more important for negative adjustment outcomes for the CD group. These 
findings are largely consistent with the results of previous cross sectional 
studies that have found associations between poor health related quality of 
life and more severe illness perceptions and emotion focused coping strategies 
(Guthrie et al, 2002, Turnball et al, 1995). 
 
At 3 month follow up, poor health related quality of life was not significantly 
associated with any cognitive, emotional or behavioural responses measured 
at time 1 for the UC group. For the CD group, baseline levels of depression and 
health related quality were found to be risk factors for poor quality of life in 
the prospective analysis.  
 
Overall these findings highlight the importance of implementing psychological 
interventions for improving initial disturbances to mood for people with IBD as, 
if left untreated, this may become a significant risk factor for the subsequent 




Strength of associations  
The magnitude of association between significantly associated cognitive, 
emotional and behavioural factors assessed at baseline and baseline cases of 
anxiety, depression, general psychological distress and poor quality of life for 
both the UC and CD group were largely similar. The strongest association was 
identified between baseline cases of anxiety and symptom focusing for the UC 
group with an odds ratio of 1.34. 
 
In the prospective analysis the strength of association between significantly 
associated psychological factors assessed at time 1 and time 2 cases of anxiety, 
depression, distress and poor quality of life were generally higher for the UC 
group. Baseline levels of anxiety (OR 1.40) and depression (OR 1.60), damage 
beliefs (OR 1.60) and symptom focusing (OR 1.55) were particularly strong 
predictors for cases of anxiety at 3 month follow up for the UC group. The only 
exception identified was the association between baseline depression and 
poor quality of life for the CD group which had an odds ratio of 1.63. Overall 
baseline disturbances to mood showed the strongest and most frequent 
associations with negative adjustment outcomes at 3 month follow up. This 
reiterates the benefits of early psychological intervention to improve mood in 
IBD.  
 
Clinical implications for improving adjustment outcomes for people with IBD. 
The findings of this study could be useful for identifying individuals that may be 




target psychological interventions at those individuals who begin to become 
preoccupied with their symptoms or who rest excessively to manage them, as 
well as those already exhibiting disturbance to mood. In contrast to 
sociodemographic or disease related factors, cognitive and behavioural 
responses are potentially modifiable through psychological interventions. The 
results of this study give a preliminary indication of potential areas to focus on 
within such an intervention with the aim of improving psychosocial adjustment 
outcomes. This is particularly important for people with IBD as anxiety and 
depression have been found to be independently associated with clinical 
recurrence (Mikocka-Walus et al, 2016).  
 
Given the overlap in cognitive, emotional and behavioural responses 
associated with the range of negative adjustment outcomes examined in this 
study, a transdiagnostic or third wave CBT approach such as acceptance and 
commitment therapy (ACT) may be best suited to treating emotional distress in 
this population. Transdiagnostic cognitive behaviour therapy (TD-CBT) targets 
the shared cognitive and behavioural processes underlying the development 
and maintenance of anxiety and low mood (Clarke & Taylor, 2009). As a 
consequence it is arguably a more efficient way to deal with patients who are 
presenting multiple clinical problems (Mansell et al, 2008). A recent meta-
analysis which included 24 RCT’s found that transdiagnostic CBT treatments 
outperformed control conditions for reducing anxiety and depression and 





It is possible that the nature of IBD symptoms means that it may be difficult to 
modify some illness specific cognitions with a transdiagnostic CBT approach. 
For example, an IBD symptom such as diarrhoea is a result of inflammation of 
the intestines. Believing that the severity of symptoms indicates that 
something serious is going on physically may therefore be a reasonably 
realistic appraisal in some instances. In addition a lack of acceptance beliefs 
towards symptoms and unhelpful behavioural responses to gastrointestinal 
symptoms were important across outcomes. Unlike transdiagnostic CBT in 
which strategies aim to change the content of the unhelpful belief,  a third 
wave CBT approach such as acceptance and commitment therapy (ACT) aims 
to change a person’s relationship and response to the belief. This approach 
focuses on reducing the behavioural and functional influence of thinking and 
seeks to foster a general process called psychological flexibility. This is defined 
as being open, aware and in contact with the present moment, and flexibly 
engaging in behaviours which facilitate overarching life goals. In essence ACT 
does not seek to alleviate the distress experienced about symptoms but 
instead it aims to increase an individual’s ability to undertake meaningful 
activity in its presence. ACT uses a range of methods to engender psychological 
flexibility, such as mindfulness exercises to enable one to be present-moment-
focused, defusion exercises to change one's relationship with thoughts, and 
values elicitation exercises to orientate participants to activities which are in 
line with personally meaningful values (McCracken, 2011). For example, a 
person would be encouraged to notice their feelings of shame and anxiety 
about symptoms and the avoidance of social situation to which this leads. 
Mindfulness practice would be utilised to encourage present moment 




unwanted thoughts and feelings. Personal values would be identified and the 
person would be encouraged to commit to taking action in pursuit of these 
values in the presence of unhelpful thoughts or sensations (Graham et al, 
2016). ACT has been applied across many long-term conditions, including 
cancer (Feros et al, 2013), multiple sclerosis (Nordin & Rorsman, 2012) and 
diabetes (Gregg et al, 2007). It has been found to reduce distress (Nordin & 
Rorsman, 2012) and improve quality of life (Feros et al, 2013). 
 
Limitations and future directions 
 Validated self-report measures were used in this study to assess symptomatic 
disease activity and symptoms of anxiety and depression. Objective 
measurements of mood through structured clinical interview and disease 
activity via endoscopy and faecal calprotectin analysis may give a more robust 
indication of these factors, given that distress may act as a confounder and 
lead to inflated reporting of this phenomenon. 
 
It is unlikely that this study was subject to selection bias as participants were 
not selected in relation to the exposure or outcomes of interest. This study 
employed a convenience sample recruited from an outpatient clinic and 
patient organisation. An advantage of this type of sampling is that it is less 
open to selection bias because the participants are likely to be less selected 
than in randomised controlled trials (Bowling A, 2009). 
Cohort studies can be subject to attrition bias due to differences between 
participants who did and did not complete the follow-up period. However, the 




demographic and clinical variables were similar between the two groups. Also 
there were no statistically significant differences between groups on the 
majority of baseline measures of psychological variables, except that 
participants who completed time 1 & time 2 measures (study completers) had 
higher mean scores for embarrassment avoidance and damage beliefs on the 
cognitive behavioural response scales (Song et al, 2010). 
 
Logistic regression was the method of analysis used in this study. This was  
effective for demonstrating the size of effect. However, due to the binary 
outcome, the extent of the effect may be concealed and some information 
contained in the continuous outcomes may have been lost. Further, a cut off 
score of 11 or more on the HADSA and HADSD was utilised to indicate 
moderate cases of anxiety and depression in the analysis. The results may have 
varied if a score of 7 or more had been employed to delineate mild cases. This 
may also have been the case if different cut off scores had been used for 
distress and poor quality of life.  
 
Due to concerns about collinearity, psychological factors were not entered 
collectively into a multivariable model for each outcome across time points. It 
was therefore not possible to assess which predictor variables were most 
important for negative adjustment outcomes, nor which predictors were 
redundant in the presence of others. Each psychological factor was however 
entered into its own model for each outcome, which was adjusted for relevant 
sociodemographic and disease related factors. It was therefore possible to 
identify the psychological factors which remained significant when taking those 





Additional longitudinal studies are required to further assess the psychological 
risk factors for anxiety, depression, distress and poor quality of life for people 
with IBD. Such studies would benefit from a longer follow up period, over 
which repeated assessments of outcomes could take place. The relatively short 
time-line between baseline and follow up in this study may have left little time 
for change and processes that are truly explanatory may not have become 
clear. Where possible, objective measures of disease related factors and of 
mood should be utilised to provide more robust data on the associations 
between these factors. In this study, data on the age at which participants 
were diagnosed with IBD was collected. In retrospect it may have been more 
useful to assess the length of diagnosis, as a new diagnosis has been linked to 
anxiety in UC in a previous study (Goodhand et al, 2012). In this analysis 
however, age of diagnosis was not associated with any outcomes at time 1 or 
time 2. 
 
In this study, illness specific cognitive and behavioural responses were not 
linked to an increased risk of depression at 3 month follow up. Future 
longitudinal studies exploring the psychological risk factors linked to 
depression for people with IBD would benefit from assessing a wider range of 
variables focused on hopelessness, stigma and self- esteem (Moreno-Jiménez 
et al, 2007, Petrak et al, 2001). 
 
5.6: Conclusion 
To date this is the first study which has utilised a prospective design to explore 




and negative adjustment outcomes. The findings pinpoint the differing 
cognitive, behavioural and emotional responses to IBD, which increase the risk 
of developing disturbances to mood and health related quality of life.  The 
results suggest different psychological factors may need to be targeted in a 
psychological intervention for different outcomes and for different IBD types. A 
third wave CBT approach, such as acceptance and commitment therapy (ACT) 
may be best suited to treating disturbances to the process of adaption in IBD, 
given the nature of the cognitive and behavioural responses identified as risk 
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Objective: Anxiety and depression are common in inflammatory bowel disease 
(IBD) and have been linked to clinical recurrence. Previous randomised 
controlled trials have found no evidence that psychological interventions 
enhance outcomes for people with IBD but have recruited patients without 
distress. This study investigates the clinical benefits of a non-randomised 
uncontrolled study of clinic based cognitive behaviour therapy (CBT) for people 
with IBD who had moderate to severe levels of anxiety or low mood and 
compares the results to a previous randomised controlled trial of CBT in this 
population.  
Method: Assessments were completed at baseline and end of treatment and 
included measures of low mood, generalised anxiety, quality of life and 
symptomatic disease activity. The patient health questionnaire and generalised 
anxiety disorder 7 measures were the primary outcomes. Results in the form of 
a standardized effect size of treatment were compared with a previous 
randomised controlled trial to consider if CBT had greater benefits for those 
with distress.   
Results: Thirty patients were deemed appropriate for CBT and twenty eight 
accepted treatment. The results from this clinic based CBT intervention suggest 
statistically significant reductions in symptoms of anxiety (<0.001), low mood 
(<0.001) and disease activity (p<0.01) and increases in quality of life 
(p<0.001).The uncontrolled effect sizes were large and superior to those found 
in published RCTs. 
Conclusion: This nonrandomised uncontrolled trial of a clinic based CBT 




severe disturbances to mood and that effect sizes can be improved by 
targeting those with distress. RCTs are required to establish efficacy.  
 


























The two most common types of inflammatory bowel disease (IBD) are Crohn’s 
disease (CD) and ulcerative colitis (UC). Both conditions are associated with a 
similar range of unpleasant and incapacitating symptoms which include 
diarrhoea, fatigue and pain in the abdomen. In UC, this is the consequence of 
inflammation which is usually restricted to the colon where as in CD any part of 
the intestines can become affected. Extra intestinal symptoms can also occur, 
the most common being anaemia (Stein et al, 2010). The course of IBD is 
changeable and episodic in nature. Its precise aetiology remains elusive and 
there is currently no conclusive cure. Current IBD treatments target the 
inflammatory response during flare episodes with regular medication to 
maintain remission (Kiebles, et al, 2010). 
 
People with IBD are at increased risk of developing anxiety and depression. The 
empirical evidence demonstrates the life time prevalence rates of these 
emotional disorders to be as high as 35.8% (Walker et al, 2008). Anxiety and 
depression are independently associated with clinical recurrence (Mikocka-
Walus et al, 2016) and have been linked to increased inflammation (Maunder 
et al, 2008). Further, psychological distress in IBD can be influenced by disease 
related factors such as relapses, as well as general psychological factors. A 
recent systematic review found that emotion focused coping strategies, 
extreme perceptions of the illness and of being stressed were significantly 
associated with worse mental health outcomes, and this was maintained when 
controlling for the influence of disease related variables (Jordan et al, 2016). 
Psychological factors are potentially modifiable through psychological 




psychological interventions to improve outcomes in IBD has increased 
(Knowles et al, 2013). 
 
Several reviews have been published which have examined the impact of 
psychotherapy on biopsychosocial outcomes for people with IBD (Gracie et al , 
2017, Knowles et al, 2013, McCombie, et al, 2013, Timmer et al, 2011). A 
Cochrane meta-analysis of randomised controlled trials (RCTs) concluded that 
there was no evidence that psychological interventions enhanced emotional 
states, quality of life (QOL) or reduced disease activity in the short term or at 
12 months in unselected adults with IBD. It did though suggest that 
psychotherapy may benefit subgroups of patients with emotional needs and 
recommended future research should evaluate this (Timmer et al, 2011). 
 
A major problem associated with the RCTs included in the Cochrane meta-
analysis is that 19 out of 20 studies included adult patients without distress at 
the start. Mean scores for mood measures indicated that participants had 
symptoms in the sub clinical range. This is likely to have significantly reduced 
any potential treatment effects as participants generally had good mental 
health (Timmer et al, 2011).  
 
Two trials published subsequently comparing group and computerised 
cognitive behaviour psychotherapy (CBT) with treatment as usual have 
continued this trend (Mikocka-Walus et al, 2015, McCombie et al, 2016). Their 
findings confirm that the impact of CBT is limited for those without disturbance 
to mood. However, post hoc sub group analysis conducted by Mikocka-Walus 




scores for anxiety and low mood at baseline. It seems intuitively sensible to 
target the group with most clinical need (Timmer et al, 2011), as 
improvements in mood may ultimately alleviate the aspect of disease activity 
which is linked to or driven by psychological distress. 
 
As yet the impact of a clinic based CBT intervention on biopsychosocial 
outcomes for people with IBD and anxiety and low mood has not been 
evaluated or considered in relation to the findings of RCTs.  This study will 
therefore evaluate whether a clinic based CBT intervention for people with IBD 
and moderate-severe anxiety or low mood shows promise. We think it is likely 
that by targeting those patients with moderate to severe low mood or anxiety 
that significant changes will be observed in the primary outcome measures. 
We will then compare the results of this open study to previous RCT results. 
The treatment location for this study was a newly developed CBT service which 
was established as an adjunct to usual IBD treatment and care. It was one of 
the first of its kind to be located within an inflammatory bowel disease service 
in the UK. As CBT has proven efficacy for improving mood in other long term 
conditions, randomly withholding this intervention from patients with 
significant emotional distress in order to evaluate its efficacy under gold 
standard RCT conditions raised ethical issues (Harris et al, 2006). We therefore 
employed a pragmatic approach to investigating the benefits of a clinic based 
CBT intervention and utilised a non-randomised uncontrolled trial design.   
 
Benchmarking is a useful way of measuring the effectiveness of a clinic based 
intervention against clinical trials and can provide a direct statistical 




treatment effects are more modest outside of RCT conditions due to for 
example, lower criteria for inclusion. However given that trials to date have 
included those without clinical levels of distress and a clinic based intervention 
focuses on patients with poor mental health, this may not be the case for IBD.   
 
It is important when carrying out a benchmarking study that the treatment 
location that is being compared to an RCT condition represents a real practice 
setting. Shadish, et al (1997) and Shadish, Matt, Navarro, and Philips (2000) 
have developed a set of criteria that can be used to assess the extent to which 
a setting is clinically representative. These criteria include; representativeness 
of problems, the setting, how referrals are sourced, representativeness of 
therapists, structure of service, monitoring of treatment, problem 
heterogeneity and also pre therapy training, ability to have therapy freedom 
and use of multiple techniques and flexibility of number of sessions. The CBT 
clinic which provides the setting for this study fulfilled the majority of the 
Shadish criteria.  
 
Within the mental health literature, benchmark studies have been produced 
for CBT for anxiety and depression (Westbrook & Kirk, 2005), chronic fatigue 
syndrome (CFS) (Quarmby et al, 2007), social phobia (Gaston, et al, 2006), 
panic (Stuart et al, 1998), post -traumatic stress disorders (Gillespie et al, 2002) 
and multiple sclerosis (MS) (Askey Jones et al, 2013).These studies revealed 
comparable effect sizes between RCTs and outpatient clinics. To date there 
have been no studies comparing results from RCTs of CBT for people with IBD 
with outcomes achieved with a clinic based CBT intervention focused on those 




important to evaluate whether a psychological intervention could help those in 
need. We therefore report on the clinical impact of a clinic based CBT 
intervention for people with IBD who had moderate to severe levels of anxiety 
or low mood and 2) compare the results to a previous randomised controlled 
trial (RCT) of CBT in this population. We hypothesise that levels of anxiety and 
depression will reduce after the clinic based CBT. In addition we hypothesise 
that the effect sizes after clinic based CBT will be superior to the effect sizes in 




We used a nonrandomised uncontrolled trial to evaluate the impact of a clinic 
based CBT intervention for people with IBD who have moderate to severe 
levels of anxiety and/or low mood. We then compared outcomes with the 
results from an RCT of CBT. The aim of the CBT in the RCT was to prolong 
remission and improve quality of life and psychological distress in adults with 
IBD (Mikocka- Walus et al, 2015). Table 6.0 provides details of the methods 
employed by the comparison study. We utilised the transparent reporting of 
evaluations with nonrandomised designs checklist (TREND) to structure the 
reporting of this study and to ensure clarity (Des Jarlais et al, 2004). 
 
Materials and Procedure 
CBT clinic & Participants 
The CBT clinic was located within a gastroenterology outpatient department in 




of gastroenterologists and IBD nurse specialists. Team members were 
encouraged to use the patient health questionnaire 9 (PHQ9) (Spritzer et al, 
1999) and generalised anxiety disorder 7 measure (GAD7) (Spitzer et al, 2006) 
to screen for symptoms of low mood and anxiety to assist their clinical 
judgements. People scoring 10 or over on either or both measures (moderate 
to severe levels of anxiety and/ or low mood) were referred. Most reported 
difficulty in dealing with or adjusting to an aspect of their diagnosis of IBD or 
perceived their emotional stress to play a significant role in their experience of 





Table 6.1: Basic CBT demographics.
Table 1: Basic CBT demographics. 
 
 
TAU=Treatment as usual, F2F= Face to face, NR=Not reported, CBT=cognitive 
behaviour therapy 
 Clinic based CBT 
intervention 
Clinic based CBT 
intervention 
RCT 
Method Nonrandomised trial of  
clinic based CBT  
Nonrandomised trial of clinic 
based CBT 
Online CBT Vs TAU 
Trial author & year of 
publication 
Jordan et al, 2018. Jordan et al, 2018.  MIkocka-Walus et al, 2015. 
No in CBT arm of trial  Complete sample n=30 Analysed sample n=27 n=68 baseline 
n=35 6months  
Age, years, M (SD) 38.67 (range 21-68, SD 
13.1) 
37.4 ( range 21-68, SD 12.6) NR for online CBT group 










NR for online CBT group. 













NR for online CBT group 










NR for online CBT group. 
Duration of illness 
M, (range) 
 




NR for online CBT group 



















The psychological therapist provided transdiagnostic cognitive behaviour 
therapy (TD-CBT) for the treatment of anxiety and low mood. This approach 
targeted the shared cognitive and behavioural processes underlying the 
development and maintenance of emotional distress (Clarke et al, 2009). It did 
not require the therapist to determine a primary diagnosis i.e. depression or an 
anxiety disorder, as is the case with disorder specific CBT.  As a consequence it 
was arguably a more efficient way to work with patients who were presenting 
with multiple clinical problems (Mansell et al, 2008). A recent meta-analysis 
which included 24 RCTs found that transdiagnostic CBT treatments 
outperformed control conditions for reducing anxiety and depression and 
improving quality of life (Newby et al, 2014).  
 
Routine outcome data was collected in the CBT clinic between November 2014 
and September 2016. Unlike previous RCTs, only patients with clinically 
significant symptoms of anxiety and low mood were referred to the CBT clinic. 
In addition patients were not excluded if they were experiencing symptomatic 
disease activity. However patients were excluded if they had cognitive 
impairment or were unable to speak English to a standard required to engage 
meaningfully in the therapy. Table 6.1 provides details of the inclusion and 
exclusion criteria employed in the CBT clinic and the comparison study. The 
CBT clinic met the majority of Shadish’s et al, (1997) criteria for clinical 
relevance. Patients were all clinically referred and heterogeneous in age, sex, 
and focal problem. Although the approach was consistent with a 
transdiagnostic approach for anxiety and depression there was no written 
manual, no monitoring of treatment other than routine supervision, the 




study and there was flexibility in the number of sessions offered to patients. 
However, the therapist was a trained and experienced cognitive behavioural 




Table 6.2: Inclusion and exclusion criteria 
 
 Clinic based CBT intervention Mikocka –Walus et al, 2015. 
Inclusion criteria 1) Individuals over aged 18 with a 
clinically established diagnosis of 
IBD  
2) Moderate to severe symptoms 
of anxiety and/or low mood 
indicated by scores of 10 and over 
on GAD7 and/or PHQ9 
  
1) Individuals over 18 with a clinically 
established diagnosis of IBD 
2) Current clinical remission or mild 
symptoms only for at least 3 months 
2) Sufficient English to understand, 
answer questionnaires and participate 
in therapy 
3) Competence to consent   
4) Willingness to complete CBT 
sessions. 
Exclusion criteria 1) Cognitive impairment or  
unable to speak English to a 
standard required to engage 
meaningfully in the therapy 
1) Serious mental illness (e.g. 
psychosis, schizophrenia) or 
alcohol/substance dependence as 
diagnosed by the Clinical psychologist  
2) Currently undergoing 
psychotherapy 
3) Significant cognitive impairment 
Recruitment strategy Consecutive referrals from 
gastroenterologists /IBD nurse 
specialists 
IBD databases at two gastroenterology 
clinics in Australia were screened by 
the clinics’ IBD nurses. 
Potentially eligible IBD patients were 





Advice was sought from the local ethics committee. As the study was part of 
routine clinical outcome collection ethical approval was not required. However 
we received audit approval from the gastroenterology directorate to collect 
clinical outcomes for common mental health problems in IBD. Informed 
written consent was obtained from all individual participants included in the 
study. The privacy rights of participants were observed and data was 
pseudonymised and held in a secure place. 
 
Procedure and treatment  
Once referred to the CBT clinic by the IBD nurse specialists or 
gastroenterologists, all patients were asked to sign a consent form confirming 
they were agreeable to having their data recorded and used anonymously for 
any future papers following service evaluation. All participants consented to 
this. The therapist provided an initial assessment of all referrals and asked 
patients to complete self- report questionnaires. Following the initial 
assessment patients were offered TD-CBT if appropriate. This approach is 
based on traditional CBT principles with a particular emphasis on helping 
people change the way they respond to their emotions. A range of TD-CBT 
strategies were utilised in sessions to target the common psychological 
processes underlying anxiety and depression, rather than targeting the 
symptoms of the specific disorders. Strategies included psychoeducation to 
introduce the main components of an emotional experience, namely thoughts, 
physical sensations and behaviour and the reciprocal relationships between 
these domains. This three component model was then employed across 




patient to understand their cognitive, behavioural and emotional responses to 
triggers and assess the short and long term consequences of their emotion 
driven behaviour. Where behaviour was identified as unhelpful, patients 
worked towards acting in alternative ways. For example, a patient may have 
identified that when traveling on trains they experienced anxiety about having 
access to a toilet and their response was to stay close to a toilet during the 
journey and monitor and time its occupation. On consideration, they may have 
recognised that this behaviour maintained attention and focus on the feared 
event and amplified their anxiety. An alternative response might therefore be 
to sit slightly further away and focus attention on a more neutral activity thus 
lessening preoccupation and anxiety. Mindfulness and attention training 
exercises were employed to encourage such present focused awareness and to 
support the development of alternative adaptive emotional responses. 
Further, to encourage flexibility in thinking patients were taught to identify and 
evaluate maladaptive automatic appraisals as well as identify and overcome 
emotional avoidance. Therapy concluded with relapse prevention whereby 
patients were encouraged to identify goals to maintain treatment gains and for 
continued progress (Barlow et al, 2011). The treatment received was not 
manualised, but was instead based on individual case formulations. Therapy 
was undertaken on 1:1 basis, weekly for 50 minutes. The amount of sessions 
offered varied and was determined by the severity of the clinical problem and 
the individual’s response to the intervention. We used the Template for 
intervention Description and Replication (TDieR) checklist (Hoffman et al. 
2014), to promote completeness in reporting and replicability of the 





Training and supervision 
The therapist was trained in cognitive behavioural psychotherapy at a post 
graduate level with 15 years’ experience of working with anxiety disorders and 
depression. Supervision was provided by a cognitive behavioural 
psychotherapist familiar with IBD (TC) on a monthly basis and consisted of face 
to face case supervision. The therapist had experience of working with people 
with IBD and anxiety and depression and this was consolidated by spending 
time with the IBD nurse specialists and gastroenterologists to gain further 
insight into the biopsychosocial impact of IBD.  
 
Outcome measures 
During the initial appointment demographic information (such as age, gender, 
marital status) as well as type of IBD, length of diagnosis, current medications 
and previous psychiatric history was elicited from participants. The clinical 
service collected routine data from all participants seen over a two year period 
(November 2014 and September 2016). 
 
Primary outcomes 
We chose two primary outcomes, anxiety (generalised anxiety disorder 7 
(GAD7) and low mood (patient health questionnaire (PHQ9) as both were 
being targeted in the transdiagnostic treatment. The GAD7 is a self- report 
questionnaire which measures symptom severity for the four most common 
anxiety disorders (generalised anxiety disorder, panic disorder, social phobia 
and post- traumatic stress disorder). Scores in the 10-14 range are indicative of 
a moderate level of symptoms, whilst 15 and above implies severe (Spitzer et 




questionnaire, a multiple choice self -report inventory (PHQ9). Scores in 10-19 
range signpost moderate to moderately severe symptoms of low mood, a 
score of 20 or more severe (Spritzer et al, 1999). Both of these measures are 
widely used to screen for clinically significant levels of symptoms within 
general medical and outpatient settings and to monitor treatment response 
over time (Spitzer et al, 2006). All patients completed these measures at pre 
therapy and immediately at the end of therapy. 
 
Secondary outcomes 
We selected two secondary outcomes, health related quality of life and 
symptomatic disease activity. As these outcomes are associated with anxiety 
and low mood we hypothesised that improvements to mood may lead to 
improvements in these domains. Health related quality of life was quantified 
by the short inflammatory bowel disease questionnaire (SIBDQ) which 
measures this construct across the 3 domains of physical, social and emotional 
status. Scores range from 10-70, with higher scores indicating a better quality 
of life (Irvine et al, 1996). Current levels of symptomatic disease activity were 
measured by the Harvey Bradshaw Index (HBI) (Harvey et al, 1980), for 
participants with Crohn’s disease and the Simple Clinical Colitis Activity Index 
for participants with ulcerative Colitis (SCCAI) (Walmsley et al, 1998). The score 
derived from the HBI is based on 5 items that assess general well-being, 
abdominal pain, number of liquid stools per day, abdominal mass, and 
complications or extra intestinal manifestations. The score derived from the 
SCCAI is based on 6 items that assess daytime and night time bowel 
movements, urgency, and presence of blood in the stool, general well-being, 




are considered to suggest remission (Higgins et al, 2005). All patients 




Statistical analysis was performed using the statistical package for the social 
sciences (SPSS) version 23. Descriptive statistics were generated to describe 
the study population The pre and post measures of health related quality of 
life (SIBDQ) and disease activity (HBI & SCCAI) for all participants were 
analysed using the paired t-test. The Shapiro-Wilks test for normality indicated 
that data may be skewed for post measures of anxiety (GAD7 W=.053 df=27 
p=0.01) and low mood (PHQ9 W=.758 df=27 p=0.001) so the two sample 
Wilcoxon rank sum (Mann Whitney) test was used for analysis. The one drop 
out was not included in the analysis as post therapy measures had not been 
completed at the time of leaving the service.  
 
Benchmarking & comparison of effects  
 A systematic review of psychological interventions for adults with IBD 
(Knowles et al, 2013), identified five studies investigating the effect of CBT 
focused interventions on clinical disease parameters as well as anxiety, low 
mood, disease related concerns and quality of life (Mussell et al, 2003, Kaneko, 
2009, Schwarz et al, 1990, Diaz Sibaja et al, 2007, longhorst et al, 2007). 
Subsequently two further trials have been published (Mikocka-Walus et al, 
2015, McCombie et al, 2016). None of these studies included participants with 
IBD who report clinically significant symptoms of anxiety or low mood either 




these domains have often been evaluated as secondary outcomes (Fiest et al, 
2016). There is also considerable variation across studies regarding the content 
of the intervention, as CBT was often used in combination with other 
strategies.  
 
In order to create a benchmark we therefore selected studies that investigated  
a 1:1 intervention which was informed by a cognitive behavioural paradigm 
(including Computerised CBT, (CCBT) for people with IBD and that reported pre 
and post mean scores and standard deviations for measures of either anxiety, 
low mood or quality of life, as well as disease activity. This led to the exclusion 
of three studies which failed to report outcomes in the required format 
(Kaneko, 2009, Schwartz et al, 1990, McCombie et al, 2016) and three which 
evaluated a group intervention (Mussell et al, 2003, Diaz Sibabja et al, 2007, 
longhorst et al, 2007). The one remaining study consisted of two interventions 
(group CBT and online CBT) tested against standard care (Mikocka-Walus et al, 
2016) (See table 6.2). For the purpose of this study only the outcome data 
from the online CBT condition was used (Mikocka-Walus et al, 2016) (since the 
CBT clinic only included an individual CBT treatment group) to compose a 
benchmark indexing the mean change of CBT under RCT condition.  
 
Details of the recruitment strategies and inclusion/exclusion criteria utilised in 
the RCT study ((Mikocka-Walus et al, 2016) which composed our benchmark 
are reported in table 6.1. Primary outcomes included symptomatic disease 
activity measured by the Crohn’s disease activity index (CDAI) (Best, 1976) and 




considered were anxiety and low mood measured by the Hospital anxiety and 
depression scale (HADS) (Zigmond et al, 1983).  
 
As it is not possible to directly compare these differing outcome 
measurements, uncontrolled effect sizes for each of these outcomes were 
calculated to standardize the treatment effects (Streiner, 1991). Such an 
uncontrolled effect size is likely to inflate the effects of therapy as compared to 
a conventional controlled effect size, because it effectively assumes that there 
would be no change without therapy. It does however provide a crude 
benchmark for comparison with other studies. Uncontrolled effect sizes were 
calculated as (M Start _ M End) / SD Start) (Cohen, 1988; Westbrook et al, 
2004). As outcomes were reported at multiple time points (e.g., post 
treatment and follow-up), we calculated the effect size with the outcome 
closest to the time interval of the clinical service which was 6 months. 




Number of sessions, attrition and drop out.  
The mode number of CBT sessions received was six (range 4-10, mean 6.70, SD 
1.68). Of the 36 patients screened; 30 were eligible for CBT. Two declined 
treatment due to being unable to attend the appointments slots offered. Of 
the remaining 28, 27 completed therapy and 1 dropped out of treatment. The 
reason given for this was that the participant changed employment and was no 
longer able to attend the clinic (See fig. 6.1). On inspection there were no 




marital status (χ2=0.6710 pr=0.715) between starters and non-starters of 
therapy. 
 
Baseline severity of anxiety, low mood, quality of life and disease activity. 
The majority of participants presented with moderate to severe levels of 
anxiety and low mood (n=20 scored 10 and above on PHQ9 & GAD7). On 
inspection there were no differences between starters (n=28) and non -starters 
(n=2) of therapy on baseline scores for the SIBDQ (t (28) =2.81 p=0.08), GAD7 
(z=-0.67 p=0.31) or PHQ9 (z=-1.17 p=0.29). 
 
Further analysis Indicated that 65% of the participants with Crohn’s disease 
scored <5 on HBI and 66% of participants with ulcerative Colitis scored <3 on 
SCCAI which suggests the majority of participants were experiencing a 
remission in disease activity. 
 
Treatments outcomes  
Analyses were conducted on 27 people who had completed pre and post 
scores on the PHQ9, GAD7, SIBDQ and either the HBI for Crohn’s disease or 
SCCAI for Ulcerative Colitis, at base line and end of therapy. There was a 
statistically significant decrease in scores for low mood on the PHQ9 from time 
1 (M 13.44, 5.31) to time 2 (M 3.44 SD 2.23, Z=.000 p<0.001). Statistically 
significant decreases in anxiety scores on the GAD7 were also observed from 
time 1 (M 12.67 SD 4.67) to time 2 (M 3.22 SD 2.55, z=.000, p<0.001). In 
addition statistically significant decreases in symptomatic disease activity were 
observed for Crohn’s disease on the HBI from time 1 (M 7.00 SD 3.95) to time 2 




time 1(M 4.93 SD 2.46) to time 2 (M 2.27 SD 1.79, t (25) =4.28 P<0.001). Finally 
statistically significant increases in scores for quality of life on the SIBDQ were 
detected from time 1 (36.22 SD 9.01) to time 2 (M 55.04 SD 6.39 t (25) =-14.65 
















   
Assessed by psychological Therapist  
Excluded 
Did not meet CBT criteria (n=3) 
Referred elsewhere (n=3) 
Eligible for CBT 
(n=30) 




Unable to make 
appointment slots (n=2) 
Discontinued intervention 
due to changing 
employment and being 











Benchmark comparison  
Uncontrolled effect sizes comparing the CBT clinic and the RCT self- report 
outcome scores are provided in table 6.2. Overall the mean effect sizes 
reported from the RCT for low mood, anxiety and symptomatic disease activity 
were small to medium ( 0.2-0.5) whilst for the CBT clinic large mean effect sizes 
were observed for these outcomes (close to or over 0.8). 
 
6.5: Discussion 
The results indicate that CBT may be of benefit for people with IBD and 
clinically significant emotional distress. Scores on measures of anxiety, low 
mood and disease activity significantly decreased over the course of the study 
whilst scores for quality of life significantly increased.  
 
The treatment effects of CBT on all outcomes for people with IBD compared to 
the RCT were favourable. This is likely to be due to the inclusion of participants 
with moderate to severe symptoms of anxiety and low mood. These findings 
suggest that it is this sub group of patients with significant levels of distress 
who benefit most from psychological intervention. The results of the majority 
of previous RCTs suggest that CBT has limited effect on self-reported disease 
course for people with IBD without disturbance to mood (Gracie et al, 2017).  
Based on our findings, future RCT’s may show improved disease related 
outcomes if participants with clinically significant symptoms of anxiety and low 
mood are recruited. As mood improves it may be that inflammation is reduced 
in combination with a shift in symptom perception. In contrast, as mood 
worsens reports of disease activity may increase and vice versa. This reciprocal 




responses. Our findings suggest that by identifying and addressing unhelpful 
responses with cognitive behaviour therapy both mood and reports of disease 





Table 6.3: Mean scores at pre & post treatment and effect sizes for the CBT 
clinic and the RCT 
 
  
Name of trial authors CBT clinic. Mikocka –Walus et al, (2015). 
CBT type Individual CCBT  
Pre-treatment scores  
(M, SD): Depression 
 












 4.1 (3.6)  
 








Post treatment scores (M, SD): 
Anxiety 
 
Effect size -Anxiety 
 
GAD7:  
12.67 (4.666)  
 
 





 6.7 ( 4.2)  
 
 
HADSA  6Months : 5.8 (3.8)   
 
0.21 
Pre-treatment scores  
(M,SD):  
Quality of life 
(higher score higher Quality of 
life) 
 
Post treatment scores(M,SD) : 
Quality of life 
 


























Post treatment scores :(M, SD) 









HBI: 7.0 (3.95)  

















CDAI 6Months : 97.3 93.7) 








This study’s findings may have been influenced by our choice of measures. We 
used the GAD7 (Spitzer et al, 2006) to measure symptoms of anxiety and the 
PHQ9 (Spitzer et al, 1999) for symptoms of low mood and it is possible that 
these measures are more sensitive to change in the IBD population than the 
HADS which was used in the comparison trial (Mikocka- Walus et al, 2015). 
There is some controversy surrounding the HADS with some studies showing it 
to be equally good at detecting anxiety and low mood as the GAD7 & PHQ9. 
However recent psychometric systematic reviews have found it to be a 
measure of general distress rather than distinct mood states (Norton et al, 
2013, Costco et al, 2012). As yet it is unclear which questionnaires are best 
suited to measuring anxiety and low mood in IBD. Further work on the validity 
of measures for this population would be useful. 
 
In the CBT clinic patients were offered transdiagnostic CBT based on individual 
case formulations meaning that treatment strategies targeted the specific 
psychological processes underpinning the symptoms and situations the patient 
described as problematic (Barlow et al, 2011). This contrasts with the CBT 
provided in the RCT which followed a protocol and was delivered online. As 
many people with IBD present with multiple co-morbidities a transdiagnostic 
approach may be more suitable. A recent preliminary evaluation of the impact 
of a one day transdiagnostic CBT group intervention on distress in IBD found 
anxiety scores were significantly reduced at 3 month follow up (Hou et al, 
2017). In addition the therapy within the clinic was delivered by a psychological 
therapist which may be more acceptable and engaging for the majority of 
patients. Drop outs reported for the CBT service (n=1, 3.5%) were small whilst 




48%. This is also likely to have reduced any treatment effects (Mikocka- Walus 
et al, 2015).  
 
Previous benchmark studies have suggested that the experience of the 
therapist as well as waiting times may influence participation and outcomes 
(Scheeres et al, 2008). In this study the therapist had 15 years of experience 
and this was a newly established psychological service. To the authors 
knowledge it is the first to be located geographically within an IBD clinical 
service in the UK. This may serve to lessen any perceived stigma in regards to 
seeking or receiving treatment for a mental health problem as it does not 
involve attending a psychiatric outpatient setting. This new service was 
received enthusiastically by both clinicians and patients. Further, there was no 
waiting time to commence treatment.  It is likely that all these factors 
positively affected engagement in therapy.  
 
Limitations and future directions    
The pragmatic design of this study and the absence of a control group means 
that the benefits of a clinic based CBT intervention for mood and quality of life 
must be interpreted with some caution. As no comparison data can be 
provided we cannot say with any certainty whether these promising results are 
truly due to the intervention, or for example repeated testing, spontaneous 
recovery or changes in treatment conditions. It has been suggested that in 
recent onset cases of depression spontaneous remittance is common and the 
benefits of psychological intervention may be modest (Clark et al 2008). In 
addition the statistical principle of regression to the mean predicts that 




control for the effects of confounding variables future studies would benefit 
from randomisation and a control condition. This may prove difficult in a 
clinical setting but a waiting list control group may be feasible next step. 
Equally important is the inclusion of participants with clinically significant 
emotional distress in future RCTs. 
  
 Measurements of anxiety, low mood, quality of life and disease activity in our 
study were all based on self- report measures. We therefore cannot say with any 
certainty whether improvements in disease activity were due to a reduction in 
inflammation or changes to the appraisal of symptoms. Ideally prospective 
studies would include objective measurements such as endoscopy and faecal 
calprotectin analysis and structured clinical interview (Jordan et al, 2016). Future 
studies should also consider assessing objectively any changes to medication or 
treatment regimens as potentially confounding variables.  
 
Further, this pragmatic study of CBT implementation embedded within an 
outpatient gastroenterology service did not follow a specific treatment manual 
and no treatment integrity checks were carried out. It is therefore possible that 
the intervention may have deviated from a CBT paradigm. Patients also 
received a variable number of sessions in comparison to the RCT and this may 
have further confounded results. In addition the number of participants 
undertaking CBT was small (n=27). In order to enhance generalisability further 
studies should consider a larger sample.  
 
Finally, three of the 27 people entered in CBT were taking antidepressants. 




participants had been receiving pharmacological treatment for more than 8 
months prior to commencing CBT. This reduces the likelihood that change 
could be attributed to the pharmacological intervention. 
 
The CBT clinic fulfilled the majority of the criteria for clinical representative  as 
set out by Shadish et al, (2000)  in that it (a) took clients who had clinically 
representative problems, (b) took place in a clinical setting, (c) saw clients who 
were referred through normal clinical routes from IBD nurse Specialists and 
gastroenterologists, (d) used a psychological therapist who had CBT training 
and held a caseload of IBD patients, (e) followed a typical structure for the 
clinical practice, (f) treatment was not monitored closely to impact the 
psychological therapists behaviour, (g) the population had heterogeneous 
problems and were clinically representative, (h) the psychological therapist did 
not receive specific training immediately prior to the clinic, (i) the psychological 
therapist could use a variety of techniques and (j) there was not a limited 
number of sessions. This is important as it adds further evidence for a clinic 







In summary, the results of this study suggest that CBT for people with IBD and 
symptoms of anxiety and low mood is beneficial when implemented in clinical 
practice for the majority of participants and that large effect sizes can be 
observed. Clinically significant levels of anxiety and low mood should be 
considered as inclusion criteria for the selection of participants in future RCTS 
and the addition of a control group should be considered for future clinic 
based intervention studies. Finding an effective psychological intervention for 
people with IBD is of vital importance given the impact that these mood 
disorders have been observed to have on disease parameters.     
 
 Given the established association between anxiety, low mood and disease 
activity and the potential impact that CBT may have on improving these 
outcomes, clinicians working with people with IBD in gastroenterology clinics 
should be trained to recognise symptoms of mood disorders and to refer to 
psychologically trained therapists. As there is some debate as to the cost-
effectiveness of widespread screening of mental health  in primary care 
(Thombs et al, 2014) and higher-risk populations (Goldberg, 2014) this may be 
a more effective means of facilitating referrals to psychological services for 





Chapter 7: Overall Discussion 
The main aim of this thesis was to investigate the psychological processes 
associated with negative adjustment outcomes for people with IBD, in order to 
identify evidence based targets which could be addressed in a psychological 
intervention. The purpose of this final chapter is to synthesise the findings 
from all 4 studies included in this thesis and consider the overall evidence for 
1) psychological factors and their associations with negative adjustment 
outcomes for adults with IBD 2) the potential benefits of a novel psychological 
intervention for improving outcomes in this population and 3) the implications 
for healthcare and further research. 
The first study in this thesis systematically reviewed the existing literature 
which addressed psychological factors which were associated with, predictive 
or explanatory of adjustment outcomes in adults with IBD. The aim was to: a) 
Identify the types of psychological factors that have been studied to date and 
their associations with adjustment outcomes in adults with IBD;  b) Establish 
which psychological variables served to explain or predict differences in how 
well people adjusted to living with IBD; c) Gain an overview of the strength of 
evidence for relationships between psychological variables and adjustment 
outcomes in IBD; d) Identify common methodological weaknesses in the 
research, gaps within the literature, and directions for future research. 
 
 Emotion focused coping strategies, perceived stress, IBD related cognitions 
(such as illness perceptions), emotions and emotional control (such as hostility, 
aggression and  alexithymia), interpersonal traits (such as anxious attachment 




found to link to negative adjustment outcomes after controlling for the 
influence of sociodemographic and disease related factors. These findings are 
illustrated in orange in figures 7.1 & 7.2 below. Personality traits, interpersonal 
traits and emotions and emotional control are depicted in this model as 
predisposing factors due to their relatively stable nature over time and likely 
influence on the way an individual responds to their diagnosis of IBD. All other 
variables are conceptualised as perpetuating factors due to their hypothesised 
role in maintaining or exacerbating problems with mood (Jordan et al, 2016).  
 
This reviews conclusions were based on the findings of a limited number of 
studies exploring a diverse range of psychological variables with only one study 
providing any longitudinal data (Jordan et al 2016).The review suggested that 
qualitative studies provided a more detailed account of the challenges of living 
with IBD from the patients perspective and could provide some direction for 
psychological factors to be considered in future quantitative studies. However 
it was acknowledged that qualitative studies currently offered no insight into 
how the challenges of living with IBD linked to anxiety or low mood (Kemp et al 
2012). A cognitive behavioural model was proposed for understanding the 
psychological processes associated with negative adjustment in IBD. This 
framework was applied in the subsequent empirical studies of this thesis to 
structure investigations of the cognitive, emotional and behavioural responses 
linked to anxiety, low mood, psychological distress and poor quality of life for 
adults with IBD. This model had not be utilised in any previous studies (Jordan 




Following the methodological weaknesses identified in this area of research by 
the literature review, a mixed method research approach was adopted in the 
subsequent studies contained within this thesis.  A qualitative approach with in 
depth semi structured interviews was employed to explore 1) the specific 
situations, thoughts, perceptions, appraisals, beliefs and behaviour that people 
with IBD described as linked to their symptoms of anxiety and low mood 2) the 
type of psychological help or support people with IBD and elevated symptoms 
of anxiety and low mood would like as part of routine medical care. A 
secondary aim was to consider these findings in relation to the knowledge 
associated with the competencies set for psychological therapists delivering 
interventions for long term conditions (Jordan et al, 2017). 
 
The qualitative analysis of participant accounts identified that concerns 
pertaining to underperformance at work and preventing an accident in public 
were linked to symptoms of anxiety. Low mood was associated with a 
perceived lack of understanding of IBD from others and stigma. In each of 
these domains distinct cognitive and behavioural responses were described by 
participants. Participants reported an all or nothing behavioural response to 
concerns about the consequences of reduced occupational functioning which 
included increasing their workload in order to compensate in advance for 
future periods of sickness. In response to anxiety about preventing the 
occurrence of an accident in public, participants described a range of avoidant 
and safety seeking behavioural responses such as changing modes of travel, 
carrying spare clothes and adjusting eating habits. Importantly the results from 
this study suggested that it was the perception or recognition that a toilet was 




sensations originating from the bowels. In response to thinking that others 
misunderstood their illness participants described feeling low in mood and 
cancelling social plans. This findings are illustrated in green in figure 7.1 and 
7.2. 
 
Overall this analysis highlighted the situations, cognitions and behaviours 
linked to symptoms of anxiety and low mood by people with IBD and some 
potentially unhelpful interactions between these factors were hypothesised. 
Anxiety related responses appeared catastrophic and lacked acceptance whilst 
responses related to low mood were more characterised by hopelessness and 
withdrawal. These cognitive and behavioural responses were potentially 
modifiable factors which it would have been possible to address in a 
psychological intervention and the vast majority of participants in this study 
stated a desire for psychological support. Significantly, the findings suggested a 
strong preference for this to be delivered by a compassionate practitioner who 
could draw on specialised knowledge of the key symptoms of IBD and their 
impact on functioning and mental health, with a focus on building coping 
strategies. Finally, the findings of this study suggested that psychological 
therapists working with this group would require advanced skills in conducting 
bio-psychosocial assessments in order to gain a clear picture of the differing 
psychological processes impacting on mood and levels of anxiety (Roth & 
Pilling 2015). 
 
Utilising a qualitative approach in this study meant that people with IBD and 
disturbance to mood had the opportunity to articulate their personal 




conforming to predefined categories and terms imposed on them by 
quantitative measures (Sofaer, 1999). Although qualitative research findings 
are argued to lack generalisability due to their subjective nature and often 
small samples, these limitations were addressed through the use of 
quantitative methods in subsequent studies.  
 
A quantitative approach was therefore adopted to further investigate the 
cognitive, emotional and behavioural responses associated with negative 
adjustment outcomes; anxiety, Low mood, general psychological distress and 
poor quality of life. Data on sociodemographic, clinical, and psychological 
factors and adjustment outcomes were collected via self-report measures at 
baseline and 3 month follow up. A cross sectional and prospective analysis was 
carried out in order to assess the relationships between psychological factors 
assessed at baseline and adjustment outcomes at baseline and 3 month follow 
up. 
 
It was hypothesised that unhelpful beliefs about experiencing and expressing 
negative emotions (BeS), unhelpful behavioural responses to gastrointestinal 
symptoms (IBS-BRQ), a lack of acceptance beliefs towards symptoms (CPAQ), 
avoiding exercise due to a fear it will make symptoms worse (CBSQ: FA), 
believing symptoms are damaging (CBSQ:D), focusing on symptoms (CBSQ: SF), 
excessive resting to manage symptoms (CBSQ: AR), all or nothing behaviour 
(CBSQ: AL) and avoidance of activities due to embarrassment about symptoms 
and worries about how others will judge symptoms (CBSQ: EA), would be 
associated with baseline (Time 1) cases of anxiety, depression, psychological 




disease related and clinical variables into account. Further, it was anticipated 
that these cognitive, behavioural and emotional responses would be 
associated with an increased risk of being a moderate case of anxiety, 
depression, psychological distress and poor health related quality of life at 
three month follow up in the prospective analysis. (Time 2).  
 
The results of the cross sectional and prospective analysis identified some 
variation and overlap in the range of cognitive, emotional and behavioural 
responses associated with and predictive of each negative adjustment 
outcome for each IBD type. The psychological factors associated with negative 
adjustment outcomes for the UC group and CD group are illustrated separately 
in figure 7.1 and 7.2 below. Cross sectional associations from this study are 
depicted in purple and are conceptualised as perpetuating factors due to their 
likely role in maintaining or exacerbating disturbance to mood and quality of 
life. Prospective associations are represented in black as risk factors for each 
outcome due to the longitudinal nature of the data.  
 
Overall the most important risk factors for negative adjustment outcomes for 
the UC group were initial disturbances to mood and quality of life. The most 
consistent psychological factors identified as perpetuating factors for this 
group were unhelpful beliefs about emotion, a lack of acceptance beliefs, 
symptom focusing and resting behaviour. For the CD group , baseline 
disturbance to mood, quality of life and avoidant, safety seeking and all or 
nothing behavioural  responses were consistent risk factors for negative 
adjustment outcomes, whilst unhelpful cognitive responses such as unhelpful 




as avoidant and safety seeking behavioural responses to manage 
gastrointestinal symptoms were frequently identified in the cross sectional 
analysis as potentially perpetuating factors. 
 
Due to a much larger sample size and the ability to take confounding variables 
into account in the analyses, the results from these types of studies are 
generally considered to be more precise, reliable and generalisable to the 
wider population. In addition, the results of the prospective analysis offered 
the strongest evidence to date for the direction of the relationship between 
psychological factors and negative adjustment outcomes.  The use of both 
quantitative and qualitative evidence has been specifically recommended for 
the process of developing and evaluating complex interventions such as 
psychological interventions (Campbell et al., 2000; Campbell et al., 2007). 
 
In combination with the findings of the qualitative study, the overall results of 
this thesis suggest that behavioural responses to managing symptoms are 
particularly significant in the development and maintenance of anxiety, low 
mood, distress and poor quality of life, especially for adults with CD. 
 
The final study of this thesis investigated the clinical benefits of a non-
randomised uncontrolled trial of clinic based cognitive behaviour therapy (CBT) 
for adults with IBD who had moderate to severe levels of anxiety and low 
mood and compared the results to a previous randomised controlled trial of 
CBT in this population. Previous randomised controlled trials had found no 
evidence that psychological interventions enhanced outcomes for people with 




It was hypothesised that levels of anxiety and low mood would reduce after 
the clinic based CBT intervention and that uncontrolled effect sizes would be 
superior to the effect sizes in the comparison RCT.  The results of this study 
identified statistically significant improvements to mood, quality of life and 
symptomatic disease activity and uncontrolled effect sizes were superior to 
those of the RCT. This suggested that CBT may have benefits for those with 
moderate to severe disturbances to mood and that the effect sizes of RCT’s 
could be improved by targeting those with distress.  Figure 7.3 below 
illustrates a logic model for the development of psychological interventions for 
improving adjustment outcomes in this population and outlines key 
interventions and behavioural change techniques to target unhelpful cognitive, 
emotional and behaviour responses  linked to these outcomes by the studies 





Figure 7.1: Psychological factors linked to adjustment for people 
with Ulcerative colitis.  
Trigger Diagnosis/onset of 
symptoms  
Initial disturbance to 
mood & QoL 
IBD stressors 
Toilet accessibility #  
Occupational underperformance # 




Cognitive: Lack of acceptance # # Damage beliefs # Symptom focusing # 
Behavioural: Resting behaviour # Avoidant behavioural responses to symptoms # 
Emotional: Baseline anxiety # # # Baseline QoL # # 
Baseline low mood # # #      
Disease related: Comorbidity # symptomatic disease activity # # # # 
Social:  Lower age # #Female # # Less years in ed.#  
 
 




                           Outcomes  
Anxiety #       Low mood # 
Distress #        Poor Quality of life # 
 
Perpetuating factors 
Cognitive: Unhelpful beliefs about emotions # # # Lack of acceptance # # # # Symptom focusing # # # Damage beliefs # 
Embarrassment avoidance #: Believing IBD will have serious consequences, Hopelessness, Stigma, Feeling socially 
constrained in relation to IBD 
Behavioural: Avoidant/avoidant behavioural responses to symptoms # Social withdrawal # Resting behaviour # # # 
All or nothing/all or nothing behaviour # # Safety seeking behavioural responses to symptoms # Emotion focused coping 
strategies  
Emotional: Emotional representation of illness 
Disease related: Symptomatic disease activity # # # #   Comorbidity # #  
Social: Lower Age # # female # less years in education # 
   
 





Cross sectional study= 
Purple 
 Literature review= 
Orange  
 
Linked to anxiety= # 
Linked to low mood= # 
Linked to distress=# 
Linked to poor quality 
of life= #  
 
Precipitating factors  
Personality Traits: Neuroticism; Type D; Perfectionism 
Emotions and emotional control: Alexithymia; Private Self-




Figure 7.2: Psychological factors linked to adjustment for people 
with Crohn’s disease.  
 
  
Trigger Diagnosis/onset of 
symptoms  
Initial disturbance to 
mood & QoL 
IBD stressors 
Toilet accessibility #  
Occupational underperformance # 
Others misunderstanding #  
Stigma # 
 
                                                              Risk factors 
Cognitive:  Lack of acceptance # #    Embarrassment avoidance #    
 Behavioural:  All or nothing behaviour # #   Avoidant & safety seeking behavioural responses 
to symptoms # #    
Emotional:  Baseline anxiety # # #   Baseline QoL # # # Baseline low mood # # # #     
Disease related: Comorbidity # symptomatic disease activity # # # # 
Social:  Lower age # #Female # # Less years in ed.#  
 
 
            Outcomes  
Anxiety #       Low mood # 
Distress #        Poor Quality of life # 
 
Perpetuating factors 
Cognitive: Unhelpful beliefs about emotions # # # Lack of acceptance # # # # Symptom focusing # # # Embarrassment 
avoidance # Hopelessness, Believing  IBD will have serious consequences, Stigma, Feeling socially constrained in relation to 
IBD 
 Behavioural: Avoidant/avoidant behavioural responses to symptoms # Safety seeking/ safety seeking behavioural 
responses to symptoms# # # # Social withdrawal #   All or nothing/all or nothing behaviour # # Resting behaviour # # # 
Emotion focused coping strategies 
Emotional:  Emotional representation of illness 
Disease related: Symptomatic disease activity # # # #   Comorbidity # #  









Cross sectional study= 
Purple 
 Literature review= 
Orange  
 
Linked to anxiety= # 
Linked to low mood= # 
Linked to distress=# 
Linked to poor quality 
of life= #  
 
Precipitating factors  
Personality Traits: Neuroticism; Type D; Perfectionism 
Emotions and emotional control: Alexithymia; Private Self-




Figure 7.3: Logic model for psychological interventions for negative 
adjustment outcomes in adults with IBD
 
 
Methodological limitations and future directions   
The overall studies contained within this thesis have some potential 
limitations. The systematic review, as a starting point of this thesis, aimed to 
identify and critique existing empirical studies of modifiable psychological 
variables and their links to adjustment outcomes. Given that this growing body 
of empirical literature had not been previously reviewed a broad and 




selection of studies being included which precluded meta-analysis. 
Furthermore much of the primary research reviewed used small samples, 
cross-sectional designs and explored a narrow range of psychological variables. 
This made the reviews conclusions tentative. Hopefully in future there will be 
enough research to conduct a more focused review on the role of cognitive, 
emotional and behavioural variables in determining adjustment outcomes in 
adults with IBD and a meta- analysis can be carried out. 
 
The qualitative study utilised a relatively small sample and the participants had 
all taken part in an online survey measuring illness perceptions, anxiety, 
depression, quality of life and functioning. It is arguable therefore that the 
deductions based on the results of this study relate to a specific cohort of 
adults with IBD which may not be generalizable to the wider population, 
although this is unlikely as some of this study’s findings were replicated in the 
cross sectional and prospective analysis (e.g. all or nothing and avoidant and 
safety seeking behavioural responses to gastrointestinal symptoms).  
 
Selection bias can be a problem in cross sectional and prospective studies but 
this is unlikely to have been the case in this thesis as participants were not 
selected in relation to the exposure or outcomes of interest. The cross 
sectional and prospective study of this thesis employed a convenience sample 
recruited from a gastroenterology outpatient clinic and IBD patient 
organisation. An advantage of this type of sampling is that is less open to 
selection bias because the participants are likely to be less selected than in 





Cohort studies can be subject to attrition bias due to differences between 
patients who did and did not complete the follow-up period. However, the 
response, rate for the cohort study in this thesis was > 75% and baseline socio-
demographic and clinical variables were similar between the two groups (e.g. 
those who completed baseline measures only and those who completed 
measures at baseline and 3 month follow up). There was also no statistically 
significant differences between these groups on the majority of baseline 
measures of psychological variables (Song et al, 2010). 
 
Logistic regression was the method of analysis used in the cross sectional and 
prospective study. This was effective for demonstrating the size of effect. 
However due to the binary outcome some information contained in the 
continuous outcomes may have been lost. Further, a cut off score of 11 or 
more on the HADSA and HADSD was utilised to indicate moderate cases of 
anxiety and depression in the analysis, the results may have varied if a score of 
7 or more had been employed to delineate mild cases. This may also have 
been the case if different cut off scores had been used for distress and poor 
quality of life.  
 
Due to concerns about collinearity psychological factors were not entered 
collectively into a multivariable model for each outcome across time points. It 
was therefore not possible to assess which predictor variables were most 
important for negative adjustment outcomes or which predictors were 
redundant in the presence of others. Each psychological factor was entered 
into its own model for each outcome which was adjusted for relevant 




identify the psychological factors which remained significant when taking those 
factors into consideration (Bland, M, 2009).  
 
A further methodological consideration pertains to the relatively short time-
line between baseline and follow up in the prospective study which may have 
left little time for change and processes that are truly explanatory to become 
clear. Overall cognitive, emotional and behavioural responses to symptoms 
were important precipitating and perpetuating factors for the majority of 
negative adjustment outcomes which suggests these factors are a useful focus 
for future research.  With the exception of the fear avoidance subscale of the 
cognitive behavioural response to symptoms scale (Skerrett et al, 2006), all 
other measures of psychological variables showed an association with either 
baseline or follow up cases of anxiety, low mood, distress or poor quality of 
life. These measures therefore seem particularly useful to pursue in in future 
prospective studies which should be carried out over an extended follow up 
period.  As cognitive and behavioural responses to symptoms were not 
identified as risk factors for depression in the prospective study additional 
measures of hopelessness, self-esteem, perceptions of stigma and social 
relationships as well as dysfunctional assumptions that relate to the self should 
be considered for inclusion in future cross sectional and prospective studies. 
Further analysis might also focus on the numbers of people who were cases of 
depression and anxiety at each time point to assess the true incidence of cases 
at time 2. 
 
 The pragmatic design of the nonrandomised uncontrolled trial of clinic based 




comparison data provided and it could not be stated with any certainty 
whether the promising results were truly due to the intervention, or for 
example spontaneous recovery, therapist attention  or regression to the mean 
(Clark et al, 2008). To establish efficacy future studies would need to employ a 
randomised controlled design with either an active comparison and/or a 
control condition. As both CBT and ACT may have benefits for improving mood 
and quality of life for people with IBD, these two psychological interventions 
could be compared in an RCT.  Given the results of the non-randomised 
uncontrolled trial of clinic based CBT reported in this thesis it is essential that 
any such study recruit participants with IBD and significant levels of 
disturbance to mood. As potential participants could be randomised to one of 
two active conditions this would circumvent any ethical issues relating to 
withholding an intervention with likely efficacy from distressed individuals, if 
such a study were to be conducted in a clinical setting. RCT’s are however 
expensive, retention can be problematic and there are concerns that results 
don’t translate into clinical practice due to for example higher inclusion criteria 
(Quarmby et al, 2007).  
 
Clinic based CBT and ACT interventions could be evaluated using a non-
randomised uncontrolled trial design. Uncontrolled effect sizes could be 
calculated for each intervention and compared and potentially benchmarked 
against RCTs.  This would provide some comparison data and an indication of 
the real world impact of these intervention for people with IBD and distress 
but would supply limited evidence for efficacy. A within participants design 
maybe of utility as participants could take part in both psychological 




In this type of design participants act as their own control and this reduces the 
amount of error which can arise from natural variance between individuals. An 
advantage of this type of design is that it requires fewer participants. A 
disadvantage concerns cross over effects whereby the first intervention 
influences the second. This could potentially be addressed by counterbalancing 
whereby the sequence of the interventions is varied (Charness et al, 2012).  
 
Irrespective of the type of design selected for further evaluation of 
psychological interventions for people with IBD and significant distress, 
psychological factors which mediate change in the adjustment process should 
be evaluated. This would provide a further test of the relationships between 
cognitive, emotional and behavioural responses and adjustment outcomes, 
helping to identify which factors are most important for alleviating problems 
with mood.  A qualitative element could be also included to explore 
participants’ experience of the intervention. For a within participant design this 
could include an evaluation of the type of intervention that was preferred by 
participants. As initial disturbance to mood was identified in this thesis as a 
significant risk factor for the development of subsequent psychopathology low 
intensity CBT and ACT intervention should also be evaluated for their benefits 
for improving mood. 
  
Finally, measurements of anxiety, low mood, quality of life and disease activity 
in all of the studies reported in this thesis were based on self- report measures. 
Objective measurements of mood through structured clinical interview and 
disease activity via endoscopy and faecal calprotectin analysis would give a 




of psychological intervention (Jordan 2016). Future studies would also benefits 
from assessing objectively any changes to medication or treatment regimens 
as potentially confounding variables.  
 
Clinical implications for treatment 
The overall results of this thesis have shown anxiety, depression, general 
psychological distress and poor quality of life to be associated with a range of 
unhelpful cognitive, emotional and behavioural responses which showed some 
similarity and variation by IBD type. A particularly important finding from this 
thesis concerns the role of initial disturbance to mood and its influence on the 
subsequent development of psychopathology. The findings of the prospective 
analysis suggest that if left untreated early symptoms of anxiety and 
depression may progress into clinically significant disturbances to mood for 
both UC and CD. Early detection of disruption to mood by clinicians working 
with people with IBD may therefore be beneficial to facilitate timely referrals 
to psychological services to prevent an escalation in psychological symptoms.  
A stepped care model would be well suited to organising the provision of 
psychological services for people with IBD.  The initial step for subthreshold 
symptoms of mild to moderate disturbance to mood could include low 
intensity psychological interventions such as working through a self-help 
manual with minimal professional support. Moderate to severe anxiety and 
low mood would be offered high intensity interventions based on a cognitive 
behavioural approach (Nice, 2018). 
 




adjustment outcomes in this study showed some overlap across IBD types.  For 
example, a lack of acceptance beliefs, avoidant and safety seeking behavioural 
responses to gastrointestinal symptoms, social withdrawal and symptoms 
focusing were all significantly linked to most outcomes for both groups. There 
was however also evidence of specificity e.g. all or nothing behaviour was an 
important risk factor for negative adjustment outcomes for the CD group only. 
A flexible approach to treating symptoms of anxiety and low mood may 
therefore be of benefit. The nonrandomised uncontrolled trial of a clinic based 
CBT intervention reported in this thesis adopted a transdiagnostic CBT 
approach to target the shared cognitive and behavioural processes underlying 
the development and maintenance of emotional distress (Clarke et al, 2009). It 
did not require the therapist to determine a primary diagnosis i.e. depression 
or an anxiety disorder, as is the case with disorder specific CBT.  As a 
consequence it was arguably a more efficient way to work with patients who 
were presenting with multiple clinical problems (Mansell et al, 2008).  
 
An additional complexity in working with emotional distress in this population 
concerns the role of disease related factors. A flare up in disease activity or 
extra intestinal complications such as anaemia might have initially necessitated 
some of these responses such as resting, staying home or always knowing the 
whereabouts of toilets but once symptoms begin to subside this may be less 
useful. The findings of the qualitative study identified that feelings of anxiety 
were often triggered by the appraisal that a toilet was inaccessible rather than 
sensations arising from the bowel and this may prove to be a useful distinction 
for recognising if behavioural responses are emotion driven or necessitated by 




resting behaviour. For example, in some cases it may be driven by physical 
fatigue relating to disease factors and in others by extreme or unhelpful 
cognitions. Psychological therapists working with this population may need to 
be particularly sensitive to the motivators for a particular behaviour before 
attempting to address it in a psychological intervention to improve mood.  
 
The CBT clinic which provided the setting for the non-randomised uncontrolled 
trial reported in this thesis was located within an IBD clinical service. This was 
advantageous for the psychological therapist as it provided frequent 
opportunities to liaise directly with the clinical IBD team. Psychological services 
provided off site via improving access to psychological service provision will 
not have the benefit of such close proximity to the patients’ clinical team and 
the opportunity for collaborative working may be compromised as a 
consequence. Further, locating psychological services within an IBD clinical 
service may serve to lessen any perceived stigma in regards to seeking or 
receiving treatment for a mental health problem as it does not involve 
attending a psychiatric outpatient setting. 
 
Conclusion 
This thesis has presented a series of studies which have investigated and 
pinpointed the situations and unhelpful cognitive, emotional and behavioural 
responses associated with and predictive of anxiety, low mood, psychological 
distress and poor quality of life. Further good quality longitudinal studies are 




In addition, the benefits of a transdiagnostic clinic based CBT approach was 
considered for modifying these cognitive, emotional and behavioural 
responses to improve outcomes in this population. This series of studies has 
provided insights into how psychological interventions should be designed and 
delivered to be helpful and acceptable for people with IBD and disturbance to 
mood and quality of life. Given the established impact that anxiety and 
depression can have on the course of IBD (Mikocka et al, 2016), further tests of 
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Appendix 1: A systematic review of the psychological correlates of 
adjustment in adults with IBD. 
 
Search Terms 




The search above was completed in combination with the following 
psychosocial factors: 
Psychological adjustment   
Psychological factors    
Psychological distress    
Emotional adjustment    
Stress       
Alexithymia      
Depression      
Anxiety      
Mood       
Personality traits     
Perfectionism     
Neuroticism     
Illness perceptions     
Illness cognitions     
Illness related attitudes     






















Electronic databases searched: 










Appendix 2 :  A qualitative study exploring the experience of people with 
IBD and elevated symptoms of anxiety and low mood and the type of 




1. Symptoms of anxiety  
1. Underperformance: Work  
1. Cognitive and behavioural responses 
2. Preventing an accident  
1. Cognitive and behavioural responses 
 
1. Symptoms of low mood 
1. Lack of understanding  
1. Cognitive and behavioural responses 
2. Stigma 
1. Cognitive and behavioural responses 
 
      3.   Psychological support 





Appendix 3: A qualitative study exploring the experience of people with 
IBD and elevated symptoms of anxiety and low mood and the type of 





Interview Schedule: A qualitative study exploring the experience of people 
with IBD and elevated symptoms of anxiety and low mood and the type of 
psychological help they would like. 
 
(Version 2.1/7/11) 
An exploration of cognitions, emotions and coping strategies associated with 




Interview date:  
 
Structured interview schedule: 
How long have you had IBD? Crohn’s or colitis? 
How old where you when you were first diagnosed? 
Can you tell me what medication you take now for your bowel problems? 
Do you have any other health problems? 
What treatment are you having for these? 






Now I would like to ask you some question about how you generally feel 
about having this health problem E.g. when you are not having a flare up. 
 
What does it mean to you to have this diagnosis? What are your main 
concerns/problems?  
How does it affect your life? 
What’s the worst thing about it? (main concern) 
What thoughts go through your mind about that? What does it mean to you to 
…..? 
How much do you think your treatment helps with your bowel problems? 
How often do you experience symptoms of your bowel problems? 
How concerned are you about having these problems? 
Are there particular situations that you find difficult because of this illness? 
 Even when you are not having a flare up? What goes through you mind about 
this? What does it mean to you? 
Does it affect how you feel about your future even when you are not having a 
flare up? If so how? 
Does having this condition affect your behaviour/ what you do when you are 
not having a flare up?    
 
I would now like to ask you some questions about how you cope when you 
have symptoms. 
How does it affect you when experience symptoms? 
What situations are most difficult? 
 
What feelings or emotions do you have about these situations? 




What feelings or emotions do you have when you are having a flare up? 
How do you cope with this? What do you do?  
Is there anything you avoid doing in case you have a flare up? 
Does anyone help you? If so how? 
What help would you like? 
How does your partner/family respond when you are unwell? 
What kind of help from healthcare services would you like? 











Kings College London 





Telephone 020 7848 3285 
20/6/12 V4 PATIENT INFORMATION SHEET 




Study Title: How stress affects people with Inflammatory Bowel Disease. 
Dear        , 
 
 We would like to invite you to take part in the above mentioned research 
study. This study will explore how stress affects people with bowel problems. 
 
The study is in two parts and will involve you completing a set of 
questionnaires online at two intervals, one now (or as soon as you have the 
time to spare) and then again in 12 weeks time. These questionnaires are 
designed to ask you about how you feel, think, cope and function with your 
bowel problems.  The first set of questionnaires is available on the following 







-Before you decide, it is important for you to understand why the research is 
being done and what it will involve. Please take time to read the study 
information enclosed with this letter. Please ask us if there is anything that is 
not clear or if you would like further information. The study is being organised 
by Dr Bu’ Hayee, Consultant in Gastroenterology at King’s College Hospital NHS 
Foundation Trust in conjunction with Cheryl Jordan, lecturer at King’s College 
London. Full contact details are provided on the accompanying information 
leaflet.   



























Study Title: How stress affects people with Inflammatory Bowel Disease. 
  
20/6/12 V4 PATIENT INFORMATION SHEET 
Rec reference no: 12/lo/1510 
 
Introduction 
You are being invited to take part in a research study. Before you decide, it is 
important for you to understand why the research is being done and what it 
will involve. Please take time to read the following information carefully. Ask 
us if there is anything that is not clear or if you would like further information. 
Take time to decide whether or not you wish to take part.  
Thank you for reading this. 
 
 
What is the purpose of the study? 
Stress is sometimes associated with the experience of Inflammatory Bowel 
Diseases such as Crohn’s Disease or Colitis. So far there has been little research 
investigating how various aspects of stress affect people and the way they 
cope. Initially this study will examine the way emotions, perceptions and 
behaviours affect the symptoms and quality of life for people with bowel 
problems.  
Why have I been invited? 
You have been invited because you are over 18 years old, and attend Kings 
College Hospital for assessment or treatment of Crohn’s Disease or Ulcerative 
Colitis. We are asking 1000 patients to take part in this study. 
Do I have to take part?  
No. It is entirely up to you whether or not to take part. A decision not to take 
part will not affect the standard of care you receive now or in the future. If you 






remove your questionnaires from the study and without giving a reason. Again, 
this will not, in any way, affect the standard of care you receive. 
What will the study involve? 
This study is in two parts A & B. Part A involves you completing 11 
questionnaires, which will take approximately 25 minutes and are available 
online at the following website address:  
https://www.surveymonkey.com/s/crohnsandcolitis1 
Then in 12 weeks’ time we would like you to complete 6 of these 
questionnaires again which will take approximately 15 minutes, this is part B of 
the study. We will write to you to remind you to do this nearer the time. These 
questionnaires are designed to ask you about how you feel, think, cope and 
function with your bowel problems.  
 
For example, you will be presented with a list of the ways you might have felt 
or behaved over a certain period and asked to respond on a scale. The 
examples of the types of questions that will be asked are shown below: 
 















When I am experiencing 
symptoms it is difficult for me to 
think of anything else 
     
I think a great deal about my 
symptoms 





We would also like to know if you would be willing to potentially talk to one of 
our researchers about how you feel, think, cope and function with your bowel 
problems. If you choose to take part in this stage of the research a member of 
the research team will interview you and will ask you a variety of questions 
about your bowel problems. This will be an individual interview between you 
and researcher only, no one else will be present. You will be asked to indicate 
your choice on the first page of the website.  
 
What will happen if I take part? 
Part A: If you decide to take part, then you will be asked to visit the following 
website to complete the questionnaires online:  
https://www.surveymonkey.com/s/crohnsandcolitis1 
You will also be asked to indicate your consent to take part in this study and to 
possibly being interviewed. If you require any help or advice to complete the 
questionnaires or would prefer paper copies then please contact Cheryl 
Jordan, details below. 
 We will then send you a reminder letter 12 weeks later which will ask you to 
visit the website again and complete part B, which is made up of 6 
questionnaires.  
 
We will be inviting a small number of people for an individual interview where 
we will be asking some questions about the way you cope with your bowel 
problems. If you are interested in taking part in this stage of the study please 
indicate this on the consent form which you will be asked to complete online 
prior to completing any of the questionnaires. If you are selected for this stage 
we will write to you and arrange a convenient time and place for you to meet 
with the researcher to carry this out. It may also be possible to carry this out 
over the phone. It will take a maximum of 1 hour of your time. 
 
 
 The responses from your questionnaires and/ or interviews will be put onto a 




order to help us collect such information. This access to your notes will be for 
the purposes of this study only. Your name, and any other features that could 
identify you such as your hospital number, will NOT be included on the 
questionnaires or on the research database. We will use a ‘code’ instead that 
would link to your name on a list held separately from all the research 
information. You will be asked to enter this code when you go to the website 
to complete the questionnaires. You will find this code at the top of this letter.  
What are the possible disadvantages of taking part? 
As you are being asked about stress and other feelings you might have about 
your bowel problems, it is possible that you might feel upset when completing 
the questionnaires. If you should feel this way you can contact Cheryl Jordan 
(Cheryl.jordan@kcl.ac.uk 02078483285) to discuss this and the possibility of 
accessing longer term support.  
 What are the benefits of taking part? 
Apart from possibly identifying that you have a need for further healthcare, 
this research will have no direct benefit to you. Nevertheless, once we have 
completed our study with a sufficient number of patients, we will combine as 
much information as possible, and publish our results. In this way, research 
results will be made available to the medical and scientific community. This 
may also benefit patients with inflammatory bowel disease in the future. 
What if something goes wrong? 
In the unlikely event you are harmed by taking part in this research project, 
there are no special compensation arrangements. If you are harmed due to 
someone’s negligence, then you may have grounds for a legal action but you 
may have to pay for it. Regardless of this, if you wish to complain, or have any 
concerns about any aspect of the way you have been approached or treated 
during the course of this study, the normal National Health Service complaints 
mechanisms should be available to you. 
Will my taking part in this study be kept confidential? 
All information which is collected about you during the course of the research 
programme will be kept strictly confidential.  




We will publish the results so that as many of our findings as possible will be 
made available to the medical and scientific community. You will not be 
personally identified in any publication (i.e. your name and identity will not be 
mentioned in any report of the findings). Any data, information or quotes used 
in any publications which arise from this study will be anonymised. The timing 
of any publication will depend mostly on the speed with which we collect data 
and cannot be predicted with certainty. 
Who is organising and funding the research? 
The study is being organised by Cheryl Jordan lecturer at Kings College London 
in conjunction with Dr Bu Hayee, Consultant Gastroenterologist at Kings 
college Hospital NHS Foundation Trust.  We are not paid for including you in 
this study. 
Who has reviewed this study? 
This study has been reviewed by the National Research Ethics Service, NRES 





Florence nightingale school of nursing and midwifery 
King's College London 
James Clerk Maxwell Building 






Dr Bu Hayee 








Many thanks for reading this information sheet.  






CONSENT FORM: cohort study (20/6/12 V4) please initial all boxes  
 I confirm that I have read and understand the information sheet dated 20/6/12   version 4 
for the above study.  I have had the opportunity to consider the information, ask questions 
and have had these answered satisfactorily. 
 I understand that my participation is voluntary and that I am free to withdraw at any time 
without giving any reason, without my medical care or legal rights being affected. 
 I understand that relevant sections of my medical notes and data collected during the 
study may be looked at by individuals from Kings College London, from regulatory 
authorities or from the NHS Trust, where it is relevant to my taking part in this research.  I 
give permission for these individuals to have access to y records. 
I agree to take part in the above study. 
 
I agree to possibly being contacted again to be interviewed about how I cope with IBD. 
 
If you would prefer to be contacted by email about this and/or about when to complete the 




            
Name of Participant   Date    Signature 
           
Name of Person              Date    Signature  
taking consent.  
Centre Number:  
Study Number: 







CONSENT FORM: Interviews 
Title of Project: Stress and inflammatory bowel disease 
Name of Researcher: Cheryl Jordan 
Please initial all boxes  
 I confirm that I have read and understand the information sheet dated 20/6/12 (version 
4) for the above study.  I have had the opportunity to consider the information, ask 
questions and have had these answered satisfactorily.  
   
 I understand that my participation is voluntary and that I am free to withdraw at any time 
without giving any reason, without my medical care or legal rights being affected. 
 
 I understand that relevant sections of my medical notes and data collected during the 
study, may be looked at by individuals from Kings College London, from regulatory 
authorities or from the NHS Trust, where it is relevant to my taking part in this research.  
I give permission for these individuals to have access to my records. 
 
 I agree to take part in the above study.  
 
 I agree to the interview being audio recorded 
We assure you that all your personal information and data will remain confidential at all times during 
and after research in accordance with the Data Protection Act 1998. Any data, information or quotes 
used in any publications which arise from this study will be anonymised 
 
            
Name of Participant   Date    Signature 
                                
            
Name of Person   Date    Signature  










Consent form: CBT Trial   
Thank you for completing these questionnaires. 
The questions will ask you about how you feel, think, cope and function at the moment. 
The responses from your questionnaires will be put onto a database. Your name and any other 
features that could identify you will not be included on the questionnaires or database. We will 
use a code instead that will link your name on a list held separately from all other information. 
The scores from the questionnaires may be used as part of service evaluation and may be part of a 
research report and used in research publications but under no circumstances will names or 
identifying characteristics be included. 
 
Contact for further information 
Cheryl Jordan 
Florence Nightingale School of Nursing and Midwifery 
King's College London 
James Clerk Maxwell Building 
57 Waterloo Road 
LONDON, SE1 8WA 
Email: Cheryl.jordan@kcl.ac.uk 
If you are happy to complete the questionnaires please indicate your consent by placing your 
initials in the box below each statement. 
Therapy measures: baseline 
1. I understand that while information gained from these questionnaires may be used as part 
of service evaluation and may be part of a research report and used in research publications, 
but under no circumstances will names or identifying characteristics be included. 
 
 
2. I understand that while information gained from the questionnaires may be published, I 




3. I agree to complete the questionnaires. 
 
 
4. Please type/sign your full name in the box below to indicate your consent to taking part 







Appendix 5: Measures 
 
Patient Health Questionnaire (PHQ-9) 
 
Over the last two weeks, how often have you been bothered by any of the following problems?  
 
Little interest or pleasure in doing things?                         Not at all 0 
Several days 1  
More than half the days 2 
Nearly every days 3 
 
Feeling down, depressed, or hopeless?                Not at all 0 
Several days 1  
More than half the days 2 
Nearly every days 3 
 
 
Trouble falling or staying asleep, or sleeping too much?                  Not at all 0 
                  Several days 1  
                  More than half the days 2 
   Nearly every days 3 
 
 Feeling tired or having little energy?                                                   Not at all 0 
                Several days 1  
                More than half the days 2 







Poor appetite or overeating?                                                              Not at all 0 
             Several days 1  
             More than half the days 2 
             Nearly every days 3 
 
Feeling bad about yourself - or that you are a failure or have let yourself or your family down?  
      
Not at all 0 
Several days 1  
More than half the days 2 
Nearly every days 3 
 
Trouble concentrating on things, such as reading the newspaper or watching television? 
Not at all 0 
Several days 1  
More than half the days 2 
Nearly every days 3 
 
Moving or speaking so slowly that other people could have noticed? 
Or the opposite - being so fidgety or restless that you have been moving around a lot more than 
usual?                                                  
Not at all 0 
Several days 1  
More than half the days 2 
Nearly every days 3 
 
Thoughts that you would be better off dead, or of hurting yourself in some way? 
Not at all 0 
Several days 1  
More than half the days 2 




Generalized Anxiety Disorder 7-item (GAD-7) scale 
 
 
If you checked off any problems, how difficult have these problems made it for you to do your 
work, take care of things at home, or get along with other people? 
 














  Over the last 2 weeks, how often have you   
  been bothered by the following problems? 










1.  Feeling nervous, anxious or on edge 0 1 2 3 
2.  Not being able to stop or control worrying 0 1 2 3 
3.  Worrying too much about different things 0 1 2 3 
4.  Trouble relaxing 0 1 2 3 
5.  Being so restless that it is hard to sit still 0 1 2 3 
6.  Becoming easily annoyed or irritable 0 1 2 3 
7.  Feeling afraid as if something awful  
     might happen 




The Short inflammatory bowel disease questionnaire (SIBDQ) 
 
This questionnaire is designed to find out how you have 
been feeling during the last 2 wk. You will be asked about 
symptoms you are having as a result of your inflammatory 
bowel disease, the way you have been feeling in general, 
and how your mood has been. 
 
1. How often has the feeling of fatigue or of being tired and 
worn out been a problem for you during the last 2 wk? 
 
-All of the time 1 
-Most of the time 2 
-A good bit of the time 3 
-Some of the time 4 
-A little of the time 5 
-Hardly any of the time 6 
-None of the time 7 
 
2. How often during the last 2 wk have you had to delay or 
cancel a social engagement because of your bowel problem? 
Please choose an option from 
-All of the time 1 
-Most of the time 2 
-A good bit of the time 3 
-Some of the time 4 
-A little of the time 5 
-Hardly any of the time 6 
-None of the time 7 
 
3. How much difficulty have you had, as a result of your 
bowel problems, doing leisure or sports activities you 
would have liked to have done over the last 2 wk? Please 
choose an option from 
 
-A great deal of difficulty, activities made impossible 1 
-A lot of difficulty 2 
-A fair bit of difficulty 3 
-Some difficulty 4 
-A little difficulty 5 
-Hardly any difficulty 6 
-No difficulty; the bowel problems did not limit sports or 
leisure activities 7 
 
4. How often during the last 2 wk have you been troubled 
by pain in the abdomen? Please choose an option from 
 
-All of the time 1 




-A good bit of the time 3 
-Some of the time -A little of the time 4 
-Hardly any of the time 5 
-None of the time 6 
 
5. How often during the last 2 wk have you felt depressed 
or discouraged? Please choose an option from 
 
-All of the time 1 
-Most of the time 2 
-A good bit of the time 3 
-Some of the time 4 
-A little of the time 5 
-Hardly any of the time 6 
-None of the time 7 
 
6. Overall, in the last 2 wk, how much of a problem have 
you had passing large amounts of gas? Please choose an 
option from 
 
-A major problem 1 
-A big problem 2 
-A significant problem 3 
-Some trouble 4 
-A little trouble 5 
-Hardly any trouble 6 
-No trouble 7 
 
7. Overall, in the last 2 wk, how much of a problem have 
you had maintaining or getting to the weight you would 
like to be? Please choose an option from 
 
-A major problem 1 
-A big problem 2 
-A significant problem 3 
-Some trouble 4 
-A little trouble 5 
-Hardly any trouble 6 
-No trouble 7 
 
8. How often during the last 2 wk have you felt relaxed and 
free of tension? Please choose an option from 
 
-None of the time 1 
-A little of the time 2 
-Some of the time 3 
-A good bit of the time 4 
-Most of the time 5 




-All of the time 7 
 
9. How much of the time during the last 2 wk have you 
been troubled by a feeling of having to go to the toilet 
even though your bowels were empty? Please choose an 
option from 
 
-All of the time 1 
-Most of the time 2 
-A good bit of the time 3 
-Some of the time 4 
-A little of the time 5 
-Hardly any of the time 6 
-None of the time 7 
 
10. How much of the time during the last 2 wk have you felt 
angry as a result of your bowel problem? Please choose 
an option from 
 
-All of the time 1 
-Most of the time 2 
-A good bit of the time 3 
-Some of the time 4 
-A little of the time 5 
-Hardly any of the time 6 


















A simple index of Crohn’s-disease activity (HBI) 
Please circle the score which most represents your symptoms over the last 24 hours; 
 
1. General well-being (yesterday) 
Very well = 0 
Slightly below par = 1 
Poor = 2 
Very poor = 3 
Terrible = 4 
 
2. Abdominal pain 
(yesterday) 
None = 0 
Mild = 1 
Moderate = 2 
Severe = 3 
 
3. Number of liquid or soft stools per day (yesterday) = ____________________ 
 
4. Abdominal mass 
None = 0 
Dubious = 1 
Definite = 2 
Definite and tender = 3 
 
5. Complications 
(check any that apply; score one 



















Simple Clinical Colitis Activity Index (SCCAI). 
 
Please circle the score which most represents your symptoms over the last 24 hours; 
 
1. (a). 
How many bowel motions have you been passing during the daytime i.e. from waking up till going 
to bed to sleep for the last 3 days? 
 
1 -3 times 0 Points  
4-6 times 1 Point 
7-9 times 2 Points 
>9 times 3 Points 
 
1. (b). 
How many bowel motions have you been passing 
during night time, i.e. after going to bed, for the last 3 nights? 
 
1-3 times 1 Point 




What degree of Urgency of defecation do you experience? 
i.e. When you feel the need to open your bowel, how quickly do  
you need to go? 
 
I have no urgency at all (i.e. just as normal)   0 Points  
I have to hurry to the toilet                                1 Point 
I have to go immediately                                  2 Points                         
have incontinence (unable to control the urge and had an accident)       3 points  
 
3. 
How much blood has been in your stool? 
 
None        0 Points 
Trace (a hint or a tiny amount)     1 Points 
Moderate (occasional obvious/ blood)     2 Points   
Severe (Usually obvious/frank blood)      3 Points  
 
4. 
General wellbeing –How do you feel about your general health? 
Very well       0 Points 




Poor        2 Points 
Very poor       3 Points 





Do you have any of the following symptoms apart from your bowels? 
 
(a).  Joint problems              1 Point 
(b).  Eye problems               1 Point 
(c). Mouth problems          1 Point 
(d)Skin problems                 1 Point 
(e) Do you have any tender, hot and red bumps which most often affect the skin on the shins, 
arms and legs ?               1 Point 
(f) Perianal problems: Do you have any tears or breakdown 
(crack/ cleft) in the skin of the anus or tender lumps (abscesses)  




























The Irritable Bowel Syndrome-Behavioural Responses 
Questionnaire (IBS-BRQ) 
 
Please consider each question and mark the choice that 
best applies to you with an ‘×' in the appropriate box, from 1 (never) to 7 (always) 
 1 2 3 4 5 6 7 
I eat specific foods to help me open my 
bowels more 
 
       
I eat specific foods to help me open my 
bowels less 
 
       
I strain when opening my bowels 
 
       
After opening my bowels I check for blood 
 
       
After opening my bowels I check my stool 
for abnormalities 
       
I spend more time on the toilet than I ideally 
would like 
       
I often go to the toilet to open my bowels and 
then do not pass anything 
 
       
I often go to the toilet to pass water and find I 
open my bowels 
 
       
I avoid exercise when I have stomach pains         
I avoid certain foods when I have bowel 
problems 




I wear baggy clothing when my stomach feels 
bloated or distended 
       
I avoid going out in case I have problems with 
my IBD 
 
       
I avoid making plans in case I have problems 
with my IBD 
       
I carry other items (e.g.: wet wipes, sanitary 
towels, spare underwear) in case my IBD 
flares up 
 
       
I take medication (e.g.: before going out) just 
in case my IBD flares up 
 
       
I carry medication with me in case my IBD 
flares up 
 
       
I avoid sex in case my IBD flares up (and 
causes embarrassment) 
 
       
When I go out I make sure I know where the 
nearest toilet is 
 
       
I ask for reassurance about my IBD 
 
       
I avoid certain work situations (e.g. meetings) 
because of my IBD 
 
       
I avoid certain social situations (e.g. 
restaurants) because of my IBD 
 
 

















I avoid certain foods (e.g. dairy products, spicy 
foods) because of my IBD 
 
       
After I open my bowels I wipe more than I 
would like 
 
       
When I have diarrhoea I do things to ease it 
(e.g. take 
prescribed medication, take alternative 
medication)  
 
       
I am constantly aware of my stomach 
 
       
I avoid staying away from home overnight in 
case my IBD flares up 
 





Hospital Anxiety and Depression Scale (HADS) 
Tick the box beside the reply that is closest to how you have been feeling in the past 
week. Don’t take too long over you replies: your immediate is best. 
  
A I feel tense or 'wound up':   
  Most of the time 3 
  A lot of the time 2 
  From time to time, occasionally 1 
  Not at all 0 
  
D 
I still enjoy the things I used to 
enjoy: 
  
  Definitely as much 0 
  Not quite so much 1 
  Only a little 2 
  Hardly at all 3 
  
A 
I get a sort of frightened feeling 
as if something awful is about to 
happen: 
  
  Very definitely and quite badly 3 
  Yes, but not too badly 2 




  Not at all 0 
 D 
I can laugh and see the funny 
side of things: 
  
  As much as I always could 0 
  Not quite so much now 1 
  Definitely not so much now 2 
  Not at all 3 
  
A 
Worrying thoughts go through 
my mind: 
  
  A great deal of the time 3 
  A lot of the time 2 
  
From time to time, but not too 
often 
1 
  Only occasionally 0 
  
D I feel cheerful:   
  Not at all 3 
  Not often 2 
  Sometimes 1 







I can sit at ease and feel 
relaxed: 
  
  Definitely 0 
  Usually 1 
  Not Often 2 
  Not at all 3 
  
D I feel as if I am slowed down:   
  Nearly all the time 3 
  Very often 2 
  Sometimes 1 
  Not at all 0 
  
A 
I get a sort of frightened feeling 
like 'butterflies' in the stomach: 
  
  Not at all 0 
  Occasionally 1 
  Quite Often 2 







I have lost interest in my 
appearance: 
  
  Definitely 3 
  
I don't take as much care as I 
should 
2 
  I may not take quite as much care 1 
  I take just as much care as ever 0 
  
A 
I feel restless as I have to be on 
the move: 
  
  Very much indeed 3 
  Quite a lot 2 
  Not very much 1 
  Not at all 0 
  
D 
I look forward with enjoyment 
to things: 
  
  As much as I ever did 0 
  Rather less than I used to 1 
  Definitely less than I used to 2 






A I get sudden feelings of panic:   
  Very often indeed 3 
  Quite often 2 
  Not very often 1 
  Not at all 0 
  
D 
I can enjoy a good book or radio 
or TV program: 
  
  Often 0 
  Sometimes 1 
  Not often 2 






Beliefs about Emotions scale (BES).  
 
Please tick the column that best describes how you think. Please note that because people are 
different, there are no right or wrong answers to these statements. To decide whether a given 
















1. It is a sign 
of weakness 




       






       
3. If I lose 





less of me 
 
       





       








to put on a 
brave face. 
 







       







       
8. I should be 
able to cope 
with 
difficulties 





       









       










11. It would 






       
12. Others 
expect me to 
always be in 
control of my 
emotions 
 






CHRONIC PAIN ACCEPTANCE QUESTIONNAIRE (CPAQ).  
 
Below you will find a list of statements. Please rate the truth of each statement as it applies 
to you. Use the following rating scale to make your choices. For instance, if you believe a statement 
is ‘Always True,’ you would write a 6 in the blank next to that statement.  
 
0  
Never true           
 
       1     
Very 
rarely true                      
        2 
Seldom 
True           
        3  
Sometimes 
true 
          4                  
Often true   
        5    
Almost 
Always 
true             





_____ 1. I am getting on with the business of living no matter what my level of symptoms   
 is.  
_____ 2. My life is going well, even though I have symptoms.  
_____ 3. It’s OK to experience symptoms. 
 _____ 4. I would gladly sacrifice important things in my life to control my symptoms  
 better. 
 _____ 5. It’s not necessary for me to control my symptoms in order to handle my life well.  
_____ 6. Although things have changed, I am living a normal life despite my symptoms.  
_____ 7. I need to concentrate on getting rid of my symptoms. 
 _____ 8. There are many activities I do when I have symptoms.  
_____ 9. I lead a full life even though I have symptoms. 
 _____ 10. Controlling my symptoms is less important than any other goals in my life. 
 _____ 11. My thoughts and feelings about symptoms must change before I can take 
   important steps in my life. 
 _____ 12. Despite the symptoms, I am now sticking to a certain course in my life. 
 _____ 13. Keeping my symptoms under control takes first priority whenever I’m doing 
                   something. 
_____ 14. Before I can make any serious plans, I have to get some control over my  
 symptoms.  




_____ 16. I will have better control over my life if I can control my negative thoughts 
                  about my symptoms. 
 _____ 17. I avoid putting myself in situations where my symptoms might increase.  
_____ 18. My worries and fears about what symptoms will do to me are true.  
_____ 19. It’s a great relief to realize that I don’t have to change my symptoms to get on  
 with life 



























Cognitive behavioural responses to symptoms questionnaire 
(CBRQ). 
 
Please indicate how much you agree or disagree with the following statements about your 
















I am afraid 
that I will 
make my 
symptoms 
worse if I 
exercise 






















going on in 
my body 















my body is 
telling me 









     












     




     
My 
symptoms 
are always at 
the back of 
my mind 
     





     
I tend to 
overdo 
things when 











     
I tend to 
overdo 
things and 
then rest up 
for a while 
     




     





     
I sleep when 

















Appendix 6: :  Cognitive behaviour therapy for distress in 
people with Inflammatory Bowel Disease: A bench marking 
study 
The template for intervention description and replication checklist and guide 
(TIDieR) 
Item  Location of information 
1) Brief Name of the intervention) Pg. 199  paragraph 1 
2) Why ( rationale, theory or goal of 
intervention ) 
Pg. 199 paragraph 1  
Pg. 202 paragraph 2 
 
3) What: Materials utilized  
4) What : Procedure followed 
Pg. 202 paragraph 2 
Pg. 203 paragraph 1 
5) Who provided: Pg. 204 paragraph 1 
6) How: modes of delivery Pg. 202 paragraph 1 & 2 
7) Where: Location of where intervention 
occurred. 
Pg.  196 paragraph 3 
Pg.197 paragraph 1 
 
8) When and how much; no of sessions, time 
scale. 
Pg. 203 paragraph 1  
 
9) Tailoring of intervention        Pg.  202 paragraph 2 
Pg.  203 paragraph 1 
10) Modifications The intervention was not modified during the course 
of the study 
11) How well; Planned (intervention 
adherence.  
Not assessed  
 
